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Abstract 
This thesis applies inorganic chemistry to develop new nanoparticulate vaccine adjuvants, 
entities added to a vaccine to inculcate robust immunity. The Introduction sets out the 
background to this work, and the Experimental Methods chapter reviews the techniques 
applied. 
Chapter 3 then reports the preparation of AlO(OH) using a continuous hydrothermal synthetic 
pathway – with sub-100 °C temperatures and atmospheric pressure – to produce nanoscale 
particles. A variety of experimental parameters was explored, and some degree of particle 
engineering could be achieved albeit over a narrow range of sizes and shapes. There was some 
evidence of particle size influencing the response of macrophages to the samples. 
Chapter 4 and Chapter 5 aim to engineer the size and shape of hydroxyapatite and zinc oxide 
nanoparticles, respectively, through different continuous hydrothermal processes. Several 
different morphologies (spheres, and mixtures of spheres/rods/platelets) could be produced. 
The morphology and particle size appear to affect cytokine production in vitro. 
Chapter 6 explores layered double hydroxides (LDHs) as inorganic adjuvants. A series of 
materials were prepared and characterised, and the effect of changing the LDH chemical 
composition on adjuvanticity determined. It was found that the size of the guest anion 
influences the immune response. Further, computational models were developed to aid the in 
silico prediction of immunogenicity, with calculated energy values being a suitable proxy for the 
zeta potential.  
The related hydroxy double salt (HDS) materials are investigated as adjuvants in Chapter 7. A 
series of materials was prepared and their chemical composition found to markedly effect the 
immune response in vitro. Computational models were sought with the same in silico aim as the 
LDH materials, however with limited success owing to a lack of detailed structural knowledge in 
the literature. 
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Finally, overarching conclusions and suggestions for the future outlook of this area of research 
are given in Chapter 8.  
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1.1 Immunity and Vaccination 
1.1.1 Preamble 
Vaccination is perhaps the most effective public health intervention of all time. It is estimated 
that some three million lives per year are saved as a result of vaccines. They allow infectious 
diseases to be controlled or even completely purged from countries: for instance, 10 Asian 
nations including India, Bangladesh and Sri Lanka have very recently been declared free of polio 
[1]. In favourable cases diseases may be eradicated, as in the case of smallpox. There exist a 
range of other disease prevention schemes including screen and treat (which screens an 
individual for a certain condition and if a positive result is obtained provides medication 
immediately), aggressive treatment regimens (targeting diseases through intensive courses of 
medication) and widespread anti-viral distribution (such as the stockpiling of oseltamivir for the 
swine-flu epidemic in 2009), all of which can be effective: for instance, screen and treat has 
successfully been used against cervical cancer [2]. However, vaccination is in general a more 
cost-effective and safer route for controlling the spread of disease [3]. In vaccination, we aim to 
expose the immune system to the infectious agent (the “antigen”; a bacterial or viral 
component) in a safe environment where there is minimal risk of an infection ensuing. This is 
akin to footballers training before a match.  
Vaccination programmes can only achieve their maximum protection potential if the majority of 
the population are inoculated against a particular infectious disease. This concept is commonly 
referred to as “herd immunity”. There is a threshold percentage of the population that must be 
inoculated in order to contain the spread of infections; this target vaccination level is dependent 
on factors including infectivity of the disease and the length of the infectious period [4]. With 
effective herd immunity, infection rates even amongst unprotected individuals are extremely 
low, due to the reduced pool of susceptible hosts available for pathogen reproduction and 
dissemination. 
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1.1.2 Innate and Adaptive Immunity 
The human immune system consists of two major arms:  innate and adaptive. Innate immunity 
is triggered by evolutionary-conserved pathogen components (pattern-associated molecular 
patterns, PAMPs) and/or by other forms of danger, including cell stress and damage (damage-
associated molecular patterns, DAMPs). The response is rapid but restricted to a relatively 
confined array of fixed (germline-encoded) specificities. 
Adaptive immunity rests on the clonal (each cell has a single specificity) expression of T cell and 
B cell receptors (TCRs/BCRs). These receptors are generated with an extraordinary number of 
specificities (calculations suggest a theoretical diversity of ca. 1015  forms for the human αβ TCR 
[5], and attempts to assess actual diversity produce estimates from 2.5 × 107 to 2.5 × 108 forms 
[6-8]) using a mechanism which involves the somatic recombination of gene elements and the 
addition and deletion of nucleotides at certain junctions [9]. This diversity of specificity allows 
adaptive immunity to mount an exquisitely targeted attack, but cells specific for a previously 
unencountered threat will tend to be extremely rare: as a result, the expansion of antigen-
specific T and B cells imposes a lag on the development of an effective response.  This lag phase 
is greatly reduced in a ‘memory’ or ‘recall’ response on the second or subsequent encounter 
with an antigen, with greatly accelerated response kinetics being due to the persistence of 
memory T and B cells. These are present at increased frequencies and have lower activation 
thresholds than naïve (antigen-inexperienced) cells [10]. Long-lived (antibody-producing) 
plasma cells may also persist long after pathogen clearance, maintaining specific antibody levels 
[11]. To provide protection a vaccine must, therefore, generate a pool of memory B and T cells, 
and/or long-lived plasma cells. 
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The key cells involved in the innate and adaptive immune response are detailed in Table 1.1.  
Dendritic cells (DC) are the primary activators of naïve T cells [12], and as such are particularly 
important  in the generation of an adaptive response. They also play a role in determining the 
nature of the T cell response [13], which, in turn, largely determines whether the adaptive 
response is appropriately tailored towards effectively combatting a given infection. 
Table 1.1: A brief summary of the key cells of immunity. 
Immune cell Description 
Dendritic cell (DC) Key antigen-presenting cell. DCs are stationed throughout the body and 
constantly sample their local environment. If a foreign body is detected, 
then the DC can migrate to the lymph nodes for presentation of antigen 
to naïve T cell populations. 
Macrophage (MØ) An antigen presenting cell whose main purpose is to engulf pathogens 
through phagocytosis. 
Monocytes A circulating phagocyte which can migrate into the tissues and 
differentiate into macrophages or dendritic cells. 
T cell Express T cell receptors (which recognise antigenic peptides bound to 
major histocompatibility complex [MHC] proteins, presented on the 
surface of other cells). T helper (Th) cells (typically CD4+) assist other 
cells in an immune response, including accelerating the maturation of B 
cells, and activating macrophages and cytotoxic T cells. Cytotoxic T 
lymphocytes (CTL, typically CD8+) destroy virally infected cells and 
cancerous cells. 
B cell Express B cell receptors (membrane-bound antibodies), and can 
differentiate into antibody-secreting plasma cells.  
DCs and macrophages are antigen presenting cells (APCs), meaning that they can take up antigen 
from their environment and process it for presentation to T cells. Antigens taken up by DCs are 
partially degraded in endosomes (internal membrane-bound compartments) into fragments 
which are then expressed on the cell surface on major histocompatibility complex class-II (MHC-
II) receptors. The resultant MHC-II/peptide complex presents antigen to CD4+ T cells.  
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Immature DCs that internalise antigen at the non-lymphatic exposure sites are only weakly 
capable of stimulating T cell activation; they first must undergo a maturation process which 
results in elevated surface expression of the co-stimulatory molecules CD80 and CD86 (see 
Figure 1.1). When they mature, DCs also secrete greater amounts of cytokines (Figure 1.1). 
Depending on the cytokine composition, a Th1 or Th2 response can be initiated, a process known 
as T cell polarisation. Th1 responses are effective against viral and intracellular infections, whilst 
Th2-type responses aid against extracellular bacterial and gastrointestinal nematodes [14]. The 
two are also known as cell-mediated (Th1) and humoral (Th2) immunity, respectively. The 
activation of cytotoxic T-lymphocytes (CTLs) occurs similarly, but with antigenic peptide being 
presented on the MHC-I receptor, and a requirement (for naïve CTLs) for “help” from Th cells. 
Figure 1.1: Schematic representation of immune cell maturation, have increased expression of cell 
surface markers (red semi-circles) such as CD86, CD80, and Major Histocompatibility Complex (MHC) I/II 
as well as increased production and subsequent secretion of cytokines such as IL-6, IL-12 and IL-1β (green 
hexagons).  
An ideal vaccine would stimulate a strong immune response of a class appropriate to the 
pathogen. For example, a Th1-type response will drive a potent CTL response and (through 
interferon [IFN]-γ production) promote macrophage activation, useful weapons against 
intracellular pathogens [10, 15]. Th2-type responses induce strong antibody responses via 
production of interleukin (IL) molecules such as IL-4, IL-5 and IL-13 [14]. 
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Further details on the mammalian immune system are available in recently published 
immunology textbooks [10, 16]. 
1.1.3 Vaccine Types and Classifications 
Vaccines may be classified by their intended purpose (prophylactic vs. therapeutic and 
immunogenic vs. tolerogenic); by the nature of antigen delivered (principally live attenuated, 
inactivated or subunit); or by the adjuvant they incorporate (discussed in Section 1.1.4). The role 
of the adjuvant is to increase the immune response induced by the administration of the 
antigen. 
Prophylactic vaccines are given to healthy individuals to provide protection, whereas 
therapeutic vaccines exploit the immune system to treat a pre-existing condition. Prophylactic 
vaccines are universally designed to be immunogenic, whereas therapeutic vaccines include 
both immunogenic (e.g. against tumours) [17] and tolerogenic vaccines (which are intended to 
resolve autoimmune diseases or allergies through restoring tolerance to 
autoantigens/allergens) [18]. 
Live attenuated vaccines contain a live form of disease-causing organism that has been rendered 
non-virulent (unable to cause disease), typically by repeated passage in vitro [10]. Their main 
advantage is the induction of strong cellular and antibody-mediated immune responses, which 
can result in the inculcation of lifelong immunity to the pathogen of interest in one or two doses 
[19]. For instance, this is true for the viral vaccine against measles, mumps and rubella [20]. 
However, there is a risk of an attenuated pathogen reverting to its virulent state, in which case 
it may cause disease in the recipient or render them an asymptomatic carrier. This can, for 
instance, occur with the polio vaccine [21]. 
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Inactivated vaccines contain chemical-, heat-, or radiation-killed pathogen; they are, therefore, 
safer than live attenuated vaccines in that there is no chance of the reversion to virulence 
provided care is taken to ensure complete inactivation. Inactivated vaccines tend to stimulate 
weaker (and predominantly antibody-mediated) responses than live attenuated vaccines, so 
most such formulations require multiple doses [22] and the use of adjuvants to induce sustained 
protective immunity [10].  
Subunit vaccines contain defined protective component(s) from the disease-causing agent, for 
instance a polysaccharide viral capsid component or an immunogenic peptide [23, 24], which 
may be produced in recombinant form or isolated from pathogen lysate.  Alternatively, DNA 
encoding a peptide antigen may be inoculated (“DNA vaccination”) [25]. A subunit vaccine, 
therefore, exposes the immune system to antigen(s) without the risk of infection associated with 
live attenuated or (to a lesser extent) inactivated vaccines [26], providing an improved safety 
profile and the possibility of administration to immunocompromised recipients. A further 
advantage is that the defined nature of subunit antigens should permit the rational design of 
advanced vaccines, although this remains one of the major challenges in vaccinology [27, 28]. 
However, most purified antigens have limited intrinsic immunogenicity so that, as with 
inactivated vaccines, subunit vaccines usually need multiple doses and the incorporation of an 
adjuvant to induce a sufficient response [10]. Both inactivated and sub-unit vaccines tend to 
stimulate antibody-mediated rather than cellular immunity, though this may be a result of the 
adjuvants used in current vaccines [29]. 
A range of other vaccine types have been described, including conjugate vaccines; recombinant 
vector vaccines; and toxoid vaccines. These are all essentially variations on either subunit or 
DNA vaccines, as described above. 
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1.1.4 The Adjuvant 
If antigens are used alone in a formulation, subunit vaccines typically have low immunogenicity. 
To ensure robust immunity, a second component known as an “adjuvant” needs to be added to 
the formulation. This helps the immune system to recognise the presence of a foreign body and 
acts to stimulate the immune response to it. Adjuvants are also generally needed for inactivated 
vaccines, but attenuated vaccines usually do not need to be adjuvanted. 
An ideal adjuvant would be cheap to manufacture, safe to administer, provide life-long immunity 
and elicit the desired immune response (either humoral, cell-mediated, or both) [30, 31]. At the 
present time, very few adjuvants are licensed for use in humans: see Table 1.2. 
Table 1.2: Adjuvants in vaccines currently licensed for human use [32, 33]. 
EMA-approved vaccine adjuvants FDA-approved vaccine adjuvants 
MF59  
AS03 AS03 
AS04 AS04 
Virosomesa Virosomesa 
Aluminium-containing compounds Aluminium-containing compounds 
a Antigens are present as virosomes in Cervarix and Gardasil, but these vaccines also contain AS04/Alum 
(respectively) as adjuvants. EMA = European Medicines Agency. 
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By far the most widely used adjuvant is “alum”, an inorganic salt first identified as potent by 
Glenny in 1926 [34, 35]. However, other metal salts, such as calcium phosphate (CaP), have also 
been used – for instance, in diphtheria-pertussis-tetanus vaccines in France [36-38] – and there 
is a significant research effort underway to look at other inorganic systems. MF59 and AS03 are 
oil-in-water based adjuvants. Virosomes (otherwise known as virus-like particles) are 
nanoparticles designed to mimic the outer surface of a virus, yet not containing any RNA or DNA 
and hence having no virulence. AS04 is a mixture of alum and monophosphoryl lipid A (MPL-a). 
MPL-a is an attenuated form of lipopolysaccharide (LPS), a component of bacterial cell walls. 
Since it contains alum, I will touch on AS04 in the discussion that follows. 
1.2 Inorganic Adjuvant Systems 
1.2.1 Alum 
“Alum” is used by chemists to refer to materials with the formula KAl(SO4)2·12H2O or 
[NH4+][Al(SO4)2]·12H2O. Immunologists, in contrast, use the term “alum” to refer to all 
aluminium-containing adjuvants. The alum of immunologists is typically poorly defined in terms 
of its chemical and physical properties – it is not unusual to receive a sample from a supplier 
labelled “Al(OH)3 solution” where a cursory visual inspection reveals it to be a suspension rather 
than a solution, and where a minimal characterisation suggests that there is in fact very little 
Al(OH)3 present at all. For these reasons, alum is often referred to as “immunologist’s dirty little 
secret” [39]. 
In fact, most commonly “alum” comprises either aluminium oxyhydroxide [AlO(OH)] or 
aluminium hydroxyphosphate [Al(OH)x(PO4)y]. AlO(OH) is a crystalline layered material, the 
surface of which comprises only hydroxyl groups. Its structure is depicted in Figure 1.2. In 
contrast, Al(OH)x(PO4)y is an amorphous material with both hydroxyl and phosphate groups on 
the particles surfaces [40]. 
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Figure 1.2: The structure of AlO(OH). AlO6 octahedra are shown in green. Hydrogen atoms are omitted 
for clarity. 
For most of the time which has elapsed since their first use nearly 90 years ago, aluminium-
containing adjuvants have been the only licensed adjuvants for use in human vaccines: only in 
1997 was the first vaccine containing an alternative adjuvant licensed (in Italy) [41]. Aluminium-
containing adjuvants are used in a wide variety of vaccines, such as those for diphtheria, tetanus 
and pneumococcal infections [33]. They promote a Th2 response, and so can be effective for 
targeting extracellular pathogens, but are much less useful for vaccination against intracellular 
pathogens and tumours. 
It should be noted that the use of “Imject alum” is frequently reported in in vivo studies in the 
literature. This is chemically quite distinct from the aluminium-containing adjuvants used in 
human and veterinary medicine. Imject alum consists of 40 mg mL-1 crystalline magnesium 
hydroxide and 40 mg mL-1 amorphous aluminium hydroxide. Magnesium ions exert an effect on 
immune and inflammatory responses [42], and have also been shown selectively to block 
calcium-ion channels resulting in the inhibition of macrophage activation and an anti-
inflammatory response [43]. The composition of Imject alum is such that it is not recommended 
for use in research aimed at elucidating the mode of action of adjuvants in licenced human 
vaccines [44], nor should it be used for research into the effects of aluminium oxyhydroxide or 
aluminium hydroxyphosphate [45]. 
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1.2.1.1 Adsorption of Antigen to Alum 
Alum and antigen are typically admixed in vaccine formulations, and it is thus vital to consider 
how the two components might interact to understand formulation efficacy. Antigen adsorption 
refers to the adhesion of antigen to the surface of an adjuvant via interactions between the two 
entities. In vaccine prophylaxis, antigen adsorption provides a means of delivering the antigen 
to the recipient for induction of an immune response. There are two main antigen adsorption 
mechanisms: electrostatic interactions and ligand exchange, both of which are discussed further 
below. 
Crystalline AlO(OH) has a point of zero charge ranging between pH 7.7 and 9.4 [46]. Therefore, 
at physiological pH, it carries a positive charge. In contrast, amorphous aluminium 
hydroxyphosphate has a point of zero charge at around pH 4, and thus at physiological pH carries 
a negative charge. Seeber et al. provided experimental evidence for electrostatic interactions 
being involved in protein adsorption to alum by studying AlO(OH), Al(OH)x(PO4)y, lysozyme and 
albumin [47]. Lysozyme has an isoelectric point (pI) of 11 [48], while the equivalent value for 
albumin is 4.8 [49]. The two proteins thus at physiological pH carry positive and negative 
charges, respectively. Positively charged AlO(OH) strongly adsorbed the negatively charged 
albumin, but no lysozyme adsorption was recorded. The inverse was shown to be true for the 
negatively charged Al(OH)x(PO4)y. These results were ascribed to the different electrostatic 
interactions in the systems, as depicted in Figure 1.3.  
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Figure 1.2: A schematic illustrating possible electrostatic interactions between protein antigens and Al-
based adjuvants. The isoelectric point (IEP) describes proteins whilst the point of zero charge (PZC) refers 
to mineral adjuvants. If the antigen and adjuvant carry opposite charges at physiological pH then there 
will be electrostatic attractions and binding between them. OVA = ovalbumin, AH = aluminium 
hydroxide, LYS = lysozyme, AP = aluminium phosphate. Reproduced from ref [44]. Copyright Harm 
HogenEsch. 2013. 
Another mechanism of antigen adsorption is ligand exchange; this provides direct covalent 
bonding between the antigen and adjuvant, and thus leads to stronger antigen binding than 
electrostatic bonding. Ligand exchange arises if the antigen is phosphorylated because these 
phosphate groups can displace hydroxides bound to aluminium [50, 51]. It has been reported 
that antigen adsorption through either ligand exchange or electrostatic interactions can be 
sufficient to induce an immune response [52]. 
Thirty-seven years ago, Edelman postulated that adjuvanticity might be dependent on complete 
adsorption of antigen to the adjuvant surface [30]. Taken with the more recent results of Seeber 
et al. (discussed above) [47], this suggests that adjuvant selection should be dependent on the 
physiological behaviour of both the adjuvant and the antigen. Upon administration of the 
vaccine, it may be necessary for the adsorbed antigen to be eluted from the surface of the 
adjuvant in order to induce an immune response. 
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However, it has also been shown that particulate adjuvants can be internalised by DC [53], and 
hence elution may not be an absolute requirement or may occur intracellularly. Antigen elution 
certainly can occur, however, as demonstrated by Iyer and colleagues, who adsorbed ovalbumin 
and dephosphorylated α-casein antigens to aluminium hydroxide and injected the admixtures 
subcutaneously to BALB/c mice [54]. Their results demonstrated that both ovalbumin and 
dephosphorylated α-casein eluted completely upon exposure to the interstitial fluid. Seeber et 
al. have additionally proposed that citrate ions in interstitial fluids cause dissolution of the 
adjuvant, subsequently freeing the antigen into solution [55].  
Recent studies have cast doubt on to what degree of antigen adsorption is desirable, however. 
Hansen and co-workers demonstrated that if the antigen is too strongly adsorbed to the 
adjuvant surface, the immune response can be impaired [56]. In this study, α-casein and 
dephosphorylated α-casein were adsorbed to aluminium hydroxide based adjuvants with 
different surface hydroxyl concentrations, and antibody titres in mice found to be inversely 
correlated with the strength of adsorption. In addition, non-adsorbed antigen has been shown 
to elicit an immune response in vivo. Romero-Mendez et al. tested three antigen-alum 
formulations containing a commercial aluminium hydroxyphosphate based adjuvant (Adju-
Phos®) in mice [57]. They found that the antibody titres were similar regardless of whether the 
antigen was adsorbed to the Adju-Phos® or not. Results from electron microscopy highlighted 
that the adjuvants create porous aggregates with the non-adsorbed antigen entrapped in the 
pores. This was found in in vitro studies to allow effective antigen uptake by DC. A range of other 
studies have cast doubt on the need for antigen absorption onto alum, with similar antibody 
titres observed both with and without adsorption [53, 58, 59].  
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In an extreme example, Flebbe and Braley-Mullen have given antigen and alum in separate 
injections and found that separate injections induced higher antibody titres than the antigen 
administered alone [60]. However, it should be noted that other studies reported that no 
immune response was initiated following separate antigen/alum injections [53, 61]. More 
recently, some authors have suggested that it is in fact favourable to have minimal interactions 
between alum and the antigen for anthrax vaccination [62], and also in the hepatitis B setting 
[63]. One reason for this might be that antigens are thought to be less stable when adsorbed to 
alum than when in solution [64], because in the former setting there is an increased 
susceptibility to physical and chemical degradation [65, 66]. Two recent reviews discuss these 
challenges in detail and posit future formulation strategies to maximise vaccine efficacy [67, 68]. 
1.2.1.2 Activation of the Immune System by Alum-Adsorbed Antigen 
Vaccines are injected at non-lymphatic sites, where antigen desorption from the surface of 
aluminium-containing adjuvants is thought to occur in the interstitial fluid [47, 53, 54, 57, 69, 
70]. Whether desorbed or not, antigen must enter the lymphatic system in order to reach the 
lymph nodes and then stimulate naïve B and T cells [71]. Antigenic particles less than 30 nm in 
size can enter into the lymph node as free antigen; however, larger antigenic species (e.g. 
antigen adsorbed to a particulate adjuvant) must be internalised by resident DCs to be delivered 
to the lymph node and be presented to naïve B and T cells for induction of a primary immune 
response [72]. 
Particle size thus significantly impacts how an antigen enters the lymphatic system: this is 
illustrated in Figure 1.4. Particles of sizes 20 – 1000 nm are taken up by cells (either by DC 
themselves or by cells which may then be phagocytosed by DC). Antigens ranging between 1 
and 30 nm can either pass through between the cellular wall of the lymphatic system for DC 
internalisation or pass straight into the lymph node as free antigen. All these routes ultimately 
deliver antigen to naïve B- and T cell populations for induction of an immune response. 
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Figure 1.2: A schematic representation of antigen delivery to the lymphatic system depending on the 
size of the antigen. Reproduced with permission from ref [73]. Copyright Macmillan Publishers Ltd 2013. 
There are three key pathways in which DC may take up antigen from their local environment: 
macropinocytosis, receptor-mediated endocytosis and phagocytosis [74]. A schematic 
representation of these pathways is given in Figure 1.5. 
 
Figure 1.2: A schematic representation of the main pathways in which antigen may be taken up by 
dendritic cells. (a) Phagocytosis, in which a dendritic cell (DC) engulfs solid particles and entraps them 
in an intracellular vesicle; (b) Macropinocytosis, in which extracellular fluid is internalised by 
invaginations of the cell membrane for entrapment in a vesicle within the DC; (c) Endocytosis, a process 
by which cells internalise particles of size 60 - 120nm from the extracellular environment and 
encapsulate them in a vesicle. Reproduced with permission from ref [75]. Copyright Macmillan 
Publishers Ltd 2010. 
A D C B 
Chapter 1 Introduction 
 
47 
 
Experimental evidence supports the idea that the DC-uptake route of the antigen can affect its 
presentation. Burgdorf and colleagues showed that endocytosis of the model antigen ovalbumin 
(OVA) by DCs results in the antigen being presented on the surface by major histocompatibility 
complex (MHC)-I co-stimulatory molecules. This leads to the activation of CD8+ cytotoxic T cells 
[76]. In contrast, if the DC internalises OVA via micropinocytosis, then the antigen will be 
presented on MHC-II, causing the activation of Th cells [77]. 
It has been suggested that antigen-alum complexes can be more readily internalised by antigen-
presenting cells than soluble antigen alone. This might cause increased interaction between the 
dosed antigen and the immune system [78], indicating that stronger absorption may be 
preferred. However, as described in Section 1.2.1.1, the experimental data are mixed, and it is 
likely that more than one mode of immune system activation is involved. 
1.2.1.3 Hypothesised Modes of Action for Alum 
1.2.1.3.1 The Depot Effect 
“Alum” was first described in 1926 when Glenny [34, 35] used it as an adjuvant for diphtheria 
vaccines and hypothesised a “depot-effect” for the mode of action. In this, he proposed that the 
adjuvant essentially act as a reservoir, slowly releasing the antigen over a prolonged period of 
time and thus inculcating robust immunity. This idea went largely unchallenged for almost 70 
years. Only in the last 20 years have further investigations into the detailed mechanism of action 
taken place. Since then, the way in which aluminium-containing adjuvants function has been 
much debated, with evidence supporting a range of hypotheses.  
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Glenny and Barr [34] used a precipitation of the diphtheria toxoid antigen with “potash alum” 
to slow the rate of antigen elimination from the injection site. Guinea pigs were injected with 
the alum-precipitated toxoid, and three days after vaccination the injection site was recovered. 
The tissue thereby collected was macerated and then re-injected into naïve guinea pigs. The 
latter animals developed an anti-toxoid response, indicating the antigen was still present in the 
tissue. The same reaction not observed when injection sites were recovered from a control 
group of guinea pigs inoculated with soluble diphtheria toxoid and transferred to a population 
of naïve animals. The authors concluded that there was sustained release of antigen from the 
alum adjuvant particles, providing prolonged exposure to the antigen and eliciting a greater 
immune response. This hypothesis is known as the “depot effect”. However, given that the 
macerated tissue must have contained alum as well as antigen, it is unclear whether this is a 
true depot effect or whether the adjuvant performed some other role.  
Another early report also proposed a depot effect to explain the adjuvant effect of alum [79]. 
The authors of this work dissected nodules from diphtheria-immunised guinea pigs, ground 
them up in a saline solution and re-injected the resultant solution into other guinea pigs. 
Antibody titres collected in these experiments suggested that the antigen could potentially 
remain at the site of injection for up to 7 weeks. Further evidence to support the depot 
hypothesis comes from the fact that the Al(OH)x(PO4)y has been found to result in less efficacious 
immune responses than AlO(OH) [80].  The phosphate content of Al(OH)x(PO4)y results in this 
salt having higher solubility, and in it being eliminated more readily from the body [81], perhaps 
reducing the exposure time of leukocytes to the antigen and thus leading to reduced 
immunogenicity. 
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However, a more recent study provides evidence that aluminium-containing adjuvants at the 
injection site are dispensable for adjuvanticity just two hours after the initial administration [82]. 
BALB/c mice were injected with alum/OVA (alum provided by Brenntag Biosector, 
Frederikssund, Denmark) and the injection sites subsequently ablated. The OVA-specific 
antibody responses were the same in mice which underwent this ablation process as in those 
that did not [82]. In summary, therefore, although the depot effect may have some role to play 
in the adjuvanticity of alum, it appears that it is not the only factor of importance. 
1.2.1.3.2 Molecular Mechanisms of Action 
In recent years, a number of authors have undertaken more detailed mechanistic studies to 
probe the molecular immunological pathways which underlie alum adjuvanticity. Unfortunately, 
a range of different protocols have been employed, with a number of different types of “alum”. 
This has resulted in inconsistent findings, and so although steps have been taken toward 
unravelling alum’s mechanism of action our understanding remains incomplete. 
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In one of the first such studies, intraperitoneal injection of the model antigen OVA with Imject 
alum was found to induce chemoattraction of key immune cells, including monocytes, to the 
site of injection in BALB/c mice [83]. The recruited monocytes internalised the desorbed OVA 
and migrated to the draining lymph node, where they differentiated into DCs. These monocyte-
derived DCs were “mature” in the sense that they had high levels of MHC-II and CD86 expression 
(both are cell surface markers that enable signalling between cells), and they induced the 
proliferation of antigen-specific T cells [83-86]. Depletion of DCs (through diphtheria toxin 
administration) abolished OVA/Imject alum adjuvanticity [83]; thus, DC activation in vivo was 
found to be key to the induction of the humoral immune response by aluminium-containing 
adjuvants. Alum has also been found to enhance macrophages’ abilities to drive T cell 
proliferation [86]. In addition to monocyte and macrophage recruitment, alum can also 
accelerate differentiation of monocytes to DCs [87]. The latter have a greater capacity for 
antigen uptake and subsequent migration in the lymph node to prime naïve B- and T cell 
populations, leading to an improved immune response. 
Alum administration has also been shown to stimulate the release of DAMPs, such as 
deoxyribonucleic acid (DNA), adenosine triphosphate (ATP) and uric acid from necrotic (dying) 
cells at the site of alum injection [88-91]. Such release has been proposed to be crucial for 
adjuvanticity since the DAMPs produced can aid the recruitment of immature DCs and 
subsequent T-cell activation following alum administration [83].  
Flach and co-workers explored the binding of aluminium caesium sulphate dodecahydrate 
(“caesium alum”) and Imject to the membranes of APCs [92]. Caesium alum was found to bind 
very strongly to DC membranes, triggering abortive phagocytosis and the internalisation of 
antigen alone. This resulted in antibody production and humoral immunity only (i.e. no cellular 
immunity) because the antigen was presented on MHC-II rather than MHC-I. Interestingly, 
strong alum binding was exhibited only by DC – and not by B-cell- or macrophage- like cell lines 
– indicating that DC may be the primary target for alum. 
Chapter 1 Introduction 
 
51 
 
A further hypothesis for alum’s mode of action concerns the activation of the nucleotide 
oligomerisation domain (NOD)-like receptor protein (NLRP)-3 inflammasome.  This is a protein 
complex whose assembly is induced during the innate immune response to stimuli, including 
bacterial and fungal components and toxins (such as lipopolysaccharide [LPS], zymosan, and 
nigericin), and signatures of cellular damage or stress (including extracellular ATP and uric acid) 
[93]; it is depicted in Figure 1.6. Inflammasome complex formation begins with the 
oligomerisation of NLRP-3 protein units [94, 95]. Recruitment and activation of the caspase-1 
enzyme then ensue. The latter can stimulate proteolytic cleavage of precursor molecules to 
proinflammatory cytokines; including interleukin (IL)-1β and IL-18, leading to secretion of the 
mature cytokines. 
 
Figure 1.2: The mechanism of NLRP-3 inflammasome activation, in which pathogen-associated or 
danger-associated molecular patterns (PAMPs or DAMPs) stimulate the activation and subsequent 
opening-up of NLRP-3 proteins to expose their PYD domains. Oligomerisation then occurs, leading to 
activation of the enzyme pro-caspase 1; this in turn results in secretion of mature pro-inflammatory 
cytokines. Reproduced with permission from ref [94]. Copyright Macmillan Publishers Ltd 2010. 
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Alum has been proposed to activate NLRP-3, but exactly how it does so remains unclear. Zhang 
et al. recently demonstrated a positive linear relationship between the surface hydroxyl content 
of alum and the induction of reactive oxygen species (ROS) synthesis [96], indicating that ROS 
stress signals may be responsible. Experimental evidence also suggests that the administration 
of alum can induce inflammasome activation by release of uric acid from necrotic cells [83]. Uric 
acid is an endogenous danger signal which causes the maturation of caspase-1, leading to the 
release of IL-1β and IL-18 [97, 98]. 
A role for the NLRP-3 inflammasome in alum adjuvanticity has not been suggested by all studies, 
however. While some groups [98-102] have found that aluminium-containing adjuvants act via 
inflammasome activation for induction of an immune response, others concluded 
experimentally that the inflammasome is in fact dispensable [83, 92, 103, 104]. A summary of 
the findings to date can be found in Table 1.3. De Gregorio et al. [103] concluded that the 
conflicting evidence for aluminium-containing adjuvants’ mode of action could arise due to 
study-to-study variation in formulation route, antigen purity, assay and other variables.  This 
seems reasonable, given that the aluminium adjuvants often used in research (e.g. Imject alum) 
are not the same as those used in the clinic, and thus are not recommended for mode of action 
studies [44, 69, 105, 106]. It seems entirely possible that this difference, coupled with variations 
in experimental protocol, account for the variations in mechanism suggested by the experiment 
work conducted to date. 
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Table 1.3: A summary of experimental findings as to whether alum's mode of action involves the 
activation of the NLRP-3 inflammasome. 
Authors and reference Alum used Vital role for NLRP-3 
inflammasome?  
Eisenbarth et al. [99] Imject-Alum Yes 
Li et al. [98] 
Imject-Alum 
Alhydrogel 
Adju-Phos 
Yes 
Li et al. [100] Alhydrogel Yes 
Kool et al. [101] Imject-Alum Yes 
Hornung et al. [102] Imject alum Yes 
Flach et al. [92] 
Cesium alum 
Imject alum 
“Clinical AlOH” 
Dispensible 
Franchi and Nunez [107] “Mixture of alum” Dispensable 
Mckee et al. [104] 
Imject alum 
Alhydrogel 
Dispensable 
Kool et al. [83] Imject alum Indirect 
Several recent reviews have discussed the mechanism of action of alum in more detail than can 
be presented here, and the interested reader is directed to these for further information [108, 
109]. A summary of the various proposed routes of action of alum is given in Figure 1.7.  
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Figure 1.2: Possible mechanisms of action for adjuvants in vivo, following intramuscular injection. 
Abbreviations: - TLR = Toll-like receptor, CLR = C-type lectin receptor, RLR = RIG-I like receptor, NLR = 
NOD-like receptor, MHC = major histocompatibility complex, CD = Cluster of Differentiation, TCR = T cell 
receptor, BCR = B cell receptor, PRR = pattern recognition receptor. These receptors are located at 
different places on the cell surface with the purpose of providing a docking site for their cognate ligand 
on another cell to induce intracellular signalling cascades. Reproduced from ref [109]. Copyright 
Frontiers Media S.A 2013. 
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1.2.1.4 AS04 
AS04 is a new adjuvant developed by GlaxoSmithKline. It comprises a mixture of aluminium 
hydroxide and MPL-a [110]. The latter is an attenuated version of LPS, which is an abundant 
component of Gram-negative bacteria. LPS is a powerful PAMP but is considered too dangerous 
to use in vaccines, whereas MPL-a is less toxic [111]. Since its regulatory approval, AS04 has been 
used in a number of vaccines, for instance the Cervarix human papilloma virus (HPV) formulation 
[112]. AS04 has been reported to perform better than alum alone in a vaccine against Herpes 
simplex virus [113]. Like alum, AS04 stimulates cytokine production at the injection site; this 
results in recruitment of DCs and monocytes, and ultimately increased numbers of antigen-
presenting cells in the lymph nodes [114]. A detailed discussion of AS04 lies outside the scope 
of this introduction, but the AS04-adjuvanted human papilloma virus (HPV) vaccine has been 
found to be highly effective, and an AS04 vaccine for Hepatitis B was determined to be more 
efficacious than one adjuvanted with alum alone [115]. AS04 is not a panacea, however: an 
AS04-adjuvanted vaccine against genital herpes was found to be ineffective [115]. 
1.2.1.5 Effect of Size and Shape of Alum Adjuvant Particles on the Immune Response 
The possible influence of surface charge on adjuvant/antigen interactions is discussed above. 
Very recently, some authors have sought to control the particle size and shape of alum and 
explored how this influences its immunogenicity. Sun and co-workers synthesised a library of 
AlO(OH) particles of different sizes and shapes [116]. It proved possible systematically to vary 
the morphology and size of the particles by varying the synthesis pH: see Figure 1.8.  
 
Figure 1.2: The variation of AlO(OH) particle morphology through synthesis pH. Adapted from ref [116]. 
Copyright American Chemical Society 2013. 
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At pH 5, rod shaped particles were obtained, while at pH 9 polyhedra-shaped particles were 
collected and at pH 10, platelets. The samples were found to stimulate ROS production, a 
property which was ascribed to their high hydroxyl contents. They were also tested for their 
ability to stimulate macrophages in vitro: macrophage-like cells were derived from phorbol 12-
myristate 13-acetate (PMA)-treatment of the THP-1 monocytic leukaemia cell line [117] and 
treated with different AlO(OH) materials in the presence of LPS to induce the production of pro-
IL-1β [116]. The results are presented in Figure 1.9 and show that three of the synthesised 
AlO(OH) rods were capable of significant NLRP-3 inflammasome activation and subsequent IL-
1β production. 
 
Figure 1.2: The production of IL-1β in response to treatment with Sun’s particle-engineered alum 
samples and LPS. AlO(OH) samples were administered to THP-1 macrophages at 500 µg mL-1 for 6 hours. 
500 µg mL-1 alum (Thermo Scientific, Pittsburgh, USA) was also dosed as a control. In water, the 
hydrodynamic sizes of the AlO(OH) samples are approx. as follows. Rod 1: 810 nm; rod 2: 592 nm; rod 
3; 451 nm; rod 4: 434 nm; rod 5: 244 nm; plate: 93 nm; polyhedron: 333 nm; alum: 452 nm. Reproduced 
from ref [116]. Copyright American Chemical Society 2013. 
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There was a clear influence of particle size and shape on cytokine production, with an increase 
in rod size causing increased secretion. While certain of the rods were effective, the platelet and 
polyhedra shaped particles had very poor capacity to stimulate IL-1β synthesis. With murine 
bone-marrow derived DC (BMDC), the rods were found to stimulate the production of IL-6 (a 
Th2-polarising cytokine), IL-12 (a Th1-polarising cytokine) and IL-1β. The largest rods (rods 1 and 
2) were again most effective here. The production of MHC-II, CD86 and CD80 was also increased 
by the AlO(OH) rods, and again the larger rods are more potent (although the trend is not 
completely straightforward). 
In vivo studies were also undertaken using OVA in C57BL/6 mice [116]. The largest rods (1 and 
2, ca. 800 and 600 nm respectively) were compared with rod 5, with the smallest particles (244 
nm), and alum. The ca. 600 and 800 nm rods were found to stimulate higher OVA-specific IgG1 
and IgE titres than 244 nm rods or alum. The 244 nm rods did not significantly boost IgG1 
production over the level induced by alum, nor did it increase IgE. Control of adjuvant particle 
size and shape therefore clearly has great promise for the design of vaccines with maximal 
efficacy. 
A second and very recent study seems to confirm the importance of alum particle size and shape 
control. Li and co-workers explored the influence of alum particle size on the immune response 
inculcated in vivo [118]. AlO(OH) nanoparticles of size 112 nm (AH-NPs) and microparticles of 
size 9.3 μm (AH-MPs) were prepared. It should be noted that the AH-NPs were found to be 
completely amorphous by X-ray diffraction, meaning it is not possible from the data presented 
to confirm the chemical composition of the materials, and the AH-MPs appear to comprise a 
mixture of poorly-crystalline AlO(OH) and Al(OH)3. Whether the two samples are chemically 
identical is thus unknown. 
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Li et al. observed increased OVA antigen adsorption to the AH-NPs (cf. the AH-MPs), as a result 
of the much greater surface area of the former. This concept is supported by work undertaken 
by Lundqvist et al. looking at protein interactions with polystyrene nanoparticles [119]. The AH-
NPs led to a stronger anti-OVA IgG response in mice than the AH-MPs [118]. Experimental data 
showing this are presented in Figure 1.10. 
 
Figure 1.2: Total serum anti-OVA IgG levels measured on day 27 following BALB/c mice inoculation with 
OVA/AH-NPs or OVA/AH-MPs. A denotes p=0.001, OVA vs. OVA/AH-NPs and b p=0.02, OVA/AH-NPs vs. 
OVA-MPs at 100x dilution factor. Reproduced from ref [118]. Copyright Elsevier 2014. 
Similar results were obtained using the anthrax AP antigen [118]: although both the AH-MPs and 
NPs induced similar antibody production after one week, after 4 weeks the titres were much 
higher with the NPs. Internalisation of the adjuvant particles by antigen-presenting cells was also 
demonstrated to be much greater with the AH-NPs than the MPs, and the amount of local 
inflammation observed to be lower with the former. 
1.2.1.6 Potential Disadvantages of Aluminium-Containing Adjuvants 
A number of possible side effects from the use of alum in vaccines have been proposed. 
Aluminium is classed as a neurotoxin [120] and has been reported to accumulate in regions of 
the brain commonly affected by Alzheimer’s Disease (AD) [121, 122]. However, the evidence is 
far from conclusive: others [123, 124] found no evidence of aluminium accumulation in AD 
brains. Elevated levels of aluminium hydroxide have also been connected to macrophagic 
myofasciitis [125-127]. 
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 Alum administration has been linked to localised effects including erythema (reddening of the 
skin) and granulomatous inflammation (accumulation of phagocytes causing a local 
inflammatory response) [128-130], although these phenomena may well be the inevitable 
correlates of the use of an immunostimulatory substance (i.e. an adjuvant) rather than being 
alum-specific [129]. The current consensus is that the side effects, even where undisputed, are 
extremely minor in comparison to the health benefits: despite the fact that alum has been the 
only licensed vaccine adjuvant for most of the past 80 years, persuasive evidence of widespread 
side effects is notable by its absence, and the FDA emphasises that it has been safely 
administered to humans since 1932 [131]. 
1.3 Layered Metal Hydroxide Anion Exchange Materials 
Layered hydroxides can carry positively charged metal hydroxide layers with interchangeable 
charge-neutralising interlayer anions. Layered double hydroxides and hydroxy-double salts are 
two subdivisions of this superfamily. There is some evidence in the literature to suggest that 
these materials, which are structurally related to AlO(OH), can also act as adjuvants [132-135].  
1.3.1 Layered Double Hydroxides 
Layered double hydroxides (LDHs) have a general structural formula [Mz+1-xM’3+x(OH)2]ζ+(An-
ζ/n)·mH2O (see Figure 1.11). When “z” equals 2, possible divalent metal cation species include 
Ca2+, Co2+, Fe2+, Mg2+, Mn2+, Ni2+, Zn2+; and for M’3+, the common trivalent metal cations are Al3+, 
Cr3+, Co3+, Fe3+, Ga3+, Mn3+ and Ni3+, in this situation ζ = x [136, 137].  When “z” equals 1, then M+ 
is Li+ and M’3+ is Al3+ to give ζ = 2x-1. “An-” denotes the interlayer anion species; this can either 
be inorganic such as Cl- and NO3- or organic (e.g. CO32-) [138]. The value of “x” is calculated by 
[M’3+/(M2+ + M’3+)]  [139] and can range between 0.1 ≤ x ≤ 0.5; however, phase pure LDH 
structures are restricted to a tighter 0.2 ≤ x ≤ 0.33 range [140] (see Figure 1.12). 
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Figure 1.3: The generic structure of a layered double hydroxide. A material of composition [Mz+1-
xM’3+x(OH)2]ζ+(An-ζ/n)·mH2O is shown; grey and purple polyhedra represent M(OH)6 and M’(OH)6 
octahedra. N atoms are shown in blue and O atoms in red. The metal cations and interlayer anions are 
considered to be fully ordered here (that is not always the case). Interlayer water molecules are omitted 
for clarity. 
 
 
Figure 1.3: Comparison of trivalent metal ratio “X” scale (top) and divalent vs trivalent ratio “R” 
(bottom) with the corresponding limits for layered double hydroxide structures. Edited from[136], 
Copyright 2001. 
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Layers within a LDH contain metal cations of similar ionic radii co-ordinated by 6 oxygen atoms 
to generate either M2+- or M3+-(OH)6 octahedra; edge-sharing results in the formation of 2-
dimensional sheets. These layers are net positively charged [141]; intercalated, charge-
neutralising interlayer anions balance the positive charge. LDHs exhibit a high degree of 
compositional flexibility by substitution of the metal cations and interlayer anions; however, 
ions with too small (i.e. Be2+) or too great (i.e. Sc3+) an ionic radius are unsuitable candidates for 
substitution as they are unable to octahedrally co-ordinate in the layer [142-144]. 
LDHs can be synthesised by a variety of different processes including co-precipitation (which 
sees the slow addition of a solution containing a mixture of M2+ and M3+ metal salts into water; 
alongside the addition of an alkaline solution for the maintenance of a constant pH-value for co-
precipitation [145, 146]) and ion exchange [147]. 
1.3.2 Other Metal Hydroxides 
There are other classes of structurally similar layered materials, such as hydroxy double salts 
(HDS). They contain two divalent metal cations in their hydroxide layer and have a general 
formula of [(M2+aN2+b)(OH)y]( 2a+2b-y )+An-(2a+2b-y)/n·zH2O. In this, M2+ and N2+ denote two different 
divalent metal cation species and An- represents a charge-balancing, interlamellar anion – the 
nature of this anionic species controls the interlayer separation [148]. The potential of HDSs as 
vaccine adjuvants has not been explored in detail to date, although there is some evidence to 
suggest that they are effective [135]. 
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1.3.3 Immunological Applications of LDHs 
Structurally, layered double hydroxides (LDHs) have strong similarities with that of aluminium 
oxyhydroxide [AlO(OH)] making them a suitable, inorganic adjuvant candidate. The first study to 
explore LDHs as adjuvants was published in 2010 by a team from Shanghai [133]. These authors 
synthesised three different LDHs containing Mg and Al, with nitrate as the interlayer ion: 
[Mg3Al(OH)8]NO3·yH2O (Mg3Al-NO3), [Mg2Al(OH)6]NO3·yH2O (Mg2Al-NO3), and 
[MgAl(OH)4]NO3·yH2O (MgAl-NO3) with particle sizes of ca. 60 nm. They then investigated the 
influence of these materials on murine DCs. The LDH particles were taken up by DCs, with 
maximum uptake reached after around 2h at 37 °C. The co-stimulatory molecules CD86 and 
CD40 (but not CD80 or MHC-II) were upregulated upon exposure to the MgAl-NO3 LDH. In 
contrast, no such upregulation was observed with the Mg2Al-NO3 or Mg3Al-NO3 materials. 
Consistent results were observed for the production of cytokines by DC in response to the LDH 
samples: the MgAl-NO3 LDH causes a significant and dose-dependent increase in the production 
of TNF-α and IL-12p70, while no change is seen when DCs are exposed to the other LDHs (see 
Figure 1.13). 
 
Figure 1.3: Dendritic cell production of TNF-α and IL-12p70 after 24 hours exposure to MgAl-NO3 (R1), 
Mg2Al-NO3 (R2) and Mg3Al-NO3 (R3), and a 1:1 physical mixture of Mg(OH)2/Al(OH)3 (iR1). ** denotes p 
< 0.01. Reproduced from ref [133]. Copyright Elsevier 2010. 
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The migration of DCs towards CCL21 (as assessed in transwell plates) was also seen to increase 
following treatment with MgAl-NO3, but not with the other LDHs. This phenomenon was found 
to be CCR7 dependent [133]. It should be noted, however, that the MgAl-NO3 material is not 
phase pure: Al(OH)3 was observed to be present in the sample as well as the LDH. It is thus 
unclear to what extent the immunogenicity of this sample was due to the presence of LDH, or 
whether the impurity is important in this regard. 
Li et al. have built on these early studies to explore the utility of LDHs in DNA vaccines [132]. 
MgAl-NO3 was found to readily form complexes with DNA, and the resultant complex had high 
transfection efficiency as evidenced using a green-fluorescent protein plasmid as a reporter. 
When C57BL/6 mice were immunised with OVA and the DNA/LDH complex and subsequently 
challenged with B16-OVA melanoma cells, the complex was found to induce significant increases 
in serum anti-OVA IgG1 and IgG2c titres over mice immunised with DNA-alone. Survival rates 
were also improved by use of the LDH. IgG2c was produced in greater amounts than IgG1, 
suggesting that a Th-1 polarised response was being provoked. This was confirmed by the 
observation of an increase in IFN-γ (but not IL-4) production by splenocytes.  OVA-specific CD8+ 
T cell activity was also increased in the presence of the LDH adjuvant [132]. Again, however, the 
LDH sample used shows clear signs of phase impurity. 
Another study explored the potential of LDH particles as adjuvants using OVA as the dosed 
antigen. The LDH particles were found to induce high levels of IgG1 antibodies, comparable to 
alum [149], and co-delivery of CpG and OVA was found to increase IgG1 and IgG2a titres. 
Therefore, the composite LDH materials were shown to polarise both Th1- and Th2-type 
immune responses, rendering them suitable for use with a wide variety of antigens, both viral 
and bacterial [149]. 
Chapter 1 Introduction 
 
64 
 
Another advance in the use of LDHs as adjuvants was reported by Wang and co-workers in 2014 
[150]. Core-shell nanoparticles of SiO2 (core) and Mg/Al LDH (shell) were prepared (denoted 
SiO2@LDH; the ratio of Mg:Al is unclear in this work). They were found to be non-cytotoxic and 
to protect DNA molecules from degradation when incubated with DNAse enzymes. When 
macrophages (RAW264.7 cell line) were exposed to the SiO2@LDH particles, increased levels of 
IFN-γ, IL-12p70 and TNF-α were observed; IL-6 production was additionally enhanced at higher 
doses. CD86 and MHC-II were also upregulated. BALB/c mice were immunised with the 
SiO2@LDH nanoparticles and hepatitis B viral DNA, which was found to result in an increase in 
anti-hepatitis B IgG titres. 
Some of the most recent work in this area was reported by Williams and co-workers [134]. These 
authors exploited the fact that LDHs have huge structural and chemical diversity, and 
investigated the immune response to a range of LDHs both in vitro (using human monocyte-
derived DC and macrophages) and in vivo (with OVA in C57BL/6 mice). A systems vaccinology 
approach was implemented in an attempt to ascertain whether the immune response could be 
correlated with the LDH physicochemical properties. This approach is illustrated in Figure 1.14.  
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Figure 1.3: The systems vaccinology approach adopted by Williams et al. A series of layered double 
hydroxide materials was prepared, and the response of human dendritic cells in co-culture or of mice 
upon OVA vaccination quantified. The physicochemical properties of the LDHs were then considered to 
be causative of the immune response, and structure/property relationships elucidated. Reproduced 
from ref  [134]. Copyright Rockefeller University Press 2014.
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It was observed that different LDHs promote quite distinct immune responses, with some 
(notably [LiAl2(OH)6]2CO3·yH2O) stimulating very significant cytokine production and co-
stimulatory molecule upregulation by DC, while others ([Mg2Fe(OH)6]Cl·yH2O, Mg2Fe-Cl) have 
almost no effect. Similarly, in vivo certain LDHs caused large uplifts in antibody titres, while 
Mg2Fe-Cl was largely ineffective. The LDHs generally performed at least as well as Imject alum 
and Alhydrogel® in these assays. In vivo, some LDHs were found to produce greater amounts of 
anti-OVA IgG1 and IgE (Th-2 type antibodies) than the standard commercial adjuvants, while 
others ([Mg2Fe(OH)6]2CO3·yH2O in particular) yielded high IgG2c titres, indicative of a Th1 
polarised response. 
Most remarkably, it was found that the immune response (both in vitro for DC and macrophages 
and in vivo) was very highly correlated with three of the physicochemical properties of the LDHs: 
the zeta potential, the interlayer spacing, and the radius of the monovalent or divalent metal 
cation (see Figure 1.14). An equation could be devised which allowed the magnitude of a 
particular immunological output to be calculated from these LDH properties (Figure 1.14). To 
test the robustness of this approach, the authors performed blinded trials, where they predicted 
the responses to two new, untested, LDHs using the mathematical model described above 
before performing immunological assays in vitro. The responses observed were found to be 
extremely close to those predicted mathematically as depicted in Figure 1.15, showing that it is 
possible to predict a priori the immune response to an LDH if its physicochemical properties are 
known. 
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Figure 1.3: Data showing that the in vitro dendritic cell response to a layered double hydroxide can be 
accurately predicted from its physicochemical properties. LiAl2-NO3 = [LiAl2(OH)6]NO3·yH2O; Mg2Al-Cl = 
[Mg2Al(OH)6]Cl·yH2O. The production of a range of different cytokines and co-stimulatory molecules 
was measured, with mean results shown as black squares and 95 % confidence intervals as bars. The 
red triangles indicate the response predicted mathematically; it is clear that these lie within the 
confidence intervals in the majority of cases. Reproduced from [134]. Copyright Rockefeller University 
Press 2014. 
These most recent results suggest that LDHs have enormous potential as bespoke adjuvants. 
The radii of metal ions are well documented, and interlayer spacing and zeta potential can be 
easily measured for a sample within a few minutes. Interlayer spacing can also be calculated in 
silico. Ultimately, in silico screening of thousands of possible LDHs should be possible, permitting 
the material required to deliver a particular immune response to be identified, and subsequently 
synthesised and tested in vitro and in vivo. 
1.4 Alternative Inorganic Adjuvants 
Although alum is by far the most commonly used adjuvant, a range of other systems have been 
explored for use in vaccine. These are discussed below. 
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1.4.1 Calcium Phosphate 
Calcium phosphate (CaP) occurs naturally within the body, and its resultant biocompatibility 
might be expected to result in reduced immunotoxicity compared with alum, although it is 
reported to be haemolytic in vitro [151]. When compared with alum, CaP has been found to 
stimulate reduced immunoglobulin-E (IgE) antibody responses and elevated IgG1 production 
following administration of diphtheria, tetanus or pertussis toxoid antigen to mice [152]. A study 
in guinea pigs indicated that CaP was as potent or less potent than an Al hydroxide adjuvant for 
diphtheria-tetanus vaccines [153]. However, in a human trial vaccinating against the same 
diseases, the CaP adjuvant was found to have higher efficacy but also to lead to more adverse 
reactions [154]. CaP has been widely administered as a vaccine adjuvant in the diphtheria-
pertussis-tetanus vaccine in France [155-157]. 
Detailed chemical characterisation studies of a commercially available CaP adjuvant found it to 
comprise not Ca3(PO4)2 as would be intuitively expected, but instead to have the chemical 
formula Ca10-x(HPO4)x(PO4)6-x(OH)2-x (with x varying between 0 and 2) [158] – it is thus a 
hydroxyapatite material. The CaP sample analysed was found to be poorly crystalline with a 
point of zero charge of 5.5, indicating that at physiological pH it is likely to adsorb positively 
charged antigens. Crystals of CaP have been shown to induce IL-1β secretion through 
inflammasome activation, [159] suggesting a similar mechanism of action to that proposed for 
alum adjuvants. However, the mechanism of CaP adjuvanticity has not been studied in detail so 
questions remain. 
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A range of studies have been performed investigating the adjuvant effect of CaP, for instance in 
vaccines for influenza [160] or herpes simplex [161, 162]. In the latter case, CaP yielded higher 
IgG2a titres than alum while provoking minimal IgE production [162]. IgG2a immunoglobulins 
indicate that a Th1-type immune response is elicited [163], thus targeting viral infections, whilst 
IgE is produced in response to allergic reactions. Therefore, a higher IgG2a titre is favourable to 
aid clearance of the infection in this case. In a murine model, CaP could also induce systemic 
immunity to herpes simplex through mucosal administration [161]. CaP has also been explored 
for tolerogenic vaccination, for instance to pollen extracts, [164] and in veterinary vaccines [165, 
166]. 
In a very recent study, Olmedo et al. explored the response in mice to Bothrops asper snake 
venom [167]. When antigen was adsorbed onto the surface of the adjuvant, CaP was found to 
be superior to aluminium hydroxide adjuvant, leading to enhanced leucocyte recruitment and 
greater antibody responses. An alternative approach was explored in which the antigen was co-
precipitated with the CaP; these samples resulted in the highest antigen loading, phagocytosis 
by macrophages, leucocyte recruitment and antibody response. The approach of co-
precipitating antigen and CaP together is a popular one, having been used by He et al. in their 
2002 study [161, 168] and also by Joyappa and co-workers for DNA vaccines [168]. The latter 
study used a DNA antigen for foot-and-mouth disease (FMD), which was incorporated into CaP 
nanoparticles through co-precipitation. The transfection efficiency of the resultant systems was 
found to be very high, and high antibody titres were also observed. 
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Co-precipitation of CaP with antigen has been shown by Zhou et al. to lead to long-lasting CD8+ 
T-cell responses in mice [169]. In Zhou et al.’s work, OVA was co-precipitated with CaP. The CaP-
OVA particles were comparable to soluble OVA in terms of antibody responses, but led to high 
levels of IFN-γ production and a potent CTL response in mice. Combinations of CaP and protein-
coated microcrystals (co-precipitated protein and amino acid or sugar formulations) have also 
been investigated, with CaP inclusion found to enhance phagocytosis in the J774.2 murine 
monocyte/macrophage cell line [170]. CaP modification also decreased the IgG1 : IgG2a ratio in 
NIH mice, indicating that its inclusion can help skew the immune response to the Th1 pathway 
[170]. 
Zn- and Mg-containing CaP adjuvants were reported by Wang et al. in 2013 [171]. The adjuvants 
were loaded with a hydrothermal extract of a human tubercle bacillus and explored for cancer 
immunotherapy. The authors hypothesised that the inclusion of Zn and Mg would enhance the 
adjuvanticity of the CaP materials, owing to the ability of Zn to enhance the activity of antigen-
presenting cells and Mg’s role in macrophage modulation. In-vitro Granulocyte macrophage 
colony-stimulating factor (GM-CSF) production by macrophage-like cells was increased by the 
inclusion of zinc or magnesium, and certain of the systems were found to have enhanced anti-
tumour activity. Flagellin-functionalised CaP nanoparticles have also been reported and shown 
effectively to activate the innate immune system [172]. 
The influence of CaP particle size and shape has also been explored. Crystalline needle-like 
particles were proposed to elicit a greater immune response than that achieved with spherical 
nanoparticles, with smaller particle sizes preferred [173]. 
1.4.2 Zinc Oxide 
Zinc oxide (ZnO) is a non-toxic entity commonly used as a dietary supplement. It could thus be 
an ideal biocompatible adjuvant candidate [174]. There is a small body of literature in which ZnO 
nanoparticles have been explored as potential adjuvants. 
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Matsumura and colleagues inoculated BDA/1J mice with the model antigen OVA and 1–3 mg of 
ZnO, and then sacrificed the animals 21 days after immunisation [175]. The addition of ZnO was 
found to significantly increase the production of anti-OVA IgG1 and IgE antibodies compared 
with mice injected with phosphate buffered saline (PBS) alone. An increase in OVA-specific 
splenocyte proliferation was discovered with higher doses (3 mg) of ZnO. Enhanced splenocyte 
production of IL-4, IL-5 and IL-17 was also observed 21 days after inoculation (although no 
statistical tests were presented). In contrast, ZnO did not yield an uplift in IgG2a production nor 
of IFN-γ production. The authors thus concluded that ZnO provokes a Th2-type response, similar 
to alum adjuvants. In the experiments reported, ZnO was found to perform approximately on a 
par with the Imject alum used as a control (it is worth restating here that Imject alum is not the 
same as the alum used in clinical vaccines, and can be less effective in stimulating an immune 
response [106]; exactly how ZnO compares with commercially used alums is thus not known). It 
was postulated that a small amount of dissolution may occur, resulting in Zn2+ being present in 
solution. This has previously been found to cause IL-4 production by T cells [176]. 
A second study was performed by Roy et al. in 2014 [174]. These authors used nano-sized ZnO 
(<50 nm) and also immunised mice (BALB/c) with ZnO and OVA. The results were largely in 
agreement with those of Matsumura et al.: OVA-specific IgG1 and IgE levels were significantly 
enhanced when ZnO was co-administered with OVA (see Figure 1.16). Studies on splenocytes 
revealed that the use of ZnO resulted in increased IL-2, IL-4, IL-6 and IL-17 production, while IL-
10 and TNF-α production declined. In the presence of ZnO, increased numbers of eosinophils 
and mast cells were detected in the lungs and spleen, and macrophages and B cells were shown 
to mature to a greater extent. T-cell proliferation was also observed. These data further support 
the stimulation of a Th2 response when ZnO is used as an adjuvant. 
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Figure 1.3: Serum antibody levels of anti-OVA (a) IgG1 and (b) IgE by BALB/c mice immunised with 
0.25 mg of ZnO nanoparticles (ZNPs) and 100 μg OVA. NA represents a negative control. An increase in 
production of both antibodies can be seen when ZnO is used as an adjuvant with OVA. * denotes 
p < 0.05. Taken with permission from Roy et al [174] Copyright Oxford University Press 2014. 
1.5 Aims of this Thesis 
This work aims to fill some of the key gaps in our current knowledge and understanding of 
inorganic adjuvant systems. It is clear that both the particle size and shape of inorganic 
nanoparticles are important in controlling the immune response they stimulate, and thus we 
aim in this thesis to use high-throughput methods to control these and assess the effect on 
immunogenicity. Further, extensive efforts are made to develop computational models and 
identify structure/property relationships which could permit the immune response to an 
inorganic material to be predicted a priori. This would ultimately permit thousands of materials 
to be assessed in silico before lead materials were synthesised for onward study. The major aims 
of this thesis are as follows: 
 To use continuous hydrothermal processes to synthesise an array of different AlO(OH), 
hydroxyapatite and zinc oxide samples, to fully characterise the resultant products, and 
to test these for adjuvant activity; 
 To elucidate structure/property relationships linking the physicochemical properties of 
these nanoparticles to the immune response they stimulate, as a step towards 
engineering materials to provoke a particular desired response; 
Chapter 1 Introduction 
 
73 
 
 To extend the previous work undertaken by Williams et al. [134] by synthesising a 
broader family of layered double hydroxide (LDH) materials, fully characterising these, 
exploring their adjuvanticity in vitro and developing structure/property relationships; 
 To develop computational methods to model zeta potential in silico, particularly for LDH 
materials. This has not been done to date, and hence computational simulations will be 
implemented to seek a proxy for this experimental physicochemical property, so as to 
replace it in the immunological equation deduced by Williams and co-workers [134] and 
permit an in silico screen of candidate adjuvant materials; 
 To explore in more depth the immunological effects of hydroxy double salt (HDS) 
materials, by synthesising, characterising, and assessing in vitro a variety of Zn(II)-
containing hydroxy double salts; 
 Attempts will also be made to elucidate relationships between the physicochemical 
properties of the HDSs and the immune response they provoke, and also to perform 
computational calculations and identify relationships between simulated parameters 
and the in vitro response. 
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2.1   Introduction 
A variety of different adjuvant candidates were synthesised in this thesis and were characterised 
using a number of techniques, modelled in silico and tested in vitro. This chapter will give an 
overview of the main principles underlying each of the experimental and analytical methods 
employed. 
2.2   Particle Engineering 
2.2.1 Batch Hydrothermal Synthesis 
Batch hydrothermal synthesis utilises near-critical water to generate a highly crystalline product 
within a pressure vessel placed in an autoclave (Figure 2.1A).  
Various microparticle- and nanoparticle-scale boehmite [γ-AlO(OH)] morphologies can be 
synthesised via batch hydrothermal processes, including leaf-like [1], platelets [2, 3] and fibre-
shaped particles [4]. The morphology can be controlled by varying the precursor concentration, 
the pH of the reaction mixture, residence time and reaction temperature [5]. For example, Liu 
and co-workers [1] synthesised leaf-like boehmite microparticles with a 0.6 M solution of 
aluminium chloride hexahydrate at 160 °C for 12 hours; however, on increasing the 
concentration to 0.8 M, 3D flower-like structures were obtained. The different morphologies 
obtained are depicted in Figure 2.1 (B, C). 
 
Figure 2.1: (A) A schematic representation of the Teflon-lined stainless steel pressure vessel used in 
batch hydrothermal synthesis; scanning electron micrographs of (B) leaf-like; and (C) flower-like 
boehmite superstructures, reproduced from ref [1]. 
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2.2.2 Continuous Plastic Flow Synthesis 
Continuous plastic flow synthesis (CPFS) uses sub-100 °C deionised water flowing through 
polytetrafluoroethylene (PTFE) tubing, heated by a silicon oil bath, to aid the reaction between 
two precursors (see Figure 2.2). The residence time is determined by the length of the PTFE 
tubing coiled within the silicon oil bath. Close-to ambient temperature water as used in this 
method has a high dielectric constant (ε = 78 at 25 °C [6]); due to its capacity to generate 
hydrogen bonds, it acts as a weak solvent for non-polar, organic substances. 
 
Figure 2.2: Schematic representation of the CPFS reactor. P1 and P2 denote HPLC pumps for two 
separate precursor feeds which mix at a T-junction to initiate reaction. The resultant mixture is heated 
in an oil bath (reactor) for a defined time period prior to collection of the precipitated product. 
The Clean Materials Technology Group at UCL has used the CPFS process to control both particle 
size and shape for different nanomaterials including cobalt oxide and silver nanoparticles [7]. 
Synthesising AlO(OH) in this manner is an attractive approach because the reactions can be 
performed at low temperatures and pressures, making them economically viable, and the 
process can readily be made Good Manufacturing Practice (GMP). 
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2.2.3 Continuous Hydrothermal Flow Synthesis 
Continuous hydrothermal flow reactors (Figure 2.3) use super-critical water – obtained at 
temperatures above 400 °C – to generate highly crystalline products [8]. Spectroscopic and 
computer simulation studies by Cummings et al. [9] highlight supercritical water as having a third 
of the capacity for hydrogen-bond formation of ambient temperature water (as used in the CPFS 
system), so it exhibits a lower dielectric constant. 
 
Figure 2.3: Schematic representation of the continuous hydrothermal flow synthesis (CHFS) reactor. P1, 
P2 and P3 denote high pressure diaphragm pumps with P1 providing the heated deionised water feed 
and P2 and P3 the precursor solution feeds. 
Initial continuous hydrothermal flow synthesis (CHFS) studies into boehmite synthesis by Hakuta 
[10] demonstrated that different particle sizes and morphologies may be obtained, with 
morphology being dependent on aluminium salt concentration. It proved possible to convert 
rhombic AlO(OH) platelets into a hexagonal platelet morphology when both the temperature 
and pressure parameters were controlled (400 °C and 30 MPa, respectively). 
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Further experimental work conducted by Hakuta [11] controlled the reaction time through 
varying the temperature of the pre-heated deionised water feed. A 20 second residence time 
and 350 °C reaction temperature produced pure phase hexagonal AlO(OH) particles of average 
diameter 70 nm. Increasing the residence time to 60 seconds also produces pure phase, 
hexagonal AlO(OH) particles, but with average diameter of 250 nm. Additional work indicated 
the role of higher pressures in generating larger particle sizes [11].  
All three approaches described above will be used within this work. The advantages and 
disadvantages of these hydrothermal processes are listed in Table 2.1.  
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Table 2.1: Advantages and disadvantages of batch, continuous plastic flow synthesis (CPFS) and 
continuous hydrothermal flow synthesis (CHFS) processes. 
Advantages Disadvantages 
Batch Hydrothermal Synthesis 
Synthesise single- or mixed-metal oxides High temperatures and pressures required, 
therefore have high energy costs 
Highly crystalline product Small yields 
Can control oxidation state of product Long reaction times 
 Low reproducibility between batches 
Continuous Plastic Flow Synthesis 
Low temperatures and atmospheric 
pressure, thus low energy costs and ease of 
translation to GMP 
Poorly crystalline product at temperatures 
≤90 °C 
High yields Scale-up 
Short residence times 
(≈10 minutes) 
 
Pure phase and reproducible product  
Continuous Hydrothermal Flow Synthesis 
High yields High temperatures (≥400 °C) 
High reaction rates with short residence 
times (<10 seconds) 
High pressures (≈240 bar) 
High product reproducibility between 
experiments 
Risk of metal contamination from pipework 
Highly crystalline product  
Can control particle size and morphology 
(via temperature, pressure, pH, flow rates 
etc…) 
 
Easily scaled-up  
2.3 In silico modelling 
There are a variety of different methods of simulating structures using computational chemistry: 
these include density functional theory [12], molecular dynamics [13] and classical codes [14]. 
The work in this thesis uses the latter in silico method. 
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2.3.1 Interatomic Potentials as a Description of Interatomic Forces 
In 1918, Max Born and Alfred Landé devised an equation coupling a short-range repulsive term 
with a long-range Coulombic interaction, called the Born-Landé equation – Equation 2.1 [15]. 
Determination of lattice energy is possible from the electrostatic potential of the ionic lattice 
and a repulsive-energy term: 
Equation 2.1 
𝑈𝑖𝑗
𝐵𝑜𝑟𝑛−𝐿𝑎𝑛𝑑é =  
𝑏
𝑟𝑖𝑗
𝑛 
where 𝑏 and 𝑛 are both variables which denote equilibrium interionic separation when 𝑛 equals 
9. Building on this, in 1932, Born introduced a short-range potential entitled the Born-Mayer 
equation [16] – Equation 2.2 – with 𝐴 and 𝑝 being variable parameters.  
Equation 2.2 
𝑈𝑖𝑗
𝐵𝑜𝑟𝑛−𝑀𝑎𝑦𝑒𝑟 =  𝐴𝑒𝑥𝑝
−
𝑟𝑖𝑗
𝜌  
The Lennard-Jones potential (Equation 2.3, [17, 18]) is an extension of the Born-Landé equation 
with the introduction of an attractive component for van der Waals interaction modelling as 
well as use of 𝑟𝑖𝑗
−6 dependence as deduced by London [19-22]; 
Equation 2.3 
𝑈𝑖𝑗
𝐿𝑒𝑛𝑛𝑎𝑟𝑑−𝐽𝑜𝑛𝑒𝑠 =
𝑏
𝑟𝑖𝑗
𝑛 −  
𝐶
𝑟𝑖𝑗
6  
with 𝑛 equalling 12. Modification of the variable 𝐶 controls the strength of the Lennard-Jones 
interaction. Removing the repulsive-component of the Lennard-Jones potential and replacing it 
with the Born-Mayer equation gives the Buckingham potential (Equation 2.4, [23]): 
Equation 2.4 
𝑈𝑖𝑗
𝐵𝑢𝑐𝑘𝑖𝑛𝑔ℎ𝑎𝑚 = 𝐴𝑒𝑥𝑝
−
𝑟𝑖𝑗
𝜌 − 
𝐶
𝑟𝑖𝑗
6  
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𝐴, 𝑝 and 𝐶 are all variable parameters; when 𝐶 equals zero, the Born-Mayer equation is 
implemented for short-range interatomic potentials. 
Short-range potentials require cut-off points because after exceeding a certain distance within 
the lattice, the interactions’ contribution to energy becomes negligible and thus can be omitted. 
Numerical values of cut-offs can be determined through iterative, identical, calculations which 
have increasing values of short-range cut-offs; the cut-off is then plotted against lattice energy. 
A plateau in the curve indicates the cut-off value has been reached because the calculated 
interionic interaction no-longer contributes to the overall energy. Cut-off values reduce 
computation time, and therefore lead to faster results. 
Two-body covalent bonds are described by short-range interatomic potentials (Equation 2.5): 
Equation 2.5 
𝑈𝑟𝑖𝑗 =  
1
2
𝑘(𝑟𝑖𝑗 − 𝑟𝑜)
2 
A more accurate description is given by the Morse potential (Equation 2.6), proposed by Philip 
Morse in 1929 [24]; this is a type of two-body interaction. The Morse potential is conveniently  
used to model covalently bonded atoms in a system, due to the parameter values becoming the 
dissociation energy of a diatomic species (𝐷𝑒), the equilibrium bond length (𝑟0) and a final term 
which is defined through coupling the dissociation energy, of a term, to the vibrational energy 
for the stretching mode of the structure (𝑎) [25]. 
Equation 2.6 
𝑈𝑖𝑗
𝑀𝑜𝑟𝑠𝑒 =  𝐷𝑒[(1 − 𝑒(−𝑎(𝑟 − 𝑟0)))
2 − 1] 
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Three-body interactions (Equation 2.7) model bond angles and, similar to two-body terms, the 
equation exists as a simple, harmonic spring, with 𝜃 being the angle between the interatomic 
vectors 𝑖 − 𝑗 and𝑗 − 𝑘. 
Equation 2.7 
𝑈𝜃𝑖𝑗𝑘 =  
1
2
𝑘(𝜃𝑖𝑗𝑘 − 𝜃𝑜)
2 
Furthermore, more sophisticated four-body potentials (Equation 2.8) can be implemented for 
dihedral or improper torsion angles. The latter is based on the generation of planes with the 
atoms 1-2-3 and 2-3-4 and the angle, 𝜓, exists between these two planes: 
Equation 2.8 
𝑈𝜓 =  
1
2
𝑘(𝜓 − 𝜓𝑜)
2 
Coulombic interactions (Equation 2.9) contribute up to 90% of the total energy for ionic 
structures; they are represented by a relatively simplistic equation with 𝑞 being the charge on 
the ions 𝑖 and 𝑗. The distance between the two charges is denoted 𝑟. 
Equation 2.9 
𝑈𝑖𝑗
𝐶𝑜𝑢𝑙𝑜𝑚𝑏 =  
𝑞𝑖𝑞𝑗
4𝜋𝜖0𝑟𝑖𝑗
 
2.3.2 Ewald Summation Method 
The Ewald summation provides a fast computational method for electrostatic quantities such as 
energies and forces [26], thus is often implemented over the slowly converging Coulombic 
equation. The concept is based on splitting the slowly convergent direct sum method into two 
distinct series for faster computation; thus the terms of the 1/𝑟 interaction are separated. 
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2.3.3 Force-Fields 
2.3.3.1 Layered Double Hydroxides 
Randall Cygan is the main author of the ClayFF force field [27], which was designed for simulation 
studies on hydrated crystalline compounds, as well as their interfaces with liquid phases [28]. 
This general force field treats the majority of the interatomic interactions as non-bonded 
potentials to accommodate modelling of both large- and highly-disordered systems [27]. Ionic-
covalent parameters for metal-oxygen interactions with hydrated phases are included, 
alongside a simple point charge model for water [29]. All metal-oxygen interactions are 
described by standard 12-6 Lennard-Jones potentials combined with Coulombic charges, with 
all atoms carrying point charges. 
Coulombic charges for oxygen and hydrogen atoms vary dependent on their bonding 
environment; i.e. their occurrence in either a hydroxyl moiety or in a water molecule. 
Furthermore, the force field incorporates harmonic terms to describe bond stretching and bond 
angle bending (three-body harmonic terms) in hydroxyl and water entities. 
With reference to layered double hydroxides (LDHs), the ClayFF force field can be implemented 
for a variety of different intercalates, thus removing the requirement for a new model for each 
individual LDH material. 
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2.3.3.2 Hydroxy Double Salts 
LDH-FF [30] is a force field that was developed through modifications to both the DREIDING and 
ClayFF [27] force-fields. The former force-field applies general force constants and geometry 
parameters instead of individual ones, as is the case for ClayFF, that are dependent on the atom 
combinations within bonds or angles [31]. These are efficient for their respective target 
structures, but they cannot model the ever-evolving class of layered materials because they only 
describe a limited number of metal cations. Therefore, the LDH-FF aimed to address this issue 
by adding in relevant interatomic potential parameters to allow in silico modelling of all the 
octahedrally co-ordinated metal cations within the hydroxide layer of the LDH. However, for this 
work, it was implemented for the simulation of hydroxy double salts (HDSs). HDSs contain both 
octahedral and tetrahedral M2+ cations in their layers, but the literature reports successful 
simulations of these materials using the LDH-FF [32]. 
2.3.4 Energy Minimisation 
To determine the equilibrium of a crystal structure, energy minimisation calculations are used 
which involve iterative numerical procedures and the adjustment of ion-positions within the 
lattice until the force exerted upon it equates to zero (Equation 2.10); 
Equation 2.10 
𝛿𝑈𝐿
𝛿𝑟
= 0 
where the 𝑈𝐿  term represents the lattice energy of a lattice which consists of 𝑁 ions with co-
ordinates 𝑟′, defined through the original co-ordinates 𝑟. 
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Computer simulation studies can readily locate local energy minima because upon reaching the 
lowest point in an energy trough (denoted “Local Energy Minimum” in Figure 2.4), the 
calculation ceases at the predicted optimum conformation of the input structure [33]. Iterative 
calculations are required to obtain global energy minima for simulated structures. One such 
method is the Newton-Raphson approximation which utilises second derivatives to converge on 
the global energy minimum for the input structure (Figure 2.4). However, this numerical process 
increases the computation time for calculations [33]. 
 
 
 
2.4  Characterisation 
2.4.1 Powder X-ray Diffraction 
Powder X-ray diffraction (P-XRD) is a characterisation technique based upon the fact that a beam 
of X-rays can be diffracted by planes of atoms in a crystal. These diffracted X-rays are recorded 
by a detector which logs the angles at which they arise, and this information helps determine 
the spacing between the various planes of atoms within a sample. The resultant diffraction 
pattern is a plot of the intensity of reflections against the angle, 2θ, whereby θ is both the 
incident and reflected angle arising between the X-ray beam and the sample.  
Figure 2.4: A graphical representation of local and global energy minima; adapted from 
http://doye.chem.ox.ac.uk/research/gopt.html. 
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Reflected X-rays have the potential to constructively interfere with one another when the Bragg 
condition is met (Equation 2.11). In this setting, “d” is the spacing between the planes, θ is the 
angle between the incident and reflected beams and the plane, and “n” is an integer for the 
order of the reflection. In any material, there are multiple different sets of planes of atoms that 
can cause diffraction, and each set of planes is defined by three Miller indices (denoted h, k and 
l), as is shown in Equation 2.11. Each set of indices corresponds to how the planes intersect the 
x, y and z axes of the material’s unit cell. Each crystalline material has its own unique 
“fingerprint” diffraction pattern which can be analysed to provide information on the crystal 
structure. 
Equation 2.11 
𝑛𝜆 =  2𝑑ℎ𝑘𝑙𝑠𝑖𝑛𝜃 
A diffraction pattern’s resolution is dependent on the number of aligned planes that are 
contributing to a given reflection. Use of the Scherrer equation – given in Equation 2.12 – 
provides a means of calculating the average dimensions of the crystallites in the sample. The 
information required for this calculation is the angular width of the diffraction peak at half its 
height (β; the full width-half maximum) and the diffraction angle θ (both of these values must 
be in radians). L denotes the crystallite size, and K is a constant. 
Equation 2.12 
𝐿 =  
𝐾𝜆
𝛽𝑐𝑜𝑠𝜃
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It is important to remember that the K-constant reflects the sample morphology, therefore data 
must be cautiously analysed if the morphology of the sample is not known or irregular. For 
simplicity, the value of K used within this work is 1. The crystallite size is not the only factor 
contributing to the width of reflections in the P-XRD pattern: strain in the particles is also 
important, and there will always be some inherent broadening from the instrument. Hence, the 
values calculated by the Scherrer equation are often not exact (unless rigorous calibration is 
performed). Nevertheless, they can be useful to compare series of samples.  
2.4.2 Scanning Electron Microscopy 
Scanning electron microscopy (SEM, Figure 2.5) allows for the direct visualisation of a solid 
material’s morphology. A high degree of magnification is achieved because the wavelength of 
the electron beam is far less than that of visible light, allowing for a higher resolution image to 
be obtained. 
 
Figure 2.5: Schematic diagram of the SEM instrumentation. 
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A sample is usually coated with a thin layer of a conducting metal prior to analysis; this 
conductive coating prevents charging of the sample with the electron beam in the high vacuum, 
high voltage, environment of the SEM chamber. The sample surface is bombarded with an 
accelerated electron beam to generate signals at the point of contact. X-rays, backscattered- 
and secondary-electrons are emitted as a result, with the latter signal type giving rise to a high 
resolution image which can be used for subsequent size and morphology analysis. 
2.4.3 Fourier Transform Infra-Red Spectroscopy 
The original means of infra-red (IR) spectroscopy was a dispersive method which separated 
individual frequencies of energy emitted from an IR source; modern methods adopt the Fourier 
transform (FT) technique because it is high-throughput and has high sensitivity. 
In FTIR, the spectrometer splits the incident IR beam into two separate beams via a beamsplitter; 
ideally, this will transmit 50% of the original IR beam to a moving mirror and the remaining 50% 
will reach a stationary mirror – as depicted in Figure 2.6. The reflected beams recombine at the 
beamsplitter where either constructive or destructive interference occur.  An interferogram 
arises from this interference, as the path difference between the two beams varies. This must 
be converted to a frequency spectrum for analytical interpretation; therefore, the FT calculation 
is performed, generating a spectral means of analysis. 
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Figure 2.6: Schematic diagram of the key aspects of an FTIR spectrometer. 
Absorption in the infra-red (IR) spectrum causes vibrational and rotational changes to a molecule 
or extended material. A material will only absorb the IR radiation if the absorption alters its 
dipole moment, but in the systems reported in this work this condition is met. As a result, FTIR 
provides structural information about the samples prepared, for example indicating the 
presence of functional groups and bonding interactions. 
2.4.4 Nuclear Magnetic Resonance  
Nuclear magnetic resonance (NMR, Figure 2.7) exploits the spin properties of atomic nuclei to 
elucidate information on the structure of a sample. The application of a magnetic field causes 
the different spin states of nuclei, which are degenerate in the absence of a field, to have 
different energies. The nuclei will adopt the lowest-energy configuration, giving rise to a 
macroscopic magnetisation which is the basis of NMR spectroscopy.  
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Nuclear magnetic moments (NMMs) are deflected away from their lowest energy configuration 
by implementation of radiofrequency irradiation. The resultant deflected NMMs begin rotating 
(precessing) about the static magnetic field, with the frequency of this precession being 
dependent on several factors including the type of atom(s) present and the strength of the 
magnetic field. Samples are placed in a small wire coil, and the precessing magnetic field induces 
an alternating voltage in the coil to generate an NMR signal.  
Spin-active atomic nuclei respond to a specific resonance frequency which can be interpreted 
to give information on its position in a chemical structure. The frequencies of precessing NMMs 
are translated to resonance lines in an NMR spectrum. Each position is representative of a 
nucleus and its location in the overall chemical structure. 
 
Figure 2.7: Schematic representation of a nuclear magnetic resonance spectrometer. The sweep 
generator aids the passage of radiofrequencies through the resonance frequencies of the sample-of-
interest, whereby they are transmitted by the radiofrequency transmitter and amplified 
(radiofrequency amplifier) for subsequent detection (by the detector) and amplified again (audio 
amplifier) in order to be displayed as a spectrum on the recorder. 
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2.4.5 Thermogravimetric Analysis 
Thermogravimetric analysis (TGA) is a quantitative measure of the change in the mass of a 
sample as a function of temperature or time. The sample is usually subjected to a gradual 
increase in temperature, in a controlled atmosphere with an inert gas (usually nitrogen). The 
analyser comprises four key parts: the electrobalance and its controller, the furnace and 
temperature sensors, the computer and the data acquisition device. In this work, TGA has been 
used to explore the thermal degradation patterns of selected samples. 
In order to determine decomposition it can be helpful to overlay the TGA curve with the 
derivative thermogravimetric curve, which depicts the rate of mass change with respect to time. 
The derivative trace provides information to help deduce the separate degradation events. 
2.4.6 X-ray Photoelectron Spectroscopy 
X-ray photoelectron spectroscopy (XPS) is a surface analytical technique. The average sampling 
depth is a few nanometres, and because of this samples must be prepared in a glove box to 
prevent surface contamination which can confound analysis. 
The technique involves irradiating a sample with low energy X-rays in order to induce the 
photoelectric effect. The energy of the emitted photoelectrons is quantified by an electron 
spectrometer. Like SEM, the sample is analysed in a vacuum chamber, which aids the 
transmission of photoelectrons to the analyser and reduces the risk of re-contamination of the 
prepared sample.  
XPS excites the core electrons from the atoms within a sample. Since the energies of these are 
largely unaffected by the local environment and bonding, we can use XPS to deduce the 
elemental composition of a sample, as well as obtain information about the co-ordination 
numbers of the atoms. 
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2.4.7 Surface Area Analysis 
By adsorbing inert (usually nitrogen) gas onto the surface of a solid, it is possible to calculate the 
surface area of the adsorbent material. As a result of measuring the amount of gas that is 
adsorbed to the solid as a function of the pressure of gaseous nitrogen, an adsorption isotherm 
can be produced. Pressure is expressed as P/P0, where P denotes the pressure of nitrogen and 
P0 represents the saturated vapour pressure at the adsorption temperature, with an anticipated 
range of 0 ≤ P/P0 ≥ 1.0. When nitrogen is the adsorbate, adsorption isotherms are usually 
collected at 77 K when the saturated nitrogen vapour pressure is 1.0 atmosphere. 
Adsorption of nitrogen onto the sample can be either via van der Waals or dative interactions 
and adsorption isotherms are categorised according to the porosity of the adsorbent. There are 
six isotherm categories under the IUPAC classification system (Figure 2.8 - [34]). 
 
Figure 2.8: IUPAC classification of isotherms [34]. Type I arises from a monolayer forming on the 
sample’s surface, II from non-porous materials with multiple adsorption layers, III indicates no 
adsorption layers, IV represents mesoporous samples, Type V is similar to Type III, having very few 
interactions arising between the adsorbent and adsorbate, and Type VI corresponds to materials with 
inconsistent pore sizes, resulting to the multiple steps in the adsorption curve. 
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The Braunauer, Emmett and Teller (BET) model is an extension of the Langmuir model and is 
applied to samples with Type I adsorption isotherms, with the main assumption being that a 
monolayer of gas is formed on the absorbent. The BET model contains its own set of 
assumptions, which include: (i) the adsorbate may form multiple layers on the sample’s surface, 
and (ii) interactions between the vapour and the surface correspond to adsorption/desorption. 
The BET equation is given in Equation 2.13: 
Equation 2.13 
𝑃
𝑉(𝑃0 − 𝑃)
=
1
𝑉𝑚𝑐
+
(𝑐 − 1)
𝑉𝑚𝑐
.
𝑃
𝑃0
 
𝑃 is the equilibrium pressure of the adsorbate and 𝑃0 is the saturated vapour pressure. 𝑉 is the 
volume of nitrogen gas adsorbed at 𝑃/𝑃0, whilst 𝑉𝑚 is the volume of nitrogen gas adsorbed to 
form the monolayer and the constant 𝑐 is attributed to the net heat of adsorption. By plotting 
the two quantities in Equation 2.14, a linear relationship between 𝑃/𝑃0 values of 0.05 and 0.35 
is obtained:  
Equation 2.14 
𝑃
𝑉(𝑃0 − 𝑃)
 𝑣𝑠.
𝑃
𝑃0
 
The intercept 
1
𝑉𝑚𝑐
 and the slope 
(𝑐−1)
𝑉𝑚𝑐
 can be used to calculate the value of 𝑉𝑚 and thus the 
sample’s surface area. The surface area is normally calculated with the desorption isotherm 
(Equation 2.15) with 𝑁𝐴 being Avogadro’s constant (6.022 x 10
23 mol-1), 𝐴𝑀 denoting the cross-
sectional area of the adsorbate molecule (0.162 nm2 for nitrogen gas) and 𝑀𝑉 representing the 
gram molecular volume (22,414 mL): 
Equation 2.15 
𝑆𝐴 =  
𝑁𝐴𝑥𝐴𝑀𝑥𝑉𝑚
𝑀𝑉
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2.4.8 Pore Volume Analysis 
The Barrett, Joyner and Halenda (BJH) method is used to calculate pore size distribution of 
porous solid samples within this thesis; it is implemented for analysis of mesoporous solid 
samples (type IV isotherms). It should be noted that the assumptions made here differ from 
those of the BET equation used for surface area analysis, but since they are being used to 
calculate different properties this should not be problematic.  The BJH method is based on the 
Kelvin equation (Equation 2.16): 
Equation 2.16 
𝑙𝑛
𝑃
𝑃0
=
−2𝛾𝑉𝑚
𝑟𝑅𝑇
. 𝑐𝑜𝑠𝜃 
Where 𝑃/𝑃0 gives the relative vapour pressure at which condensation occurs in the pores with 
a liquid nitrogen droplet of radius 𝑟, and a contact angle of the condensed liquid within the pore 
of 𝜃.  𝛾 denotes the surface tension, 𝑉𝑚 is the molar volume of the liquid, 𝑅 is the universal gas 
constant, and 𝑇 is the temperature in Kelvin. 
The following assumptions are made for the BJH method: 
1. All pores are of a uniform shape 
2. All pores are in the mesoporous range of 2 – 50 nm 
Pores in the surface of the adsorbent material can affect the shape of the adsorption/desorption 
isotherm because the equilibrium vapour pressure above a condensed liquid in a pore, where 
the surface of the liquid has a meniscus, is lower than that above a liquid with a flat surface. 
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The Kelvin equation relates the equilibrium vapour pressure of a liquid in a pore to both the 
radius of the pore, 𝑟, and the contact angle, θ. As the equilibrium vapour pressure above a 
curved surface is lower than that obtained for a flat surface, the vapour condenses in the pores 
at lower P/P0 values than that of a flat surface. It also follows that narrow pores fill at lower 
pressures than wider ones.  Using the pressure at which condensation occurs, it is possible to 
calculate the radius of the pores in the solid material – see Equation 2.17. 
Equation 2.17 
𝑟 =  − 
2. (8.85. 10−3). (3.467. 10−5)
(8.314). (77.3). ln (
𝑃
𝑃0
)
 
The BJH method includes a correction term for the pore radius, accounting for a film of 
condensed vapour lining the pore wall, and thus the pore radius is larger than the radius 
calculated for the meniscus. 
2.4.9 Zeta Potential 
The zeta potential (ZP) is a physical property arising when particles are dispersed in liquid for 
the generation of a suspension. It can be used to determine a formulation’s stability and is 
defined as the charge at the boundary between the inner and outer layers in the electrical 
double layer. In order to obtain a zeta potential measurement, an electric field must be applied 
to a dispersion of particles contained within a folded, zeta-capable cell (Figure 2.9), which allows 
the negatively-charged particles to move towards the cathode (Figure 2.9) with a velocity that 
is related to their zeta potential. The velocity is determined using a laser interferometric 
technique that calculates the electrophoretic mobility, and thus zeta potential, of the particles. 
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Figure 2.9: The folded, zeta-capable capillary cell used in zeta potential measurements. Application of 
an electrical current causes particles bearing a negative surface charge to migrate to the cathode 
(indicated by the left arrow). 
However, stability problems with the dispersion or solution can hinder the calculation of zeta 
potential values. It is possible for aggregates to form in these systems if the particles adhere to 
one another, and these may sediment due to the effects of gravity. A loosely bound aggregate 
is referred to as a “floc”, and in such instances the particles can easily be separated by shaking.  
However, if the particles aggregate to generate a tightly-bound coagulant this cannot be broken 
apart and ultimately will result in caking, which occurs when densely packed sediments which 
cannot be re-dispersed are formed. After sedimentation, particles have limited or no velocity 
following the application of an electric field, therefore, their electrophoretic mobility cannot be 
calculated. 
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2.4.10 Dynamic Light Scattering 
Dynamic light scattering (DLS) measures Brownian (random, non-directed) motion and relates 
this to the size of the particles in the sample. DLS shines a laser beam through the sample and 
uses the resultant fluctuations in intensity of scattered light to deduce the rate of movement 
and hence the size of the particles. A speckle pattern (see Figure 2.10) is obtained by the 
machine with each dot representing an active particle. The bright regions indicate constructive 
interference between scattered light of the same phase, whilst dark regions highlight destructive 
interference of out-of-phase scattered light.  
 
Figure 2.10: Schematic of the speckle pattern seen by DLS. Moving particles generate a speckle pattern 
which is not static and constantly evolves with changes in the suspension due to particle movement. 
Consistent with Brownian motion, large particles move more slowly and cause reduced intensity 
fluctuations. As a result, the speckle pattern does not change as frequently as is seen with 
smaller particles in suspension. These changes in the scattering pattern are used to determine 
particle size with the DLS technique. 
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2.5  Immunoassay Experiments 
2.5.1 RAW264.7 Cell Line 
The murine macrophage RAW264.7 cell line was used for immunoassay experiments. This is a 
semi-adherent cell line derived from adult, male BALB/c mice with Abelson leukaemia virus-
induced tumours. This macrophage cell line was selected for immunological studies because 
macrophages are antigen-presenting cells, and thus important mediators of the immune 
response. Macrophages are fundamental in engulfing and processing pathogenic entities for 
presentation of the antigen to T-cells. 
2.5.2 Cell Viability Assays 
Cell viability assays used the Alamar Blue reagent which exploits the reducing environment of 
healthy cells’ cytosol. Alamar Blue is sodium resazurin dissolved in complete-Dulbecco’s 
Modified Eagle Medium (DMEM) to a concentration of 5mM. Sodium resazurin is a non-toxic 
compound that can permeate cell membranes. Once inside the cells’ cytosol, the minimally 
fluorescent blue solution is reduced to a highly fluorescent purple sodium resorufin compound 
by healthy, living cells. The change in fluorescence can be quantified using a plate reader. It is 
possible for the resazurin to be reduced by the medium too, however; therefore, it is necessary 
to have appropriate controls to make sure that the changes observed can be attributed to the 
cell viability rather than any other factors. 
2.5.3 Cytokine Production Assays 
A “sandwich” Enzyme-Linked ImmunoSorbent Assay (ELISA) provides a quantitative means of 
determining the cytokine concentrations produced (in this work by RAW264.7 macrophages) in 
response to adjuvant exposure. After culture, the supernatant is isolated and frozen for future 
analysis. 
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The assay works by coating a clean absorbent plastic plate with a capture antibody specific for 
the cytokine of interest. The plate then has any non-specific binding sites blocked via a protein 
buffer solution. The defrosted cytokine-containing supernatants are added, and the cytokine 
molecule therein will be bound by the capture antibody. After an incubation period, the 
supernatant is aspirated and the plate washed prior to the addition of a specific primary 
antibody which binds to, and hence “sandwiches”, the cytokine of interest. 
Subsequently, an enzyme-linked secondary antibody is added and binds to the primary antibody. 
Finally, unbound enzyme-antibody conjugates are removed prior to the addition of a 2,2’-azino-
bis(3-ethylbenzothiozoline-6-sulphonic acid) [ABTS] substrate solution. The substrate is 
converted by the enzyme to a fluorescent molecule which is quantified to determine the relative 
concentration of cytokine in the supernatant. 
2.5.4 Confocal Microscopy 
Confocal microscopy uses laser light sources, with the excitation line bandwidth being 
determined by the source. The laser beam illuminates the entire visual field, rapidly scanning 
across the sample in a raster fashion. The fluorescence recorded at each point is measured by 
the photomultiplier tube to generate a complete image (Figure 2.11). The key advantage of this 
microscopy technique is that you can excite different fluorophores, within different regions of a 
cell, at the same time to view them as a single image. 
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Confocal is a sophisticated fluorescence microscopy with a pinhole situated directly in front of 
the photomultiplier tube (this is used for the detection of weak signals) to remove all out-of-
focus fluorescence, with the hole diameter controlling the vertical distance from which 
fluorescence is detected (capture). Therefore, optical slices can be produced which allow the 
three-dimensional structure of a cell to be visualised. A smaller pinhole diameter corresponds 
to thinner optical slices. 
 
Figure 2.11: (A) schematic representation of a confocal microscope and (B) the function of the pinhole. 
The objective lens is located near to the sample and, thus, has a short focal length. The dichroic mirrors 
have different reflection and transmission properties at different wavelengths, while the galvanometer 
mirror is an electrochemical device which deflects light beams in response to electrical currents. 
Altering the focus of the microscope enables a 3-dimensional (3D) image of the object to be 
formed; each image is known as a “z-section” and can be stacked on top of one another to create 
a single 3D image. 
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3.1   Introduction 
AlO(OH) is the most commonly used adjuvant in vaccine formulations [1]. It can be synthesised 
via different hydrothermal routes to control its crystal habit [2], as is discussed in more detail in 
Section 1.2.1.5. 
The objective of the work reported in this chapter was to develop a library of AlO(OH) samples 
with different particle size and shape, to characterise these, and to perform a range of 
immunoassays. Different preparative methods were investigated, using nitrate, chloride and 
sulphate salts of aluminium in the presence of a precipitating agent – either sodium or potassium 
hydroxide. The ultimate goal was to relate the particle size and shape of the synthesised 
adjuvant materials to their immunogenicity in vitro, in the hope of being able to tune the 
immune response through chemistry. 
3.2   Materials and Methods 
3.2.1 Synthesis  
3.2.1.1 Continuous Plastic Flow Reactor 
A schematic representation of the continuous plastic flow synthesis (CPFS) apparatus is 
presented in Figure 3.1. Two high-performance liquid chromatography (HPLC) pumps supply 
two streams of liquid to a T-piece. 
 
Figure 3.1: (A) Diagrammatic representation of the continuous plastic flow synthesis (CPFS) process, 
with the example of aluminium sulphate as the precursor. 'P-1' and 'P-2' are high pressure liquid 
chromatography (HPLC) pumps, and 'reactor' denotes a heated silicon oil bath; (B) photograph of the 
CPFS apparatus. 
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One pump was designated for the aluminium salt precursor solution (P-1), and the second for 
the precipitating agent (P-2) precursor, e.g. aluminium sulphate and sodium aluminate, 
respectively (see Figure 3.1).  Both precursors are pumped at a rate of 10 mL min-1 (at 
atmospheric pressure) through 1/16” inner diameter polytetrafluoroethylene (PTFE) tubing, 
before mixing at the T-piece junction. The mixture then flows through an 8 metre length of 1/8” 
diameter PTFE tubing, coiled inside a silicon oil bath, to give a residence time of 10 minutes. The 
flow rates were controlled digitally by the HPLC pump interface (Gilson model 305/25.0 mL 
pump head), while the temperature of the silicon oil bath was set by a thermostat. The pH of 
both precursors, the pH of the product slurry, and the temperature of the oil bath were 
monitored throughout the experiment. 
The product slurry was continuously collected from the output-end of the coiled PTFE -tubing. 
A solid white product was then recovered by centrifugation (4500 rpm for 5 minutes) and 
washed with copious amounts of deionised water. Sequential rounds of washing and 
centrifugation were performed until the conductivity of the supernatant water was reduced to 
a value less than 50 S m-1. The product was then freeze-dried at -40 °C under vacuum (between 
70-80 mTorr) for approximately 24 hours (Virtis Genesis 35XL freeze drier) prior to 
characterisation and further analysis. 
Precursor slurries of 0.6 M sodium aluminate (Sigma Aldrich, 0011138491) and 0.1 M aluminium 
sulphate hydrate (Alfa Aesar, 17927-65-0) were initially made up in deionised water. These 
solutions had pH values of 14 and 4, respectively. Other salts were also explored and details will 
be given in Sections 3.4.3 and 3.4.4. 
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3.2.1.2 Continuous Hydrothermal Flow Synthesis 
A diagrammatic depiction of a three-pump lab scale continuous hydrothermal flow synthesis 
(CHFS) process is presented in Figure 3.2A. The majority of the core components were 
constructed from SwagelokTM 316 SS components. Control and monitoring of reaction conditions 
(i.e. pump flow rates, heater output and process temperature) was achieved real-time on a 
computer (CompactRio, National Instruments) using the LabViewTM software (National 
Instruments). Three high-pressure diaphragm pumps (Milton Roy, Primeroyal K) can be used 
simultaneously (see Figure 3.2B) with the first pump, denoted P-1 in Figure 3.2A, pumping 
deionised water. This flows at a rate of up to 80 mL min-1 (at 240 bar) through two custom made 
7 kW heaters (denoted “electrical heater” in Figure 3.2A), with specific design details described 
by Gruar et al. [3]. The remaining pumps (P-2/P-3) are identical to P-1, and are used to deliver 
precursors – usually water-soluble metal salts, acids and bases – with a combined flow rate of 
up to 300 mL min-1. 
During the CHFS process, supercritical water (red arrow in Figure 3.2C, [3]) enters the inner pipe 
at the base of the confined jet reactor whilst the precursors (blue and green arrows in Figure 
3.2C) are fed in below the outlet of supercritical water, which then exits the inner pipe as a 
turbulent jet [3]. The resultant mixture flows upwards (3/8” outer diameter (OD), 0.103” wall 
thickness, length 0.5m) prior to passing through a cooling pipe section (denoted “cooler” in 
Figure 3.2A) [1/4” OD, 0.049” wall thickness, length 1.5 m], around which cooling water flows 
concurrently (flow rate of 10 L min-1, inlet T = 15 °C). The cooled product exits the CHFS process 
via a manually actuated back-pressure regulator (denoted ”BPR” in Figure 3.2B; BPR, Tescom) 
and was continuously collected at atmospheric pressure [4]. 
The product was recovered in the same manner as for CPFS, described in Section 3.2.1.1.
Chapter 3 Particle Engineering of Aluminium Oxyhydroxide 
 
115 
 
 
Figure 3.2: (A) A diagrammatic representation of the CHFS reactor; P-1, P-2 and P-3 are pumps supplying 
deionised water (D.I. H2O), aluminium nitrate nonahydrate [Al(NO3)3·9H2O] and potassium hydroxide 
(KOH), respectively. Adapted and reproduced from [5]; (B) a photograph of the 3-pump continuous 
hydrothermal reactor used for direct synthesis of aluminium oxyhydroxide nanoparticles; BPR = back-
pressure regulator; and (C) the geometry of the confined jet reactor in CHFS; reprinted  from ref [3], 
copyright © 2014, American Chemical Society. 
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3.3   Characterisation 
3.3.1 Powder X-Ray Diffraction 
Powder X-ray diffraction (PXRD) patterns were collected using a Rigaku MiniFlex 600 
diffractometer supplied with Cu-Kα radiation (λ = 1.5418 Å). Each sample was loaded onto an 
aluminium plate and scans were undertaken at a rate of 2.5° min-1 over a 2θ range of 3-70°. The 
X’Pert Data Viewer software package was used to visualise the data. 
3.3.2 Scanning Electron Microscopy 
Samples were prepared for scanning electron microscopy (SEM) by placing a small amount of 
each sample onto double-sided carbon tape fixed to an aluminium support, and then sputter 
coating with gold. A FEI Quanta 200 FEG ESEM was used for generating SEM images, which were 
collected by Mr David McCarthy or Mrs Kate Keen. Measurements of particle size and 
morphology were carried out using the freely available ImageJ software 
(http://imagej.nih.gov/ij/), on 300 individual particles.  
3.3.3 Fourier Transform Infra-Red Spectroscopy 
Fourier Transform Infra-Red (FTIR) spectroscopy was performed on a Perkin-Elmer Spectrum 
100 instrument fitted with an attenuated total reflectance (ATR) accessory over the 
wavenumber range of 4000 to 650 cm-1, with the resolution for each measurement being 1 cm-
1. 
3.3.4 Solid State NMR Spectroscopy 
27Al-magic angle spinning (MAS) NMR was performed by Dr Abil Aliev (Department of Chemistry, 
UCL) using a Bruker Avance I spectrometer fitted with 4 mm double resonance MAS probes, 
where the X-channel is tuneable in the frequency range 15N to 31P and the decoupling channel is 
tuned to 1H. The frequency used for 27Al-MAS measurements was 78 MHz. 
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3.3.5 X-ray Photoelectron Spectroscopy 
X-ray photoelectron spectroscopy was performed for the amorphous alum samples using a K-
AlphaTM+ XPS System (ThermoFisher Scientific) supplied with a micro-focussed, monochromated 
Al K-α source. XPS spectra were obtained at the National EPSRC XPS Users’ Service (NEXUS) at 
Newcastle University, an EPSRC Mid-Range Facility. 
3.3.6 Zeta Potential Measurements 
Zeta potential measurements were performed using a Nanozetasizer ZS (Malvern Instruments); 
10 mg of each sample was dispersed in 1 mL of either phosphate-buffered saline (PBS) or 
ultrapure water with resistance of at least 18.2 mΩ (UP-water). The resultant suspension was 
transferred to a folded zeta-capable capillary cell (DTS 1070, Malvern Instruments) for 
measurements. Twelve measurements were recorded for each sample, with each suspension 
made up twice, and 6 measurements recorded on each. The data are reported as the mean ± 
the standard deviation. 
3.3.7 In vitro and Immunoassay Experiments 
Murine RAW264.7 cells (ATCC) were cultured in Dulbecco’s Modified Eagle Medium (DMEM, Life 
Technologies) supplemented with 10% v/v foetal bovine serum (FBS, Life Technologies), 2 mM 
L-glutamine, 100 U mL-1 penicillin and 100 µg mL-1 streptomycin (Life Technologies) to produce 
complete-DMEM. Cells were maintained in culture flasks at 37 °C in a humidified atmosphere of 
5% CO2. 
The maximum viable passage number is 18, because there are changes in transfection efficiency 
past 25 passages [6], and cells were passaged every 2 – 3 days. The cell concentration at the 
start of a new passage was 5x105 cells mL-1.  
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3.3.7.1 Alamar Blue Assay 
All assays were performed with RAW264.7 cells below passage number 15. Cytotoxicity assays 
were performed using the Alamar Blue® protocol, with cells cultured in 96 well flat-bottomed 
plates. 200 μL of a cell suspension at 5x105 cells mL-1 was added to each well in the presence of 
10 μL of lipopolysaccharide (LPS) solution or 10 μL of an adjuvant suspension (10 mg mL-1) and 
incubated for 24 hours. The final concentrations were 100 ng mL-1 of LPS and 476 μg mL-1 of 
inorganic adjuvant. Commercially-used alum adjuvants (Alhydrogel and Adju-Phos, Brenntag 
Biotech) were used as controls at 10 mg mL-1 initial concentrations, giving rise to final 
concentrations of 476 μg mL-1 of each. Following a 24-hour exposure period, 40 μL of Alamar 
Blue® solution (5 mM sodium rezaurin in complete DMEM) was added to each well and the 
plates were further incubated at 37 °C. At various time points thereafter, measurements of 
optical densities at an excitation of 555 nm and emission of 585 nm were undertaken using a 
microplate reader (SpectraMax M2e, Molecular Devices). Independent experiments were 
performed in triplicate, with three plates per experiment and three tests per plate, giving rise to 
27 replicates. 
3.3.7.2 Enzyme-Linked Immuno-Sorbent Assay 
RAW264.7 cells were stimulated with LPS, commercially available alums and synthesised 
AlO(OH) adjuvant samples, using the same protocol as in Section 3.3.7.1. Culture supernatants 
were collected after 24 hours following centrifugation of the 96-well plates; aspiration of 150 μL 
of the cell-free supernatant from each well was achieved through the use of a multi-channel 
pipette. These were transferred to a new plate and were stored at -20 °C until assayed for 
cytokines. Three independent experiments were performed, with three replicates in each.  
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Levels of tumour necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) in the cell-free 
supernatant were quantitatively determined using enzyme-linked immunosorbent assay (ELISA) 
kits according to the protocol suggested by the manufacturer (Insight Biotechnology). Colour 
development was monitored using a SpectraMax M2e microplate reader. End-point 
measurements of maximum optical density were obtained at 5-minute intervals for a period of 
30 minutes with the plate reader set to 405 nm with wavelength correction set to 650 nm. 
3.3.7.3 Fluorescence and Confocal Microscopy 
All assays were performed with RAW264.7 cells below passage number 15.  
Prior to assaying, the adjuvant samples were labelled with fluorescein isothiocyanate (FITC; 
Sigma Aldrich UK) by continuously mixing the material in a 5mM solution of FITC (5 mL) for at 
least 24 hours. Successive rounds of centrifugation and washing with PBS were undertaken until 
the supernatant of the sample was clear and colourless, in order to remove any unbound FITC 
from the adjuvant suspension. 
A 24-well plate was used and 13 mm-diameter circular glass cover slips were added to each well. 
50 μL of well-dispersed RAW264.7 cell suspension (5x105 cells mL-1) was dropped onto the glass 
cover slip. FITC-labelled commercially-used alum adjuvants (Brenntag Biotech) were used as 
controls, alongside FITC-labelled adjuvant samples prepared in this work (10 mg mL-1 in PBS). A 
10 μL volume of the labelled sample was dropped on top of the cell suspension, which was then 
incubated for 24 hours in a humidified atmosphere of 5% CO2 at 37 °C. 
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After 24 hours, 10 μL of 0.1 μg mL-1 solution of 4’, 6-diamidino-2-phenylindole (DAPI) stain 
(Sigma Aldrich, UK) was dropped onto the cell/sample droplet, which was then returned to the 
incubator for 30 minutes prior to capturing images using a fluorescent microscope (EVOS FL Cell 
Imaging System, Life Technologies Ltd) to determine the location of adjuvant sample in relation 
to the RAW264.7 cells. An x20 objective lens was used in this study. The FITC was excited at 470 
nm and the emission fluorescence monitored at wavelengths of ca. 510 nm. The DAPI was 
excited at 360 nm and the emission fluorescence collected at ca. 450 nm. Overlays were 
obtained by stacking the two fluorophore images to determine any co-localisation.  
Samples were prepared for analysis using a confocal microscope via application of 50 μL of a 4% 
v/v aqueous solution of formaldehyde (fixing agent) to the cell/adjuvant droplets, prepared as 
detailed above, at 4 °C. The plates were gently agitated for at least 30 minutes and the fixing 
solution was removed. The cells were then washed and 50 μL of complete-DMEM added. The 
cover slips were retrieved from the 24-well plate and mounted on a glass slide. 
A Zeiss LSM 710 confocal microscope was used for these studies. It is equipped with a 30 mW 
405 nm diode laser which is used for visualisation of the DAPI stain, a 25 mW argon ion laser 
(lines produced at 458, 488 [for the green FITC stain] and 514 nm), as well as a 25 mW 595 nm 
diode laser and a 5 mW 633 nm HeNe laser which are for red fluorophores. However, in this 
setting no red dyes were used, thus these lasers were used to determine any sample 
degradation.  
3.4   Results and Discussion 
3.4.1 Continuous Plastic Flow Synthesis – Sulphate System 
3.4.1.1 Synthesis 
Aluminium sulphate and sodium aluminate precursors were dissolved into deionised water to 
0.1 and 0.6 M concentrations, respectively. The residence time was set to 10 minutes and 
reactions performed at 45, 65, 80 or 90 °C; see Table 3.1. Approximately one gram of product 
was obtained after 10 minutes of collection. 
Chapter 3 Particle Engineering of Aluminium Oxyhydroxide 
 
121 
 
Table 3.1: Synthesis details for preparation of AlO(OH) particles via a continuous hydrothermal flow 
process, using aluminium sulphate as the aluminium source. 
Sample ID 
[Al2(SO4)3·H2O] 
/ M 
[NaAlO2] 
/ M 
Flow rate  
/ mL min-1 
Reaction 
temperature 
/ °C 
Product 
pH 
CPFS-Sulphate-45 0.1 0.6 20 45 6 
CPFS-Sulphate-65 0.1 0.6 20 65 6 
CPFS-Sulphate-80 0.1 0.6 20 80 14 
CPFS-Sulphate-90 0.1 0.6 20 90 14 
3.4.1.2 Characterisation 
Powder XRD patterns of the products obtained are shown in Figure 3.3. The CPFS-Sulphate-45 
and CPFS-Sulphate-65 samples were found to be completely amorphous, with no Bragg 
reflections visible in their P-XRD patterns. In contrast, all detectable reflections for the 80 and 
90 °C products can be assigned by their positions to standard Bragg reflections of the boehmite 
polymorph of AlO(OH) [γ-AlO(OH)] [7]. No impurities were detected. The reflections observed 
are very broad, indicative of small crystallite sizes. 
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Figure 3.3: P-XRD patterns of AlO(OH) samples synthesised via the CPFS process. The reference pattern 
for γ-AlO(OH) is obtained from the ICSD (93734 [7]) as is that for the gibbsite polymorph of Al(OH)3 (6162 
[8]). The experimental patterns in (A) are of CPFS-Sulphate-45 and -65, whilst the crystalline materials 
in (B) are CPFS-Sulphate-80 and -90. 
In order to gain more information on the materials prepared, particularly the amorphous low-
temperature systems, solid state NMR and XPS analyses were undertaken. 
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Figure 3.4: Solid state NMR spectra recorded to deduce the composition of the amorphous products 
from sub-60 °C synthesis, via comparison to a known γ-AlO(OH) standard. (A) the spectra obtained after 
CPFS synthesis at 45 and 65 °C; (B) the spectrum from γ-AlO(OH) synthesised at 90 °C and (C) a literature 
spectrum for the gibbsite polymorph of Al(OH)3 [9]. 
27Al-MAS solid-state nuclear magnetic resonance (SS-NMR) spectra show that the CPFS-
synthesised pure-phase AlO(OH) has a single peak arising at 5.45 ppm, whereas the CFPS-
Sulphate-45 and CPFS-Sulphate-65 samples have two peaks (Figure 3.4). The main peak is 
observed at ca. 4.26 ppm indicative of octahedrally co-ordinated aluminium [10], with a second, 
smaller peak detected at ca. 33 ppm. These peak positions match closely with the literature data 
for γ-Al(OH)3 at 7.5 and 36.5 ppm  [11]. These findings indicate that below 70 °C the CPFS process 
is yielding amorphous gibbsite. The results of XPS analysis – Table 3.2 – also tend to imply that 
these products comprise aluminium hydroxide [Al(OH)3] [9, 12], although the O:Al ratio is less 
than 3:1 suggesting that some AlO(OH) or other Al-containing species may also be present. 
The phase-pure CPFS-Sulfate-90 material has Al2p and O1s peaks at 74 and 532 eV, consistent 
with octahedral Al3+ and the presence of OH groups, respectively [10]. The amorphous samples 
analysed show an Al2p peak with a binding energy of 75 eV, which is consistent with the 
literature values for octahedrally co-ordinated aluminium [10].  
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Furthermore, CPFS-Sulphate-45 and CPFS-Sulphate-65 have O1s peaks at binding energies ca. 
533 eV; this is indicative of amorphous content with OH groups present [10]. Overall therefore, 
while it is not possible to unambiguously determine the nature of the materials formed at 45 
and 65 °C, it is clear that they do not comprise the desired AlO(OH) product, and the data suggest 
they are likely to be Al(OH)3 phases. 
Table 3.2: XPS analysis of the materials synthesised at 45, 65, and 90 °C, compared with expected data 
from reference [12], with atomic percentages listed for both aluminium and oxygen. 
Sample ID Al 2p 
/ % 
O 1s 
/ % 
Ratio  
/ O : Al 
Expected ratio 
/ O : Al [12] 
Structure 
formed 
CPFS-Sulphate-45 27.77 72.23 2.60 3 Al(OH)3 
CPFS-Sulphate-65 28.70 71.30 2.48 3 Al(OH)3 
CPFS-Sulphate-90 34.11 65.90 1.93 2 AlO(OH) 
Increasing the temperature of the silicon oil bath thus appears to have caused a phase transition 
from Al(OH)3 to AlO(OH), as well as an increase in the crystallinity of the product. 
The particle size and morphology were analysed using SEM (Figure 3.5). 
 
Figure 3.5: SEM images of the CPFS-Sulphate products synthesised at (A) 45, (B) 65, (C) 80 and (D) 90 °C. 
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SEM images shows the product materials are composed of aggregates of nanoparticles 
exhibiting spherical morphology (Figure 3.5A-D). As a result, the Scherrer equation can be used 
to analyse the P-XRD patterns (with K = 1) and calculate average crystallite sizes – see Table 3.3. 
Table 3.3: Details of mean crystallite and particle size and morphology of samples synthesised via the 
CPFS process using aluminium sulphate as the precursor. Mean crystallite size data was calculated using 
all visible reflections of the P-XRD pattern, mean ± standard deviation. 
Sample ID 
Mean crystallite 
size by P-XRD / nm 
Mean particle 
size by SEM / nm 
Morphology 
CPFS-Sulphate-45 Amorphous 75 ± 2 Spherical 
CPFS-Sulphate-65 Amorphous 69 ± 13 Spherical 
CPFS-Sulphate-80 5.1 ± 3.6 38 ± 9 Spherical 
CPFS-Sulphate-90 6.7 ± 6.0 42 ± 11 Spherical 
The Scherrer analysis of the X-ray diffraction data (Table 3.3) indicates a difference in crystallite 
size of roughly 1.6 nm between the 80 and 90 °C samples. Due to the amorphous nature of the 
45 and 65 °C samples, crystallite size could not be determined by P-XRD. However, mean particle 
size data were additionally calculated from the SEM images by analysing 300 individual particles; 
the resultant data are also presented in Table 3.3. These reactions display a trend that increasing 
the reaction temperature not only results in a switch from producing gibbsite to boehmite, but 
also results in the collection of generally smaller particles. The latter is not documented in the 
literature [13, 14]. Considering the two pairs of samples (gibbsite and boehmite) separately, a 
higher temperature seems to give rise to slightly smaller particles, although they are the same 
within the standard deviations. 
The values calculated from the Scherrer equation and SEM analysis both show the same trend. 
However, the Scherrer values are lower than the SEM values because the former are crystallite 
sizes for individual crystals within the powdered samples, whilst the SEM-derived particle sizes 
are calculated on the bulk – potentially aggregated – material. 
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FTIR spectra (Figure 3.6) of the phase-pure AlO(OH) materials depict a strong band at ca. 3250 
cm-1 and a shoulder at ca. 3100 cm-1 which can be attributed to H-bonded νs(Al)O-H and νas(Al)O-
H stretching vibrations of the hydroxyl moieties in the AlO(OH) nanoparticles, respectively [15, 
16]. The band at 1050 cm-1 and the shoulder at 1125 cm-1 are assigned to the symmetric and 
asymmetric bending modes of (Al)-OH [17] whilst the band at 750 cm-1 is ascribed to the OH 
torsional mode [18]. The three peaks present in the range 1250 -1750 cm-1 are attributed to the 
Al-OH stretching and bending vibrations in the AlO(OH) lattice [19]. All the bands described are 
consistent with AlO(OH).  
 
Figure 3.6: FTIR spectra of CPFS-Sulphate products synthesised at (A) 80 and (B) 90 °C. 
3.4.2 PEGylated Systems 
Since the use of sub-100 °C temperatures to produce different crystal habits of boehmite was 
unsuccessful, producing spherical particles at all temperatures when the precursors were solely 
dissolved in deionised water, polyethylene glycol (PEG) solutions were explored as an alternative 
to deionised water. This enables the maximum temperature of the oil bath to exceed the 95 °C 
maximum temperature of deionised water; experiments can be performed up to 180 °C. 
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A PEGylated system was tested with aluminium sulphate as the aluminium source. Initially there 
were difficulties with poor precursor solubility in pure ethylene glycol. After resolving these 
issues by diluting in water, one synthesis was performed at 100 °C but the precursor solutions 
solidified in the PTFE tubing and caused a blockage. Therefore, the reactions were stopped 
because further testing with this solvent system would cause damage to the reactor. As a result, 
it was concluded that the use of PEG was not practicable here, and instead experiments moved 
on to explore other Al precursor salts. 
3.4.3 Continuous Plastic Flow Synthesis – Chloride System 
Experimental optimisation was undertaken using different ratios of Al-source to precipitating 
agent (NaOH). The precipitating agent was changed from NaAlO2 to NaOH for these experiments 
because the additional aluminium content of NaAlO2 was not required to facilitate the formation 
and precipitation of AlO(OH). 
Experiments performed using a 1:4 Al-source to base ratio did not yield any solid product, which 
we believe is because any solid formed would have dissolved in the highly basic environment 
formed as a result of the reaction. Reducing the ratio to 1:3 saw the generation of amorphous 
products (Figure 3.7). The experimental parameters for the products obtained with aluminium 
chloride as the precursor are detailed in Table 3.4. 
Table 3.4: Synthetic details for attempted preparation of AlO(OH) particles via a continuous 
hydrothermal flow process, using aluminium chloride as the aluminium source. 
Sample ID 
[AlCl3·6H2O] 
/ M 
[NaOH] 
/ M 
Flow rate 
/ mL min-1 
Reaction 
temperature 
/ °C 
Product 
pH 
CPFS-Chloride-70 0.2 0.6 20 70 5 
CPFS-Chloride-80 0.2 0.6 20 80 5 
CPFS-Chloride-90 0.2 0.6 20 90 5 
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Figure 3.7: P-XRD patterns of samples synthesised via the CPFS process using aluminium chloride as the 
precursor; the reference pattern for γ-AlO(OH) is obtained from the ICSD (93734 [7]) as was that of γ-
Al(OH)3 (6162 [8]). The peaks marked with an asterisk (*) denote those attributed to the sample holder. 
As shown in Figure 3.7, amorphous P-XRD patterns were obtained for the three products, and 
therefore their identity cannot be confirmed by P-XRD alone. Solid state NMR and XPS analysis 
were undertaken in a bid to deduce the content and possible structures of these samples.  
The O: Al ratios are indicative of the sample type, with data presented in Table 3.5 [12]. The 
CPFS-Chloride samples analysed contain octahedrally co-ordinated aluminium within their 
structures, with Al2p peaks having a binding energy of ca. 75 eV, which is consistent with the 
literature values [10]. The O1s peaks are found at binding energies ca. 532 eV, meaning there 
are hydroxyl groups contained within the samples [10]. 
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Table 3.5: XPS analysis of materials synthesised using aluminium chloride as the Al source. CPFS-
Sulphate-90 is used as the aluminium oxyhydroxide reference standard, with expected ratios from the 
literature from [12], with atomic percentages listed for both aluminium and oxygen. 
Sample ID Al 2p / % O 1s / % Ratio / O : Al 
Expected 
ratio /  
O : Al [12] 
Sample Type 
CPFS-Chloride-70 32.76 67.25 2.05 2.00 AlO(OH) 
CPFS-Chloride-80 32.65 67.35 2.06 2.00 AlO(OH) 
CPFS-Chloride-90 33.33 66.67 2.00 2.00 AlO(OH) 
CPFS-Sulphate-90 34.11 65.90 1.93 2.00 AlO(OH) 
27Al-MAS NMR spectra show pure-phase AlO(OH) of the boehmite polymorph (as described in 
Section 3.4.1.2) has a single peak arising at 5.45 ppm, whereas the chloride CPFS samples have 
two peaks (Figure 3.8). The main peak is observed ca. 4.3 ppm, with a second, smaller peak 
detected at ca. 32 ppm. The former peak provides evidence of octahedrally co-ordinated 
aluminium within the samples; however, given the XPS data indicate these materials are 
AlO(OH), the latter peak is anomalous and may arise due to an impurity or due to the presence 
of unsaturated aluminium at the surface of the NPs [20-23]. Coupling these data together 
suggests that these are all amorphous AlO(OH) products. 
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Figure 3.8: Solid state NMR data on the samples prepared from chloride precursors (A – C), via 
comparison to a known γ-AlO(OH) standard (D) synthesised at 90 °C using aluminium sulphate as the 
Al-source. 
The SEM images presented in Figure 3.9 show aggregated particles in the samples. All three 
materials appear to have spherical morphology, with average particle size decreasing as the 
temperature of the reaction increased (Table 3.6). Therefore, there is evidence of some degree 
of particle engineering for the chloride system. 
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Figure 3.9: SEM images of the CPFS-Chloride products synthesised at (A) 70, (B) 80 and (C) 90 °C. The 
larger shapes – evident in the background of the images – are those of the carbon stubs used in the 
mounting process. 
Table 3.6: Details of mean particle size and morphology for the samples synthesised via the CPFS process 
using aluminium chloride as the precursor. The size and morphology were deduced using SEM analysis 
(Figure 3.9), mean ± standard deviation. 
Sample ID 
Mean particle 
size via SEM / nm 
Morphology 
CPFS-Chloride-70 197.8 ± 49.7 Spherical, aggregate 
CPFS-Chloride-80 91.0 ± 34.1 Spherical, aggregate 
CPFS-Chloride-90 87.8 ± 20.4 Spherical, aggregate 
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3.4.4 Continuous Plastic Flow Synthesis – Nitrate System 
A series of reactions were performed using Al nitrate as the Al-containing precursor (Table 3.7). 
Sodium aluminate was replaced with an alternative precipitating agent because the extra 
aluminium content was not required for AlO(OH) synthesis with aluminium nitrate as the Al-
source. Poorly-crystalline gibbsite was obtained when the reactions were performed at 80 °C 
using aluminium nitrate and potassium hydroxide as the precursors (Figure 3.10), with some 
amorphous material also apparently present. However, increasing the temperature to 90 °C was 
sufficient to initiate a phase transition to produce the desired γ-AlO(OH). Broad peaks in the P-
XRD pattern of CPFS-Nitrate-90 are indicative of the sample’s small crystallite size (Figure 3.10). 
 
Figure 3.10: P-XRD patterns of samples synthesised via the CPFS process using aluminium nitrate as the 
precursor at (A) 80 and (B) 90 °C. The reference patterns for γ-AlO(OH) and γ-Al(OH)3 were obtained 
from the ICSD - 93734 [7] and 6162 [8], respectively. 
The reaction conditions are detailed in Table 3.7, with a summary of the characterisation data 
listed in Table 3.8. 
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Table 3.7: Synthesis details for materials prepared via a continuous hydrothermal flow process, using 
aluminium nitrate as the aluminium source. 
Sample ID 
[Al(NO3)3·9H2O] 
/ M 
[KOH] 
/ M 
Flow rate  
/ mL min-1 
Reaction 
temperature 
/ °C 
Supernatant 
pH 
CPFS-Nitrate-80 0.2 0.8 20 80 11 
CPFS-Nitrate-82 0.2 0.8 20 82 5 
CPFS-Nitrate-84 0.2 0.8 20 84 11 
CPFS-Nitrate-86 0.2 0.8 20 86 11 
CPFS-Nitrate-88 0.2 0.8 20 88 12 
CPFS-Nitrate-90 0.2 0.8 20 90 11 
The initial two temperatures tested led to the formation of two phases, with 80 °C producing 
the gibbsite material and 90 °C giving rise to boehmite; see data in Table 3.8. Further 
investigations into the nitrate system were hence undertaken (Table 3.7), with temperature 
increments of 2 °C tested to deduce the point at which phase transition from gibbsite to 
boehmite occurs. The patterns in Figure 3.11 provide evidence that this event happens when 
the reaction is performed at 86 °C, with the 84 °C product appearing to be a mixture of the two 
materials (see Figure 3.11A). No clear trend in particle or crystallite size can be elucidated across 
this temperature range, as is clear from the data in Table 3.8. 
Table 3.8: Details of mean crystallite and particle size, morphology and product nature for samples 
synthesised via the CPFS process using aluminium nitrate as the precursor, mean ± standard deviation. 
Sample ID 
Mean crystallite 
size by P-XRD / 
nm 
Mean particle 
size via SEM / 
nm 
Morphology Product 
CPFS-Nitrate-80 16.1 ± 10.12 147.0 ± 0.5 Rods Al(OH)3 
CPFS-Nitrate-82 19.3 ± 18.55 87.1 ± 25.5 Spherical Al(OH)3 
CPFS-Nitrate-84 19.9 ± 15.68 70.6 ± 21.5 Platelets Al(OH)3/AlO(OH) 
CPFS-Nitrate-86 17.8 ± 23.2 82.0 ± 32.6 Spherical AlO(OH) 
CPFS-Nitrate-88 25.0 ± 24.4 82.8 ± 20.9 Rods AlO(OH) 
CPFS-Nitrate-90 3.9 ± 1.5 115.0 ± 25.5 Various AlO(OH) 
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Figure 3.11: P-XRD patterns of alum samples synthesised via the CPFS process using aluminium nitrate 
as the precursor, with varying reaction temperatures, 82 and 84 °C (A) and 86 and 88 °C (B). The 
reference pattern for γ-AlO(OH) is obtained from the ICSD (93734 [7]) as was that of the gibbsite 
polymorph of Al(OH)3 (6162 [8]). The peaks marked with an asterisk (*) denote those attributed to the 
plate holder.  
SEM images (Figure 3.12) provide visual evidence of the differences in particle morphology 
across the six materials. The magnified squares in Figure 3.12 show enlargements of selected 
regions. 
 
Figure 3.12: SEM images for CPFS-Nitrate samples prepared at (A) 80, (B) 82, (C) 84, (D) 86, (E) 88 and 
(F) 90 °C. 
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As is evident from Figure 3.12, the particle size and shape were not consistent across the six 
samples prepared using Al nitrate, with different morphologies being obtained at different 
temperatures. These results thus suggest that particle habit and the Al hydroxide obtained can 
be engineered using this synthetic route. 
3.4.5 CPFS Discussion 
The effects of concentration and temperature on the morphology and particle size of 
nanoparticles produced by CPFS were studied. It is evident that concentration ratios of Al-source 
to precipitating agent are fundamental in generating solid products such that, if the ratio is 
incorrect, then any precipitate will dissolve in the excessively acidic or basic aqueous 
environment of the reaction. The three different synthetic routes investigated in this chapter 
show there is some evidence for control of both particle size and shape of the AlO(OH) products 
produced. Particle morphology was tuneable when using the nitrate synthetic route, whilst 
particle size seemed to be controlled when using a chloride Al-source. 
The control obtained using the CPFS process appears to be limited, however; therefore, 
continuous hydrothermal flow reactor processes were investigated to assess whether greater 
control is achievable. 
3.4.6 Continuous Hydrothermal Flow Synthesis 
3.4.6.1 Synthesis 
The CHFS process used an in-line mixed feed of water-soluble metal salt (aluminium nitrate 
nonahydrate) and base (potassium hydroxide) which instantly forms a solid precipitate upon 
mixing with a supercritical water flow (240 bar, 450 °C) [24]. A series of samples were prepared 
with varied precursor concentrations and flow rates, as detailed in Table 3.9. 
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Table 3.9: Experimental conditions for samples prepared using a continuous hydrothermal flow process 
with aluminium nitrate as the Al source and potassium hydroxide as the base. All reactions were 
performed at 450 °C with either a balanced or unbalanced flow rate. For instance, 80/80 denotes that 
each precursor (metal salt and base) were pumped at 80 mL min-1 each to give a combined flow rate of 
160 mL min-1. 
Sample ID 
[Al(NO3)3·9H2O] 
/ M 
[KOH] 
/ M 
Flow rate  
/ mL min-1 
Mix-point 
temperature / °C 
Product 
pH 
CHFS-1 0.05 0.2 80/80 274 9 
CHFS-2 0.05 0.2 80/50 314 9 
CHFS-3 0.10 0.4 80/80 272 9 
CHFS-4 0.10 0.4 80/50 314 9 
3.4.6.2 Characterisation 
Powder XRD patterns are shown in Figure 3.13. All observed reflections can be assigned by their 
positions to those of the reference pattern for the boehmite polymorph of AlO(OH) [7]. No peaks 
were observed belonging to impurities. Crystallite sizes were calculated using the Scherrer 
equation, as summarised in Table 3.10. 
 
Figure 3.13: P-XRD patterns for samples synthesised by the CHFS process, including a reference pattern 
for the boehmite polymorph of AlO(OH) (ICSD: 93734 [6]). 
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The CHFS samples display high crystallinity, as observed in the P-XRD patterns (Figure 3.13). 
They are found to have small crystallite sizes due to the limited time for growth following 
nucleation at the point of mixing in the confined jet mixer (Figure 3.2C). The rapid cooling 
procedures ensure that crystal growth is inhibited. 
Table 3.10: Details of mean crystallite and particle size, morphology and product type of the samples 
synthesised via the CHFS process using aluminium nitrate as the precursor, mean ± standard deviation. 
Sample 
ID 
Mean crystallite 
size by P-XRD / 
nm 
Mean 
particle size 
via SEM / nm 
Morphology Product 
CHFS-1 31.11 ± 16.20 69.04 ± 12.84 Spherical AlO(OH) 
CHFS-2 22.89 ± 8.20 66.39 ± 14.76 
Hexagonal plates, 
rod-like particles 
AlO(OH) 
CHFS-3 28.30 ± 10.52 68.45 ± 16.42 Spherical AlO(OH) 
CHFS-4 35.58 ± 14.62 67.41 ± 14.21 
Hexagonal plates, 
rod-like particles 
AlO(OH) 
SEM analysis (see Figure 3.14A-D) shows the reaction products are composed of nanoparticles 
of spherical morphology for CHFS-1 and -3. These samples were prepared with balanced flow 
rates of 80 mL min-1 for each precursor, giving rise to a mix-point temperature of 274 °C. In 
contrast, CHFS-2 and -4 were prepared with 80 and 50 mL min-1 flow rates for the Al-source and 
precipitating agent, respectively, creating a 314 °C mix-point temperature as there is a higher 
flow rate of the pre-heated precursor. A mixture of hexagonal platelets and rod-like particles 
with average particle size 66 - 67 nm were obtained for CHFS-2 and -4. These are smaller in size 
than those synthesised with lower mix-point temperatures. 
Chapter 3 Particle Engineering of Aluminium Oxyhydroxide 
 
138 
 
 
Figure 3.14: SEM images of the CHFS products: (A) CHFS-1, (B) CHFS-2, (C) CHFS-3 and (D) CHFS-4; and 
Fourier transform infra-red spectrum of (E) CHFS-2. 
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The FTIR spectrum for the CHFS product (Figure 3.14E) is sharper than that obtained for CPFS 
products; this can be attributed to the better crystallised and more homogeneous nature of the 
reaction products here. There are two strong bands at 3100 and 3250 cm-1 which can be 
attributed to νas(Al)O-H and νs(Al)O-H stretching vibrations of the hydroxyl moieties in the 
AlO(OH) nanoparticles [15, 16]. The band at 1050 cm-1 and the shoulder at 1125 cm-1 are 
assigned to the symmetric and asymmetric bending modes of (Al)-OH respectively [17], whilst 
the band at 750 cm-1 is ascribed to the OH torsional mode [18]. All the bands described are 
consistent with AlO(OH). 
3.4.6.3 CHFS Discussion 
In the absence of base, no precipitate was collected; however, introduction of base in a 1:4 
molar ratio (Al: KOH) resulted in the production of a white powder product. Pure phase AlO(OH) 
was obtained. The lack of solid product obtained with no base is in contrast to published work 
from Sue et al. [25], who obtained a biphasic product composed of AlO(OH) and Al2O3 with 
average crystallite sizes of 10.8 nm and 4.4 nm, respectively, when aluminium nitrate 
nonahydrate was used as the precursor in the absence of potassium hydroxide. It appears that 
the addition of base drives the reaction to a monophasic product. The only notable difference 
between the experiments reported here and the literature is the CHFS experimental set-up, 
because Sue and co-workers implement a quench at the end of the reaction. This could explain 
why they collected solid product in the absence of base (the quench may hold the pH at a value 
suitable for precipitation due to rapid cooling of the reaction product). In the reactions 
undertaken in this chapter, using Al(NO3)3·9H2O and deionised water gave a product supernatant 
with a pH reading of 1 – in the absence of a quench – and so any solid product which may have 
formed is likely to have dissolved prior to collection due to the acidic environment. 
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The effects of concentration, temperature and flow rate on the morphology and particle size of 
aluminium oxyhydroxide were studied, with a summary of the data presented in Table 3.10. At 
low concentrations the impact of an unbalanced flow rate is evident (sample CHFS-2). Here the 
mix-point temperature increases to 314 °C due to reduced flow of the preheated water, 
producing highly crystalline AlO(OH). The samples collected were composed of hexagonal 
platelets and rod-like AlO(OH) particles with average crystallite size 51-60 nm. However, the 
CHFS-1 sample was synthesised with a balanced flow rate for a mix-point temperature of 274 
°C, yielding highly crystalline AlO(OH) particles with spherical morphology and average  
crystallite size 61-70 nm. A similar trend is observed with higher precursor concentrations 
(samples CHFS-3 and CHFS-4). Therefore, altering the flow rates provides control over the 
particle shape through varying the mix-point temperature. 
3.4.7 Synthetic Route Comparisons 
All samples recovered from the CPFS synthetic routes were white in colour, suggesting there are 
no impurities. The PTFE tubing used within this reactor can be autoclaved which ensures sterility 
of the reaction products and potentially could conform to Good Manufacturing Practice (GMP) 
guidelines. However, the materials collected from the CHFS process had a slight blue 
discolouration to their appearance, indicating some form of contamination. It is thought that 
there is likely to be a degree of metal contamination due to the nature of the pipework installed 
in this reactor. In vitro cell viability assays (see Section 3.5) provide evidence that there is no 
cytotoxic effect caused by this contamination, but this is nevertheless a concern which must be 
addressed in future studies. 
Chapter 3 Particle Engineering of Aluminium Oxyhydroxide 
 
141 
 
3.4.8 Zeta Potential Measurements 
Previous studies have indicated that zeta potential (ZP) is important in determining 
immunogenicity [26]. Zeta potential values for the samples prepared are given in Table 3.11. Six 
CPFS samples do not have values listed in Table 3.11 because the suspensions rapidly sediment 
within the zeta-capable cell, which resulted in unreliable and highly variable values being 
recorded. Longer sonication times were applied in an attempt to keep the samples dispersed in 
the solvent, but these efforts proved unsuccessful. 
The zeta potential will vary with the dispersion medium: in the majority of cases, zeta potential 
measurements will become more negative when dispersed in phosphate-buffered saline (PBS) 
because of phosphate ion adsorption to the surface of the particles. In contrast, these anions 
are missing from the ultrapure water (UP-water) dispersant. As would be expected, CPFS-
Sulphate-80 and CPFS-Nitrate-90 have less negative zeta potential measurements when 
dispersed in UP-water, indicating that these two suspensions are relatively unstable in this 
environment. Hence PBS may be a more optimum diluent, given the measurements are closer 
to a -30 mV reading which would likely lead to a stable colloidal dispersion [27]. All other 
samples’ zeta potential values suggest relatively stable suspensions have formed with most 
values close to +30 or -30 mV [27].  
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Table 3.11: Zeta potential measurements for all the CPFS/CHFS samples, performed in both ultrapure 
water at resistivity of 18.2 mΩ and 0.01 M phosphate-buffered saline at pH 7.4. Lines marked “-“ denote 
situations where the ZP could not be recorded owing to rapid sedimentation of the samples. 
 Zeta Potential / mV 
 Ultrapure water Phosphate buffered saline 
Sample ID 0 minutes 10 minutes 0 minutes 10 minutes 
CPFS-Sulphate-45 - - - - 
CPFS-Sulphate-65 - - - - 
CPFS-Sulphate-80 -7.53 ± 0.84 -8.03 ± 0.50 -21.63 ± 1.79 -23.52 ± 1.81 
CPFS-Sulphate-90 -32.98 ± 0.28 -30.78 ± 0.78 -31.65 ± 1.18 -34.28 ± 1.19 
 
CPFS-Chloride-70 36.3 ± 0.65 36.73 ± 0.50 -26.23 ± 1.79 -26.88 ± 1.21 
CPFS-Chloride-80 37.23 ± 1.07 33.27 ± 0.63 -31.77 ± 2.39 -24.02 ± 1.31 
CPFS-Chloride-90 35.67 ± 1.24 40.30 ± 0.91 -21.30 ± 0.83 -22.68 ± 1.21 
 
CPFS-Nitrate-80 -35.15 ± 0.87 -33.70 ± 1.17 -27.30 ± 1.13 -27.73 ± 1.32 
CPFS-Nitrate-82 - - -23.27 ± 0.94 -24.40 ± 1.48 
CPFS-Nitrate-84 - - - - 
CPFS-Nitrate-86 - - -26.65 ± 1.96 -28.38 ± 1.57 
CPFS-Nitrate-88 - - - - 
CPFS-Nitrate-90 -9.30 ± 0.41 -8.63 ± 0.62 -26.55 ± 1.68 -28.25 ± 1.30 
 
CHFS-1 30.77 ± 1.42 22.88 ± 2.03 -17.13 ± 0.86 -19.57 ± 1.15 
CHFS-2 26.15 ± 0.24 26.47 ± 0.23 -18.60 ± 1.43 -19.93 ± 1.23 
CHFS-3 24.62 ± 0.97 25.48 ± 0.30 -14.27 ± 1.28 -15.82 ± 1.30 
CHFS-4 26.08 ± 1.01 25.02 ± 0.99 -12.48 ± 1.25 -13.93 ± 1.23 
Attempts were made to elucidate relationships between zeta potential measurements and the 
chemical nature of the nanoparticles, but none were obvious. For instance, it is evident from the 
data presented in Table 3.12 and Figure 3.15 that there are no discernible trends between the 
particle size of the NPs and their zeta potentials. 
Chapter 3 Particle Engineering of Aluminium Oxyhydroxide 
 
143 
 
Table 3.12: The results of attempts to determine relationships between NPs’ zeta potential 
measurements and their respective particle sizes – as determined by SEM analysis. 
Alum type Experimental parameters Equation R2 correlation 
 x / nm y / mV   
CPFS-Chloride Particle size 
ZP_UP water 
Initial 
y = 2.2268x – 43.49 0.5156 
ZP_UP water 
10 minutes 
y = -0.4361x + 53.701 0.3967 
ZP_PBS 
Initial 
y = -0.3078x + 29.531 0.4388 
ZP_PBS 
10 minutes 
y = 0.6052x + 52.511 0.2846 
     
CPFS-Nitrate Particle size 
ZP_PBS 
Initial 
y = -9.6079x – 141.42 0.3388 
ZP_PBS 
10 minutes 
y = -5.2712x – 35.495 0.1098 
     
CHFS Particle size 
ZP_UP water 
Initial 
y = 0.2246x + 61.767 0.2688 
ZP_UP water 
10 minutes 
y = -0.6403x + 83.793 0.7021 
ZP_PBS 
Initial 
y = 0.0811x + 69.078 0.0374 
ZP_PBS 
10 minutes 
y = 0.0159x + 68.086 0.0016 
There are no data for the CPFS-Sulphate samples in Table 3.12 because there were not enough 
data points available. The same is true for the CPFS-Nitrate samples’ and the zeta potential 
obtained using UP_Water as the dispersant; no data could be collected because rapid 
sedimentation occurred during the measurements. 
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Figure 3.15: Plots of zeta potential vs particle size for (A) CPFS-Chloride, (B) CPFS-Nitrate and (C) CHFS 
samples using the experimental parameter which gave the strongest correlation for each synthesis 
route. 
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3.5   In vitro Experiments 
3.5.1 Cell Viability 
Cellular cytotoxicity was quantified using the Alamar Blue assay after RAW264.7 cells had been 
incubated with the various samples prepared by both CHFS and CPFS processes; the resultant 
data can be found in Figure 3.16. Cell viability was greater than 90% in all cases. The adjuvant 
materials prepared in this work lead to viabilities indistinguishable from those of untreated cells 
or cells treated with the commercial Alhydrogel or Adju-Phos adjuvants. 
3.5.2 Immunoassay experiments 
Two cytokines were selected to gain insight into the immunomodulatory behaviour of the CPFS 
and CHFS samples. Tumour necrosis factor-alpha (TNF-α) is a pro-inflammatory cytokine 
predominantly secreted by macrophages. Its production initiates a cytokine cascade targeting 
the vascular endothelium [28] causing increased permeability, and leading to subsequent 
macrophage and neutrophil recruitment to the site of injection and induction an immune 
response. Interleukin-6 (IL-6) is another cytokine secreted by both T-cells and macrophages. It is 
often associated with a Th2 polarisation and is reported to be involved in the immune responses 
induced by aluminium-containing adjuvants [29]. 
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Figure 3.16: Cell viability results. RAW264.7 macrophages were exposed to AlO(OH) nanoparticles at 
476 μg mL-1 for 24 hours. Cells exposed to commercial alums (Alhydrogel® and Adju-Phos®) were used 
for comparative purposes, alongside lipopolysaccharide (LPS). Cell viability was quantified by Alamar 
Blue assays with n=3 independent experiments and each individual experiment containing 9 replicates. 
Data are shown for (A) CPFS-Sulphate, (B) CPFS-Nitrate, (C) CPFS-Chloride and (D) CHFS materials. 
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3.5.2.1 Sulphate precursor 
The nanoparticles prepared using aluminium sulphate as the precursor in the CPFS reactor 
induce TNF-α production by murine macrophages (Figure 3.17). The four samples perform 
better than the commercially available alums; interestingly, as the synthesis temperature is 
increased, a reduction in TNF-α secretion appears to be observed. Comparing the four products, 
the size of the NPs and Al-content may provide a means of explaining this apparent trend. The 
two sub-70 °C Al(OH)3 samples have approximate size of 70 nm; in contrast the two AlO(OH) 
samples (80 and 90 °C) have smaller nanoparticles of roughly 40 nm. Additionally, the Al-content 
is lower in the Al(OH)3 samples than it is in the AlO(OH) samples [12]. Both the decrease in 
particle size and changes in the chemical composition of the NPs could lead to a lower TNF-α 
secretion pattern.  
 
Figure 3.17: TNF-α production by RAW264.7 macrophages exposed to AlO(OH) nanoparticles at 476 μg 
mL-1 for 24 hours. Cells exposed to commercial alums (Alhydrogel® and Adju-Phos®) were used for 
comparative purposes with lipopolysaccharide (LPS) as a positive control. TNF-α cytokine secretion was 
quantified by ELISA assays (n=3) with each individual experiment containing 9 replicates.  
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The inverse trend is recorded for the secretion of IL-6 (Figure 3.18), with production increasing 
with synthesis temperature. Experimental work by Sun and co-workers [2] on bone-marrow 
derived dendritic cells demonstrated that an increased length of boehmite rods induced much 
higher IL-6 production from these cells:  nanorods of approximately 200 nm in length could 
induce the production of 2 – 3 times the concentration of IL-6 than rods of 150 nm lengths. In 
contrast, the spherical particles prepared in this work exhibited a maximum of 15 pg mL-1 
difference in IL-6 production by RAW264.7 macrophages.  This could be due to there being a size 
difference of ca. 30 nm across the four samples, whilst Sun et al. [2] had length differences of 
approximately 200 nm. 
 
Figure 3.18: IL-6 production by RAW264.7 macrophages exposed to AlO(OH) nanoparticles at 476 μg 
mL-1 for 24 hours. Cells exposed to commercial alums (Alhydrogel® and Adju-Phos®) were used for 
comparative purposes with lipopolysaccharide (LPS) as a positive control. IL-6 cytokine secretion was 
quantified by ELISA assays. n=3, with each individual experiment containing 9 replicates. 
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3.5.2.2 Chloride Precursor 
All samples synthesised using the CPFS-Chloride protocol performed at least on par with of 
commercially available Adju-Phos in both assays. Samples prepared at the minimum and 
maximum reaction temperatures exhibit more IL-6 production than the mid-temperature 
materials. The greatest IL-6-output is recorded for the smallest particle sized NPs (ca. 88 nm at 
the maximum reaction temperature) with 86 pg mL-1 IL-6 production, which contradicts what is 
observed with the NPs synthesised using a nitrate Al-source (Section 3.5.2.3). No clear trends 
are evident in the TNF-α data, with all three samples leading to very similar levels of cytokine 
production. 
3.5.2.3 Nitrate precursor 
Considering the nitrate-precursor NPs, all performed at least on par with Adju-Phos in terms of 
both TNF-α and IL-6 production. The inflammatory cytokine profile for the Al(OH)3 NPs prepared 
at 80 and 82 °C shows more IL-6 than TNF-α production – ca. 70 pg mL-1 IL-6 concentrations 
coupled with ca. 42 pg mL-1 TNF-α - thus suggesting a Th2-type immune response might be 
elicited following adjuvant application. The mixed-phase NPs generated at 84 °C could produce 
more TNF-α secretion (ca. 100 pg mL-1) and less IL-6 which could indicate more of a bias to a Th1 
response. These particles are smaller than those prepared at lower temperatures, and thus this 
work agrees with the literature in that smaller particles are more likely to induce Th1-type 
responses [30]. 
The pure-phase boehmite NPs produced at 88 and 90 °C appear to stimulate different in vitro 
immune responses. The decrease in crystallite size on going from 88 to 90 °C appears to have 
the effect of tailoring the cytokine profile towards IL-6, indicating that perhaps more of a Th2-
type response might be initiated.  
Chapter 3 Particle Engineering of Aluminium Oxyhydroxide 
 
150 
 
3.5.2.4 CHFS samples 
All the alums synthesised by the CHFS process perform at least on par with Adju-Phos. As the 
particle morphology changes from spherical NPs to platelet/rod structures with CHFS-1 and 2, 
there is evidence of a marginal increase in the IL-6 output, with roughly constant TNF-α 
production. 
The spherical NPs (CHFS-1 and 3) give an increase in IL-6 production when the crystallite size is 
reduced (CHFS-3 is smaller than 1); whereas the bi-phasic materials have similar IL-6 outputs. 
These findings might indicate that particle engineering-induced reduction of the crystallite size 
of the spherical AlO(OH) materials can lead tuning of the immune response. 
3.5.3 Fluorescent Microscopy 
Representative microscopy images are given in Figure 3.19. All the NPs were labelled with FITC 
and the RAW264.7 cells with the DAPI nuclear stain, giving rise to green and blue images under 
the fluorescent microscope, respectively. All the CHFS NPs prepared in this work appear as 
aggregates under the fluorescence microscope, with evidence of co-localisation of the 
aggregated spherical nanoparticles with the RAW264.7 cells. The images suggest that the NPs 
might elicit their immunogenic effect in a manner consistent with the suggestion of Flach and 
co-workers that lipid membrane disturbances result in immunogenicity [31]. 
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Figure 3.19: Fluorescent microscopy with FITC-labelled samples and DAPI nuclear staining; (A) cells 
alone, (B) Alhydrogel, (C) Adju-Phos, (D) CHFS-3, (E) CPFS-Sulphate-80, (F) CPFS-Nitrate-82; and (G) 
CPFS-Chloride-90. 
Confocal microscopy was also attempted, but the adherent nature of the RAW264.7 cells meant 
that they ruptured during transfer from a 24 well plate to a microscope slide for imaging and 
hence images could not be obtained. 
3.6   Structure/Property Relationships 
The complete data sets for each adjuvant prepared were assessed for relationships between the 
particles’ physicochemical properties and the production of cytokines by RAW264.7 cells. The 
results are given in Table 3.13, with graphical depictions of some presented in Figure 3.20. 
Caution must be taken in assessing the relationships deduced from these datasets, since the 
number of data points in each is relatively small. Often, there are no clear relationships between 
the properties of the particles and the immune response initiated (see Table 3.13 and Figure 
3.20), but in some cases there appear to be very distinct correlations present.   
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Table 3.13: Relationships between the physicochemical properties of the adjuvant particles prepared 
and cytokine production by RAW264.7 cells. It was not possible to deduce correlations for the CPFS-
Sulphate materials due to having only a very limited number of data points, and due to rapid 
sedimentation of CPFS-Nitrate NPs in UP water no data are available here either. Particle size is 
recorded in nm and zeta potentials in mV. 
Alum type 
Experimental 
parameter / x 
Cytokine 
concentration 
/ y 
Equation 
R2 
correlation 
CPFS-Chloride 
Particle size TNF-α y = -1.9305x + 113.75 0.9943 
 IL-6 y = -5.1624x + 216.9 0.4375 
ZP_UP water TNFα y = -4.6152x 209.03 0.5909 
 IL-6 y = -24.13x + 945.79 0.9939 
ZP_PBS TNFα y = 0.6452x + 58.087 0.5144 
 IL-6 y = 3.6265x + 163.31 1.0000 
CPFS-Nitrate 
Particle size TNF-α y = -0.6876x + 140.27 0.6449 
 IL-6 y = -0.0061x + 70.139 0.0005 
ZP_UP water TNFα --- --- 
 IL-6 --- --- 
ZP_PBS TNFα y = 12.503x + 390.48 0.7824 
 IL-6 y  = -3.2366x – 14.484 0.5175 
CHFS 
Particle size TNF-α y = -0.338x + 66.521 0.0043 
 IL-6 y = -3.7446x + 321.77 0.5793 
ZP_UP water TNFα y = -0.6312x + 60.583 0.7858 
 IL-6 y = -1.753x + 115.01 0.6766 
ZP_PBS TNFα y = 0.5428x + 52.08 0.6201 
 IL-6 y = 0.9792x + 83.141 0.2252 
The CPFS-Chloride samples demonstrate strong relationships between experimental properties 
of the NPs and their elicited cytokine profiles (Table 3.13). The TNF-α production by RAW264.7 
cells is strongly related to the particle size of the NPs (R2 = 0.9943) – Figure 3.20A. Furthermore, 
the IL-6 output by the RAW cells is strongly related to zeta potential measured in both UP water 
and PBS (R2 = 0.9939 and 1.0000, respectively) – Figure 3.20B and C, respectively. 
The zeta potential measured for CPFS-Nitrate samples, using PBS as the dispersant, link well with 
the TNF-α secretion (R2 = 0.7858, Figure 3.20D). With reference to the CHFS samples, there is a 
relatively strong relationship evident for the production of TNF-α by RAW264.7 cells using the 
zeta potential measured when UP water was the dispersant (R2 = 0.7858 – Figure 3.20E); when 
linking the same zeta potential measurements to the IL-6 production, an R2 value of 0.6766 is 
obtained (Figure 3.20F). There are no other apparent trends between the two assayed cytokines 
and the three physicochemical properties selected for analysis. 
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Figure 3.20: Graphical representation of six relationships described in Table 3.13 with (A-C) being 
connections deduced from experimental data of the CPFS-Chloride family of NPs, (D) CPFS-Nitrate family 
and (E-F) for the CHFS family. 
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3.7  Conclusion 
In conclusion, controlling the synthesis parameters of the CPFS process to tune the AlO(OH) 
particle size and morphology is non-facile; the use of low temperatures results in amorphous 
materials and while elevating the temperature does lead to a change in particle size, over the 
temperature range which can be accessed there are minimal changes. CPFS largely produces 
spherical nanoparticles with Al(OH)3 or AlO(OH) composition. The nature of the precursors used 
and temperature impacts the phase formed, with gibbsite being synthesised at low 
temperatures and boehmite at higher ones. In addition, the crystallinity and morphology and 
the induced immune response are also affected.  
Within the CHFS process, flow rates are a key parameter in controlling the particle shape and 
size of the boehmite prepared, as a result of an increase in temperature of the mix-point arising 
from an unbalanced flow rate. Particle morphology is dependent on the reaction temperature:  
low temperatures result in spherical particles – consistent with output of the CPFS process – 
whilst higher temperatures give rise to a mixture of both hexagonal platelets and rod-like 
nanoparticles.  
There is little experimental evidence to suggest that changes in morphology of the CHFS NPs 
results in significantly different in vitro immune responses; all the samples tend to produce more 
IL-6 than TNF-α. That said, there is some degree of tunability in cytokine production, and all the 
materials prepared perform at least on a par with commercially available alum adjuvants. The 
samples prepared are generally not cytotoxic in vitro, with viabilities > 90%. This is favourable 
for onward application. 
The CPFS samples are cheap to manufacture due to the low temperatures and pressures used 
within this system. However, the energy costs involved in the CHFS process could make this an 
unfavourable synthesis route. In addition, the process uses metal pipework which leads to metal 
corrosion by the supercritical water feed and contamination of the AlO(OH) samples. 
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Overall, it appears that using these processes to generate tuneable and bespoke adjuvants is 
likely to be challenging, and significant further development of the experimental procedures is 
required. 
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4.1   Introduction 
Calcium phosphate is a natural compound found within the human body [1], and has been 
widely used as an adjuvant in the diphtheria-pertussis-tetanus vaccination in France [2-4]. 
Characterisation of commercial calcium phosphate adjuvants determined their chemical 
composition to be Ca10-x(HPO4)x(PO4)6-x(OH)2-x, with “x” varying between 0 and 2 [5], and thus 
chemically these are calcium-deficient hydroxyapatite materials. The effect of the particle size 
and shape of hydroxyapatite have been investigated in the context of vaccinology, with 
crystalline needle-like particles found to evoke a stronger immune response than spherical 
particles [6]. Furthermore, smaller particles sizes were reported to be preferred for eliciting 
greater responses [6]. The previous patent report [6] is not completely clear in terms of exactly 
which measures were used to assess these improvements in immune response, however. 
Previous work has identified that using the continuous plastic flow synthesis (CPFS) approach, it 
is possible to control the size and shape of hydroxyapatite particles [7]. The objective of the work 
reported in this chapter was to engineer hydroxyapatite particle size and morphology using the 
CPFS process, and then assess impact of these parameters on immunogenicity. 
4.2   Materials and Methods 
4.2.1 Continuous Plastic Flow Synthesis of Hydroxyapatite 
The continuous plastic flow synthesis (CPFS) reactor set-up was similar to the system described 
in Section 3.2.1.1, but adapted to pre-heat both precursor feeds using additional oil baths, (see 
Figure 4.1). This CPFS system used a 9 m length of polytetrafluoroethylene tubing to give a 4.7 
minute residence time when the combined flow rate equalled 25 mL min-1. Individual flow rates 
of the two precursor feeds were 12.5 mL min-1, with solutions of calcium nitrate (CaN; Sigma 
Aldrich UK) and diammonium hydrogen phosphate (DAP; Fisher Scientific) solutions used as the 
precursors. 
Chapter 4 Particle Engineering of Hydroxyapatite Nanoparticles 
 
159 
 
Aqueous solutions of CaN and DAP were first prepared in deionised water. The pH of both 
precursor solutions was adjusted to 10 with addition of 2% v/v or 6% v/v ammonium hydroxide, 
resulting in final pH-adjusted solutions with concentrations of 0.6 M for CaN and 0.3 M for DAP. 
Ammonium hydroxide was used as a base source instead of potassium hydroxide to minimise 
carbonate formation in the solutions. 
The product was rapidly cooled at the point of collection to cease the reaction. The white solid 
product was left to settle for approximately 30 minutes prior to recovery by centrifugation. The 
initial centrifugation cycle was performed at 4500 rpm for 5 minutes.  Sequential rounds of 
washing and centrifugation were performed with methanol or water (50 mL per wash) as the 
solvent and 30 minute centrifugation times. Once the conductivity of the supernatant was 
reduced to a value less than 50 S m-1, the product was dried in a vacuum oven at 40 °C for 24 h 
(Vacutherm, Heraeus Instruments). 
For P-XRD characterisation, a small amount of the cleaned sample was subjected to a heat 
treatment (Carbolite CWF 1300 furnace) at a rate of 10 °C min-1 up to a temperature of 1000 °C, 
where it was held for 1 hour before cooling. This was undertaken to aid determination of the 
hydroxyapatite phase formed, since the fresh collected sample was amorphous. The bioactive, 
amorphous product was used for all other investigations. 
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Figure 4.1: Tandem CPFS reactor design for the direct synthesis of hydroxyapatite nanoparticles with 
two HPLC pumps (P-1 and P-2) to pump the precursor solutions through PTFE-tubing immersed in 
preheated oil baths (B1 and B2, respectively) prior to mixing at the T-piece for reaction initiation. 
4.3   Materials Characterisation 
4.3.1 Powder X-ray Diffraction 
Powder X-ray diffraction (P-XRD) data were collected using a Rigaku MiniFlex 600 diffractometer 
supplied with Cu-Kα radiation (λ = 1.5418 Å). Each sample was loaded onto an aluminium plate 
and scans were undertaken at a rate of 2.5° min-1 over a 2θ range of 10-30°. Also, a STOE STADI-
P diffractometer using a molybdenum source supplied with Kα1 radiation of wavelength 0.7107 
Å. Each sample was loaded onto a transmission sample holder within zero-scattering polymer 
films and scans were undertaken at a rate of 1.25° min-1 over a 2θ range of 5-25°. The X’Pert 
Data Viewer software package was used to visualise and analyse the data. 
4.3.2 Scanning Electron Microscopy 
See Section 3.3.2.  
4.3.3 Fourier Transform Infra-Red Spectroscopy 
See Section 3.3.3. 
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4.3.4 Surface Area and Pore Volume Analysis 
Surface area and pore volume measurements were made using a SA3100 instrument (Beckman 
Coulter) using nitrogen as the adsorptive gas. BET surface areas were calculated from the 
isotherm data using the in-built software. Prior to analysis, samples were degassed at 100 °C 
under vacuum for 10 minutes to remove any residual moisture and other volatiles. 
4.3.5 Zeta Potential Measurements 
See Section 3.3.6. 
4.3.6 Immunoassay Experiments 
See Section 3.3.7. 
4.3.6.1 Alamar Blue Assay 
See Section 3.3.7.1. 
4.3.6.2 Enzyme-Linked Immuno-Sorbent Assay 
See Section 3.3.7.2. 
4.3.6.3 Fluorescence and Confocal Microscopy 
See Section 3.3.7.3. 
4.4  Results and Discussion 
4.4.1 Continuous Plastic Flow Synthesis of Hydroxyapatite 
Two different hydroxyapatite phases were obtained through altering the solvent used in the 
sequential centrifugation cleaning steps. Either deionised water or methanol were used to 
obtain pure phase- and calcium-deficient hydroxyapatite materials, respectively. 
4.4.1.1 Particle Size Control 
The temperature was altered in attempts to control the size and shape of the resultant 
hydroxyapatite nanoparticles. A summary of the reactions performed is presented in Table 4.1. 
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Table 4.1: Synthesis details for hydroxyapatite nanoparticles via a continuous hydrothermal flow 
process. 
Sample ID 
[CaN]  
/ M 
[DAP]  
/ M 
Flow rate 
/ mL min-1 
Reaction 
temperature 
/ °C 
Product 
pH 
Clean-up 
Solvent 
HA_70 0.6 0.3 25 70 9 Methanol 
HA_80 0.6 0.3 25 80 9 Methanol 
HA_90 0.6 0.3 25 90 9 Methanol 
HA_90_Water 0.6 0.3 25 90 9 
Deionised 
water 
4.4.2 Materials Characterisation 
The materials isolated from the CPFS reaction were found to be amorphous, as shown from the 
P-XRD patterns given in Figure 4.2, and thus from these data their chemical compositions and 
structures cannot be determined. 
 
Figure 4.2: P-XRD patterns for the as-synthesised hydroxyapatite samples; with the asterisk (*) denoting 
peaks attributed to the aluminium plate that samples were mounted on. (A) HA_70, (B) HA_80, (C) 
HA_90, and (D) HA_90_Water. 
Chapter 4 Particle Engineering of Hydroxyapatite Nanoparticles 
 
163 
 
The literature reports that hydroxyapatite phases are stable up to 1200 °C [9-12], and thus small 
amounts of each CPFS sample were calcined at 1000 °C to obtain more insight on the materials 
formed. The resultant P-XRD patterns are shown in Figure 4.3. The calcination process will have 
facilitated crystallisation to allow more insight on the CPFS productions to be obtained, but 
should not have changed the chemical composition of the phases obtained at 70, 80 and 90 °C, 
as has been reported previously [7]. 
 
Figure 4.3: P-XRD patterns for hydroxyapatite samples with the reference pattern for hydroxyapatite 
(ICSD: 26204 [13]). Asterisks (*) noted on the pattern, denote a small reflection at ca. 17° (2θ) which is 
attributed to the loss of calcium from the materials [14]. 
All detectable reflections in Figure 4.3 can be assigned by their positions to hydroxyapatite (HA) 
in accordance with published data (ICSD reference: 26204; [13]). No peaks were observed 
belonging to impurities. The reflections observed are sharp, indicative of high crystallinity post-
calcination. The small reflections at ca. 17° (2θ) identify the three materials produced in 
methanol as calcium-deficient hydroxyapatites [14]. The presence of this reflection suggests a 
species with 10% calcium deficiency, and thus a composition of approximately 
Ca9(HPO4)(PO4)5(OH) [14].  
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The HA_90_Water pattern does not contain this reflection (and is the same as the reference 
pattern). Therefore, when the cleaning solvent is changed from methanol to deionised water in 
this series of experiments, pure phase hydroxyapatite is obtained. These findings are 
summarised in Table 4.2. 
Table 4.2: Details of the material generated for samples synthesised via the CPFS process. 
Sample ID Product 
HA_70 Ca-deficient HA 
HA_80 Ca-deficient HA 
HA_90 Ca-deficient HA 
HA_90_Water Pure phase HA 
Calcium-deficient HA is most commonly used as a vaccine adjuvant [2-4], and thus it is 
encouraging that such a system can be produced in the CPFS approach, with an “x” value of 1 in 
the generic formula Ca10-x(HPO4)x(PO4)6-x(OH)2-x. 
SEM analysis (Figure 4.4 and Table 4.3) reveals that the particle size does not differ significantly 
between the four hydroxyapatite products. However, it is evident from Figure 4.4 that the 
morphology changes depending on the reaction conditions and the washing treatment. 
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Figure 4.4: SEM images of the hydroxyapatite products (A) HA_70, (B) HA_80, (C) HA_90, and (D) 
HA_90_Water. 
Table 4.3: Details of the mean particle size and morphology of the hydroxyapatite nanoparticles 
synthesised via the CPFS process, deduced with SEM image analysis, mean ± standard deviation. 
Sample ID Mean particle size / nm Morphology 
HA_70 156 ± 34 Spherical 
HA_80 159 ± 42 Spherical, rod-shaped 
HA_90 158 ± 49 Spherical, rod-shaped 
HA_90_Water 162 ± 35 Spherical, rod-shaped and platelets 
Increasing the temperature used to prepare the calcium deficient samples HA_70 to HA_90 
leads to a change of morphology from a solely spherical product at low temperature to samples 
consisting of both spherical and rod-shaped nanoparticles. The pure-phase hydroxyapatite has 
an additional platelet habit detected within the sample. 
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FTIR analysis was also performed, with the spectra presented in Figure 4.5. A shallow broad band 
is observed at ca. 3000 cm-1; this is assigned to the absorption bands for hydroxyl groups present 
within the hydroxyapatite samples. Peaks at ca. 1090 and 1020 cm-1 can be attributed to the 
asymmetric stretching modes of P-O and that at ca. 960 cm-1 is assigned to the stretching modes 
of symmetric phosphate groups [15, 16]. All bands listed are consistent with those described for 
hydroxyapatite in the literature [15, 16]. 
 
Figure 4.5: FTIR spectra of hydroxyapatite samples. 
4.4.3 Surface Area and Pore Volume 
In all cases, the samples were dried at 100 °C under vacuum prior to analysis.  
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The isotherms, as presented in Figure 4.6, are evidently Type II. This classification of isotherm 
corresponds to the materials being non-porous, with multiple adsorption layers arising on the 
adsorbent’s surface. This is supported by analysis of the pore volumes (Table 4.4); all samples 
have a pore volume less than 0.41 mL g-1. The intermediate, plateau portion of the isotherm 
indicates the formation of a monolayer. A full adsorption/desorption program was run between 
0 and 1 relative pressures to confirm the absence of any mesopores (mesoporous structures 
would exhibit a plateau in the isotherm at ca. 0.9 Ps/Po [17]). 
 
Figure 4.6: Adsorption isotherms of the hydroxyapatite materials showing (A) HA_70, (B) HA_80, (C) 
HA_90 and (D) HA_90_Water. 
Table 4.4: Surface area and pore volume data. 
Sample ID Surface Area / m2 g-1 Pore volume / mL g-1 
HA_70 72.796 0.1551 
HA_80 53.649 0.4094 
HA_90 73.449 0.1341 
HA_90_water 54.437 0.1244 
The largest two hydroxyapatite NPs – as measured by SEM – exhibit the smallest surface areas, 
with 53.649 and 54.437 m2 g-1 for HA_80 and HA_90_Water, respectively. However, there is no 
clear trend: in terms of particle size, we see HA_70 < HA_80 ≈ HA_90 < HA_90_Water, but the 
surface area measurements follow the trend HA_90 < HA_70 > HA_90_Water < HA_80. This 
might be attributed to varied aggregation patterns in the different samples. 
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4.4.4 Zeta Potential Measurements 
As mentioned in Section 1.3.3, the zeta potential has been shown to be an important 
physicochemical property in calculating the magnitude of the immune response to LDH 
adjuvants; therefore, this was also investigated for the hydroxyapatite class of materials. Data 
are presented in Table 4.5 and Table 4.6. It is evident that changing the dispersion medium 
causes a change in the zeta potential: negative readings are recorded when PBS is used as the 
dispersant due to negative phosphate anions within the PBS solution being adsorbed to the 
surface of the NPs and altering the charge at the slipping plane. Positive readings are obtained 
when UP-water was used as the dispersant, and there is evidence of stable dispersions being 
formed with ca. +30 mV readings [18].  
Table 4.5: Mean zeta potential measurements for the hydroxyapatite materials when dispersed in UP-
water with resistance of 18.2 mΩ, presented as mean ± standard deviation. 
Sample ID ZP initially / mV ZP after 10 minutes / mV 
HA_70 28.17 ± 1.11 28.87 ± 1.26 
HA_80 32.40 ± 0.83 32.48 ± 1.34 
HA_90 34.47 ± 0.66 37.15 ± 1.05 
HA_90_water 24.25 ± 0.54 26.35 ± 0.89 
 
Table 4.6: Mean zeta potential measurements for the hydroxyapatite materials, when dispersed in 0.01 
M phosphate buffered saline (PBS) solution at pH 7.4; mean ± standard deviation. 
Sample ID ZP initially / mV ZP after 10 minutes / mV 
HA_70 -8.9 ± 0.77 -1.6 ± 0.68 
HA_80 -9.5 ± 0.93 -11.3 ± 0.51 
HA_90 -9.8 ± 0.77 -12.6 ± 1.18 
HA_90_water -12.5 ± 0.88 -15.1 ± 2.25 
Efforts were made to relate the zeta potential measurements to the particle size of the 
hydroxyapatite NPs, since such relationships were previous found to exist for AlO(OH) systems 
(see Section 3.4.8). None were evident for the UP water data set (Table 4.7 and Figure 4.7). 
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Table 4.7: Relationships between zeta potential measurements and experimental properties of the 
hydroxyapatite materials. 
Experimental 
parameter / μm (x) 
Zeta potential / mV 
(y) 
Equation R2 correlation 
Particle size 
ZP in UP-water y = -0.6757x + 137.04 0.1270 
ZP in UP-water 
(10 minutes) 
y = -0.4855x + 108.25 0.0616 
ZP in PBS y = -0.6004x + 85.096 0.8152 
ZP in PBS 
(10 minutes) 
y = -2.2746x + 350.78 0.8505 
However, there appears to be a structure/property relationship connecting the potentials 
measured in PBS with the particle size of the hydroxyapatite materials, suggesting that it may 
be possible to tune the zeta potential through varying the size of the particles. Visual 
representations of these relationships are presented in Figure 4.7. It should be noted, however, 
that the standard deviation in the size of the particles are large, which means that caution needs 
to be applied in drawing conclusions from these data. 
 
Figure 4.7: Graphical representation of the relationships described in Table 4.7; with panels A and B 
depicting connections between particle size (deduced by SEM analysis) with zeta potential 
measurements using UP-water and panels C and D with zeta potentials measured using PBS. 
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4.4.5 In Vitro Experiments 
4.4.5.1  Cell Viability 
There is very little cytotoxicity recorded following exposure of the RAW264.7 macrophages to 
the hydroxyapatite nanoparticles (Figure 4.8), consistent with the biocompatible nature of this 
compound. These findings are in agreement with the literature [1]. In all cases, viability is 
observed to be above 90 %. 
 
Figure 4.8: Cell viability results. RAW264.7 macrophages were exposed to hydroxyapatite particles at 
476 μg mL-1 for 24 hours. Cells exposed to commercial alums (Alhydrogel and Adju-Phos) were used for 
comparative purposes and concentrations were the same as those used for hydroxyapatite. Cell viability 
was quantified by Alamar Blue assays with n=3; each independent experiment contained 9 replicates. 
4.4.5.2  Immunoassay Experiments 
Cytokine secretions were quantified by means of an ELISA assay on the cell-free supernatants 
from the RAW264.7 cells. TNF-α secretion is constant with all the hydroxyapatite samples and 
there is no apparent impact of phase, size or morphology on this cytokine (Figure 4.9). The 
materials perform approximately on par with the commercial adjuvants, being somewhat more 
potent than Adju-Phos but less than Alhydrogel. 
Chapter 4 Particle Engineering of Hydroxyapatite Nanoparticles 
 
171 
 
 
Figure 4.9: TNF-α production in response to hydroxyapatite adjuvants. RAW264.7 macrophages were 
exposed to hydroxyapatite materials at 476 μg mL-1 for 24 hours. Cell free supernatants were collected 
and TNF-α cytokine secretions were quantified via ELISA assays with n=3 and each independent 
experiment containing 9 replicates. Commercial alums (Alhydrogel and Adju-Phos) were used for 
comparative purposes and lipopolysaccharide (LPS) was used as a positive control. 
There is evidence of changes in the production of IL-6 by the RAW264.7 cells in response to 
application of the different hydroxyapatite NPs (Figure 4.10). A reduction in IL-6 concentration 
is seen with an increase in reaction temperature. This outcome may therefore be affected by 
the morphology of the NPs, which differs with the reaction temperature. The materials prepared 
at 70 and 80 °C show performance intermediate between the two commercial comparators, 
while those prepared at 90 °C (both Ca-deficient and non-deficient) are less potent than both. 
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Figure 4.10: IL-6 production in response to hydroxyapatite adjuvants. RAW264.7 macrophages were 
exposed to hydroxyapatite materials at 476 μg mL-1 for 24 hours. Cell free supernatants were collected 
and IL-6 cytokine concentrations were quantified via ELISA assays with n=3 and each independent 
experiment containing 9 replicates. Commercial alums (Alhydrogel and Adju-Phos) were used for 
comparative purposes and lipopolysaccharide (LPS) was used as a positive control. 
4.4.5.3  Fluorescent microscopy 
All hydroxyapatite materials were labelled with FITC and the RAW264.7 cells with the DAPI 
nuclear stain, giving rise to green and blue images under the fluorescent microscope, 
respectively. The four samples’ interaction with the RAW cells was investigated with a 
fluorescent microscope, with images given in Figure 4.11. 
All the hydroxyapatite materials are rod-like in appearance which suggests that aggregation of 
the NPs has occurred because their morphology differs from what is observed in the SEM images 
(Figure 4.4); the observed particle size is far greater too. Nevertheless, there is evidence of 
cellular attachment of the RAW cells to the surface of the samples. Flach and co-workers 
proposed the concept of lipid membrane disturbances as a possible mechanism of adjuvanticity 
for alum [19]; the fluorescent micrograph images in Figure 4.11 are consistent with this theory. 
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Figure 4.11: Fluorescent microscopy with FITC-labelled hydroxyapatite samples (green) with DAPI 
nuclear staining of RAW264.7 cells (blue); (A) cells alone, (B) Alhydrogel, (C) Adju-Phos, (D) HA_70, (E) 
HA_80, (F) HA_90; and (G) HA_90_Water. 
Confocal microscopy was undertaken but proved unsuccessful due to the semi-adherent nature 
of the murine macrophage cell line, meaning that the cells ruptured during the transfer stage 
from the plate to the microscope slide. 
4.4.6 Structure/Property Relationships 
Attempts were made to elucidate relationships between the immunological outputs of 
RAW264.7 macrophages following exposure to hydroxyapatite materials and the 
physicochemical properties of these samples (Table 4.8). 
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Table 4.8: Relationships between physicochemical properties and immunoassay data of the 
hydroxyapatite materials, with particle size being determined by SEM analysis (nm) and zeta potentials 
recorded in mV. 
Experimental 
parameter (x) 
Cytokine concentration / pg mL-1 (y) Equation 
R2 
correlation 
Particle size 
TNF-α y = -0.1073x + 73.801 0.0154 
IL-6 y = -4.226x + 705.86 0.7380 
ZP in UP-water 
TNF-α y = -0.0432x + 58.07 0.0090 
IL-6 y = 0.1089x + 32.575 0.0018 
ZP in UP-water 
(10 minutes) 
TNF-α y = -0.1503x + 61.475 0.1156 
IL-6 y = -0.3842x + 47.814 0.0234 
ZP in PBS 
TNF-α y = 0.3741x + 60.588 0.0827 
IL-6 y = 5.7163x + 93.987 0.5981 
ZP in PBS  
(10 minutes) 
TNF-α y = 0.1044x + 57.842 0.0886 
IL-6 y = 1.8957x + 55.064 0.9048 
The correlation coefficients presented in Table 4.8 indicate that there are very few relationships 
between these data, with the majority of the R2 values not exceeding 0.12. TNF-α production by 
RAW264.7 cells has no strong relationships with either the particle size or zeta potential; 
however, the IL-6 concentration appears to be closely related to the zeta potential 
measurements recorded in PBS (10 minute-time point) with an R2 value of 0.9048. There is also 
a slightly weaker trend observed for IL-6 concentrations with the particle size of the 
hydroxyapatite NPs obtained from SEM analysis, with an R2 value of 0.7380 (Table 4.8). Visual 
representations of selected relationships are presented in Figure 4.12, with all other plots given 
in the Appendix 2. 
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Figure 4.12: Graphical representation of relationships between the particle size data and (A) TNF-α and 
(B) IL-6 cytokine concentrations; together with the analogous relationships between the zeta potential 
measurements recorded in PBS (10 minute-time point) and (C) TNF-α and (D) IL-6. 
It appears that the PBS zeta potential seems to influence the production of IL-6 from RAW264.7 
cells in vitro, but all other relationships are unclear given the errors in the data. 
In the literature, it is reported that spherical particles of AlO(OH) stimulate weaker immune 
responses than rod-like particles (in terms of 400 and 1000 pg mL-1 production by macrophages, 
respectively) [20]. The HA_70 material consists solely of spherical nanoparticles and leads to the 
production of roughly equal amounts of IL-6 and TNF-α (Figure 4.9 and Figure 4.10).  
The addition of rod-like hydroxyapatite nanoparticles, obtained through increasing the reaction 
temperature, results in a decrease in IL-6 output with no change in TNF-α. This trend is different 
to that described in the literature by Sun et al., who found that rod-like nanoparticles stimulate 
a greater IL-6 output, suggesting a Th2-type polarisation may be induced [20]. However, Sun 
explored AlO(OH), and in addition we have mixed populations of mixed particle habits here. 
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It appears that in the case of hydroxyapatite the introduction of rod-shaped particles leads to a 
reduction in immunogenicity. This effect is further accentuated in the HA_90_Water sample 
with a mixture of spherical, rod-like and platelet shaped nanoparticles (Figure 4.9 and Figure 
4.10). Thus, from these findings it appears that it is not universally true that rod shaped particles 
are more potent in their immunogenicity. 
4.5   Conclusions 
The adapted CPFS reactor provided an easy and reproducible means of synthesising 
hydroxyapatite. The NPs produced were found to be similar in size, regardless of the 
temperature used for reaction. However, SEM analysis provided evidence for a degree of 
particle engineering, in terms of the morphology: as the reaction temperature is increased, there 
is a change from a single morphology (spheres) to a biphasic mixture (spheres and rods). The 
solvent used for washing the product was shown to impact the hydroxyapatite phase collected. 
Deionised water gave rise to pure-phase hydroxyapatite, whilst use of methanol generated a 
calcium-deficient phase. 
Assessment of the cytokine production induced following administration of the samples to 
RAW264.7 cells indicated that the TNF-α production is constant, regardless of the phase and 
particle shape. The IL-6 concentrations are found to vary however, indicating the potential to 
tune the immune response through hydroxyapatite particle engineering. 
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5.1  Introduction 
Zinc oxide (ZnO) is a non-toxic entity commonly used as a dietary supplement [1]. There is a 
small body of literature in which ZnO nanoparticles have been explored as potential adjuvants. 
Work by Matsumura and colleagues involved inoculating BDA/1J mice with the model antigen 
ovalbumin (OVA) and 1 – 3 mg of ZnO, before the animals were sacrificed 21 days post-
immunisation [2]. Exposure to ZnO significantly increased the production of both anti-OVA IgG1 
and IgE antibodies, compared with the mouse subjects dosed with phosphate buffered saline 
(PBS) alone. The highest dose of ZnO (3 mg) saw an increase in OVA-specific splenocyte 
proliferation, coupled with elevated cytokine release profiles of IL-4, IL-5 and IL-17. However, no 
increases in either IgG2a or IFN-γ were observed. The authors concluded that ZnO provokes a 
Th2-type response which was found to be on par with that of the Imject alum used as a control. 
However, it is important to note that Imject alum is not identical to the alum adjuvant used in 
clinical vaccines [3]. Therefore, how ZnO compares with clinically-used alums adjuvants remains 
unknown. Matsumura hypothesised that some dissolution of the particles may have occurred, 
resulting in free zinc (II) cations being present; this has previously been reported to stimulate 
interleukin-4 (IL-4) production by T-cells [4]. 
A second study immunised BALB/c mice with OVA and ZnO nanoparticles (of < 50 nm in size) [1]. 
The conclusions drawn from the data were largely in agreement with those of Matsumura et al. 
[2], with anti-OVA IgG1 and IgE antibody titres being significantly increased following co-
administration of ZnO and OVA. The splenocyte studies in this work revealed an increase in IL-
2, IL-4, IL-6 and IL-17, whilst the production of both IL-10 and TNF-α declined. These data support 
ZnO adjuvant materials as being inducers of Th2-type responses. 
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There exists also some work where continuous hydrothermal syntheses of zinc oxide particles 
have been undertaken. Work by Ohara et al. describes a system whereby a solution of 
Zn(NO3)2·6H2O mixes with supercritical water. A potassium hydroxide feed acts as a quench, and 
this system resulted in the generation of nanorods with average diameter of 150 nm and length 
600 nm [5]. 
The key objective of the work described here was to synthesise ZnO particles of varying shape 
and size, then assess their immunological impact in vitro. By providing a better understanding 
of the parameters controlling the size of ZnO NPs, there are expected to be other benefits for 
the use of these materials in other applications such as sunscreen and paints. 
5.2   Materials and Methods 
5.2.1 Reactor Design for Continuous Hydrothermal Flow Synthesis of Nanoparticles 
Three identical diaphragm pumps (Milton Roy, Primeroyal K, Pont Saint-Pierre, France) were 
used simultaneously, providing three pressurised feeds at 240 bar: 0.20 M zinc nitrate 
hexahydrate solution at a flow rate of 40 mL min-1 (P1; in Figure 5.1.A), 0.40 M potassium 
hydroxide solution at a flow rate of 40 mL min-1 (P2) and deionised water at a flow rate of 80 mL 
min-1 (P3).  
The flow of zinc nitrate hexahydrate was heated to 450 °C using a bespoke 7 kW electrical heater, 
with specific design details described by Gruar et al. [6]. This hot stream was mixed with the flow 
of potassium hydroxide at room temperature in a confined jet mixer (Figure 5.1B) where the 
nanoparticles were formed. A deionised water quench was used and a second mixer was added 
between the confined jet mixer and the heat exchanger (depicted in the upper portion of Figure 
5.1B).  
In the second mixer, the hot nanoparticle slurry from the confined jet mixer entered the inner 
pipe and deionised water at room temperature flowed up through the outer annulus at 80 mL 
min-1. This diluted the ZnO nanoparticle slurry, which as a result was rapidly cooled to ca. 100 °C 
prior to further cooling to room temperature in the counter-current heat exchanger. 
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 In further syntheses, small amounts of aqueous Ti(II) were added to the Zn nitrate solution in 
order to obtain control of particle size, with mixed solutions made up at final concentrations of 
0.02 and 0.06 M Ti(II) and 0.18 and 0.14 M Zn nitrate respectively. All samples were synthesised 
by Dr Alistair Holdsworth.i 
The white, solid product was then recovered by centrifugation (4500 rpm for 5 minutes) and 
washed with copious amounts of deionised water. Sequential rounds of washing and 
centrifugation were performed until the conductivity of the supernatant water was reduced to 
a value less than 50 S m-1. The washed product was freeze-dried in a Vitris Genesis 35XL Freeze 
Drier (SP Scientific) by first freezing to -40 °C followed by treatment at -60 °C for approximately 
24 hours at 70-80 mTorr. 
                                                          
i The precise details of the Ti(II) salt used are confidential to Croda 
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Figure 5.1: (A) Simplified diagram of the CHFS process and (B) a diagram of the confined jet mixer for 
nanoparticle formation at mixing-point (lower part) with a downstream quench (upper part). 
5.3   Materials Characterisation 
5.3.1 Powder X-ray Diffraction 
See Section 3.3.1. 
5.3.2 Scanning Electron Microscopy 
See Section 3.3.2. 
5.3.3 Fourier Transform Infra-Red Spectroscopy 
See Section 3.3.3. 
5.3.4 Surface Area and Pore Volume Analysis 
See Section 4.3.4. 
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5.3.5 Zeta Potential Measurements 
See Section 3.3.6. 
5.3.6 Immunoassay Experiments 
See Section 3.3.7.  
5.3.6.1 Alamar Blue Assay 
See Section 3.3.7.1. 
5.3.6.2 Enzyme-Linked Immuno-Sorbent Assay 
See Section 3.3.7.2. 
5.3.6.3 Fluorescence and Confocal Microscopy 
See Section 3.3.7.3. 
5.4   Results and Discussion 
5.4.1 Continuous Hydrothermal Flow Synthesis of Zinc Oxide 
The reaction conditions for synthesis of the ZnO materials are presented in Table 5.1. Two of 
the three product slurries were acidic, whilst the product with the highest aqueous titanium 
content had a weakly alkaline pH. 
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Table 5.1: CHFS reaction conditions for the synthesis of different zinc oxide nanoparticles, P denotes 
pump, with P1 pumping deionised water, P2 pumping the zinc precursor Ti(II) salt solution (for Medium- 
and Small-ZnO reactions only) and P3 pumping the precipitating agent. 
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5.4.2 Characterisation 
 
Figure 5.2: Panel displaying the P-XRD patterns obtained for the three zinc oxide samples to confirm 
their identity against the published wurtzite reference pattern (ICSD: 26170, [8]). 
P-XRD patterns of the samples are shown in Figure 5.2. All detectable reflections can be assigned 
by their positions in those present in the published pattern for the wurtzite polymorph of ZnO 
[8]. No peaks were observed belonging to impurities. All samples are highly crystalline and the 
reflections observed increase in broadness as increasing concentrations of Ti(II) are employed. 
This arises because the size of the crystallite decreases (Table 5.2). 
Table 5.2: Crystallite size data calculated using the Scherrer equation with K = 1, given as mean ± 
standard deviation. 
Sample ID Mean crystallite size / nm 
Large ZnO 28.96 ± 4.02 
Medium ZnO 18.98 ± 1.52 
Small ZnO 11.70 ± 1.29 
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Figure 5.3: SEM images of the zinc oxide nanoparticles; (A) Large ZnO, (B) Medium ZnO and (C) Small 
ZnO. 
SEM images (Figure 5.3) revealed different shaped nanoparticles with varied sizes are produced 
with changes in the amount of Ti(II) added to the reaction. Samples with larger particles 
consisted solely of spherical nanoparticles, as shown in Figure 5.3A, whilst the samples with 
smaller particles were composed of mixed morphologies, as depicted in Figure 5.3B, C. 
Increasing the Ti concentration causes not only the production of smaller spherical 
nanoparticles, but also the formation of microparticles of different morphologies – platelets and 
rods – as summarised in Table 5.3. 
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Table 5.3: Mean particle size - categorised into morphology type - calculated from SEM analysis; mean 
± standard deviation, both measured in nm. Measurements for rod-like particles are the length of the 
rod. 
 Particle size (in nm) for each ZnO Morphology 
Sample ID    
Large ZnO 89.75 ± 24.85 - - 
Medium ZnO 46.18 ± 9.48 291.33 ± 86.21 - 
Small ZnO 42.09 ± 9.04 359.05 ± 258.74 423.21 ± 104.33 
FTIR analysis was performed on each of the samples (see Figure 5.4). While the P-XRD data 
clearly show the presence of phase-pure ZnO, the IR data are more complex. The broad peaks 
at ca. 3100-3500 cm-1 are attributed to the stretching modes of hydroxyl groups [9, 10], believed 
to arise from the presence of water, KOH or Ti(OH)2 within the sample. The  split peak ca. 2950 
cm-1 is assigned to the bending modes of M-OH [9]. The sharp peaks at ca. 1740 and 1390 cm-1 
are attributed to the carbon dioxide absorption in water molecules and M-OH modes, 
respectively. It should be noted that the transmission percentages are all very high (> 95 %), and 
thus we believe that we are simply observing small amounts of impurities in the samples here. 
Furthermore, the band spanning 980 – 650 cm-1 represents the vibrational modes of M-O bonds 
[9]. 
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Figure 5.4: FTIR spectra obtained for (A) Large-ZnO, (B) Medium-ZnO and (C) Small-ZnO materials; with 
all percentage transmission values > 95%, so very little absorption by the ZnO NPs is occurring. 
5.4.3 Surface Area and Pore Volume 
Surface area and pore volume analyses were completed for each of the three ZnO-NP samples, 
with the adsorption isotherms presented in Figure 5.5. In all cases, the samples were dried at 
100 °C prior to analysis under vacuum.  
 
Figure 5.5: Adsorption Isotherms of the three zinc oxide materials, (A) Large ZnO, (B) Medium ZnO, 
and (C) Small ZnO. 
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Following the IUPAC isotherm classifications, these systems are all Type II, indicating that the 
samples are non-porous structures [11]. The plateau within the curves means that a monolayer 
was formed during this phase of the analysis. Surface area and pore volume data for the three 
ZnO materials are presented in Table 5.4. 
Table 5.4: Surface area and pore volume data. 
Sample ID Surface Area / m2 g-1 Pore Volume / mL g-1 
Large ZnO 12.259 0.0269 
Medium ZnO 51.363 0.3835 
Small ZnO 115.08 0.9122 
The data in Table 5.4 demonstrate that a decrease in the size of the nanoparticles causes an 
increase in the surface area of the ZnO materials, as would be expected. 
5.4.4 Zeta Potential Measurements 
Zeta potential measurements were obtained using two different dispersants, ultrapure water 
(Table 5.5) and phosphate-buffered saline solution (PBS, Table 5.6). 
Table 5.5: Zeta potential measurements for the three ZnO materials when dispersed in UP-water with 
conductivity of 18.2 mΩ; mean ± standard deviation. 
Sample ID 
Initial ZP / mV 
ZP after 10 
minutes / mV 
Large ZnO -3.27 ± 0.31 -2.97 ± 0.22 
Medium ZnO 6.77 ± 0.37 6.13 ± 0.62 
Small ZnO -6.12 ± 2.53 -1.37 ± 0.31 
 
Table 5.6: Mean zeta potential measurements for the three ZnO materials when dispersed in 0.01 M 
phosphate-buffered saline (PBS) solution at pH 7.4; mean ± standard deviation. 
Sample ID 
Initial ZP / mV 
ZP after 10 
minutes / mV 
Large ZnO -30.3 ± 1.95 -32.3 ± 1.14 
Medium ZnO -23.6 ± 1.47 -28.4 ± 2.19 
Small ZnO -28.8 ± 1.35 -27.6 ± 1.52 
The zeta potential values in water are all close to zero. All zeta potential measurements recorded 
using PBS as the dispersant showed strongly negative values owing to the presence of phosphate 
anions which can adsorb to the surface of the ZnO materials. 
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Attempts were made to elucidate relationships between the sample size of the ZnO NPs and 
their zeta potential measurements; the results of these are detailed in Table 5.7. 
Table 5.7: Relationships between zeta potential measurements and experimental properties of the ZnO 
materials. 
Experimental 
parameter / μm (x) 
Zeta potential / 
mV (y) 
Equation R2 correlation 
Particle size 
ZP in UP-water y = -0.0595x + 2.6544 0.0538 
ZP in UP-water 
(10 minutes) 
y = -0.1395x + 9.7857 0.6551 
ZP in PBS y = -0.0817x – 22.717 0.3769 
ZP in PBS  
(10 minutes) 
y = -0.0949x – 23.803 0.9932 
For both dispersants, there appeared to be no apparent relationships between the data 
obtained from the initial zeta potential measurements and the particle size of the ZnO NPs, with 
R2 values of 0.0538 and 0.3769 for UP-water and PBS, respectively (Table 5.7). For potentials 
measured at the 10 minute time point, there is a clear structure/property relationship linking 
the zeta potential in PBS with the particle size of the ZnO materials. Therefore, this suggests that 
the zeta potential may be tuned by varying the size of the ZnO NPs (R2 value of 0.9932; Table 
5.7). Visual representations of these are presented in Figure 5.6. 
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Figure 5.6: Graphical representation of the relationships described in Table 5.7, with panels A and B 
depicting connections between particle size (deduced by SEM analysis) with zeta potential 
measurements using UP-water and panels C and D those with zeta potentials measured in PBS. 
5.5   In vitro Experiments 
5.5.1 Cell Viability 
Cell viability data are given in Figure 5.7. In general, viability is high at all time points studied, at 
> 90 %. The viability at times below 27h is slightly lower than that after this time, which may be 
attributed to the doubling time of the RAW264.7 cells [12]. As a result, the cell count appears to 
diminish during the mitotic stages of cell division but the viability level is restored in the 
following hour. It appears that the adjuvant causes a temporary reduction in cell numbers, but 
these recover within an hour. 
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Figure 5.7: Cell viability results. RAW264.7 macrophages were exposed to ZnO nanoparticles at 476 μg 
mL-1 in PBS for 24 hours. Cells exposed to commercial alums (Alhydrogel® and Adju-Phos®) were used 
for comparative purposes. Cell viability was quantified by Alamar Blue assays with n = 3 and each 
individual experiment containing nine replicates. 
5.5.2 Immunoassay Experiments 
Cytokine secretions were quantified by ELISA assays on the cell-free supernatants collected 
following a 24-hour exposure to the ZnO samples. TNF-α secretions are largely constant for all 
three ZnO materials, and there is no significant impact of the particle size or morphology on the 
production of this cytokine by RAW264.7 cells (Figure 5.8). That said, there appears to be a small 
decrease in TNF-α production as the particle size increases. The ZnO NPs give very similar results 
to the commercially used Alhydrogel adjuvant. 
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Figure 5.8: TNF-α production in response to ZnO adjuvants. RAW264.7 macrophages were exposed to 
ZnO nanoparticles or commercial adjuvants at 476 μg mL-1 for 24 hours, with lipopolysaccharide (LPS) 
used as a positive control. Cell-free supernatants were collected after this initial exposure period and 
the TNF-α cytokine secretions were quantified by ELISA assays with n = 3 and each individual 
experiments contained nine replicates. 
In contrast, there is evidence of distinct changes in the production of IL-6 induced by the 
RAW264.7 cells (Figure 5.9), with larger particles inducing much greater amounts of this 
cytokine. The concentration of IL-6 is similar to the concentration of TNF-α for both Small- and 
Medium-ZnO samples. However, for the Large-ZnO material, approximately 60 pg mL-1 of TNF-
α is produced following exposure of RAW cells to this adjuvant candidate, whilst ca. 150 pg mL-
1 IL-6 is secreted. The dominant cytokine for this material is IL-6, which suggests that the Large-
ZnO might induce a Th2-type immune response, consistent with what has been reported in the 
literature for ZnO materials [1, 2]. This trend has also been postulated for AlO(OH) particles [13]. 
While the small and medium samples lead to the production of similar amounts of IL-6 to the 
commercial Alhydrogel, the large sample generates considerably more, and more even than the 
LPS positive control. 
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Figure 5.9: IL-6 production in response to ZnO adjuvants. RAW264.7 macrophages were exposed to ZnO 
nanoparticles or commercial adjuvants at 476 μg mL-1 for 24 hours, with lipopolysaccharide (LPS) being 
used as a positive control. Cell-free supernatants were collected after this initial exposure period and 
the IL-6 cytokine secretions were quantified by ELISA assays with n = 3 and each individual experiments 
contained nine replicates. 
5.5.3 Fluorescent Microscopy 
All ZnO materials were labelled with FITC and the RAW264.7 cells with the DAPI nuclear stain 
giving rise to green and blue images under the fluorescent microscope, respectively. The three 
samples’ interaction with the murine macrophages was investigated, with images presented in 
Figure 5.10. The ZnO materials appear to exhibit spherical and rod-like morphologies (Figure 
5.10) with ZnO NPs appearing to have aggregated to form larger structures in vitro. 
There is evidence of cellular attachment of the RAW264.7 macrophages to the surface of the 
ZnO materials (Figure 5.10). There are various proposed routes by which alum adjuvants 
function with one theory suggesting that disturbances of the cells’ lipid membrane may evoke 
immunogenicity [14]; the interactions observed in Figure 5.10 suggest the ZnO samples may also 
function via this mechanism. 
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Confocal microscopy was undertaken but proved unsuccessful due to the semi-adherent nature 
of the murine macrophage cell line meaning that the cells ruptured during the transfer stage 
from the transwell plate, to the microscope slide. 
 
Figure 5.10: Fluorescent microscopy with FITC-labelled zinc oxide nanoparticles and DAPI nuclear 
staining of the RAW264.7 cells; (A) cells alone, (B) Alhydrogel, (C) Adju-Phos, (D) Large ZnO, (E) Medium 
ZnO; and (F) Small ZnO. 
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5.6 Structure/Property Relationships 
Analysis was performed to determine any potential links between the physicochemical 
properties of the ZnO NPs and their immunological effect on RAW264.7 cells. The results of 
these are presented in Table 5.8. There are strong structure/property relationships connecting 
the IL-6 output of RAW264.7 cells to either the zeta potential measured in PBS (at 10 minutes) 
or particle size of the ZnO materials. Similar relationships appear to exist for TNF-α, although 
the range over which the concentration varies is small. Therefore, it may be possible to tailor 
the elicited immune response through control of particle size and/or zeta potential (as discussed 
above in Section 5.4.4, these two parameters are themselves highly correlated). Visual 
representations of these relationships are presented in Figure 5.11.  
Table 5.8: Relationships between experimental parameters and immunoassay data of the ZnO 
materials; with particle size (nm) being derived by SEM analysis and zeta potential measurements in 
mV. 
Experimental 
parameter (x) 
Cytokine concentration / 
pg mL-1 (y) 
Equation 
R2 
correlation 
Particle size 
TNF-α y = -0.1138x + 69.526 0.9524 
IL-6 y = 1.9471x – 26.319 0.9973 
ZP in UP-water 
TNF-α y = 0.0064x + 62.78 0.0002 
IL-6 y = -1.3751x + 88.024 0.0327 
ZP in UP-water 
(10 minutes) 
TNF-α y = 0.4477x + 62.098 0.4378 
IL-6 y = -8.7986x + 102.51 0.6046 
ZP in PBS 
TNF-α y = 0.3729x + 73.081 0.1822 
IL-6 y = -8.3766x – 141.69 0.3270 
ZP in PBS  
(10 minutes) 
TNF-α y = 1.2131x + 98.479 0.9811 
IL-6 y = -20.473x – 513.36 0.9991 
In all other cases, no clear relationships can be elucidated (see plots located in Appendix 3). 
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Figure 5.11: Graphical representation of the particle size data related to (A) TNF-α and (B) IL-6 cytokine 
concentrations; and the zeta potential measurements recorded in PBS (10 minute-time point) related 
with (C) TNF-α and (D) IL-6. 
From the literature, we anticipate Th2-type immune responses to be elicited in vitro following 
administration of ZnO particles [1, 2]. It appears that the samples generated in this work concur 
with these findings. However, the data presented here suggest that particle size of the ZnO 
materials can influence the immune response evoked, thus proposing a possible route to tune 
this towards a Th1-type response through decreasing the size of the nanoparticles (see Figure 
5.9). In principle, this can be controlled via the precursor ratios used in reaction, with an increase 
in Ti(II) concentration likely to lead to smaller particles. 
5.7   Conclusions 
The synthesis of zinc oxide by a CHFS process has been studied using varying concentrations of 
zinc nitrate and aqueous Ti(II). An increase in the Ti(II) concentration is found to lead to a 
decrease in particle size and a wider range of particle morphologies seen within the sample.  
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High cell viabilities (> 90%) were observed following exposure to the different ZnO materials, 
indicating their biocompatibility. Assessment of the production of selected cytokines by ELISA 
confirmed the particles to be immunogenic. TNF-α production by RAW cells in response to ZnO 
application is approximately constant regardless of the size or morphology of the sample. 
However, IL-6 concentrations are profoundly impacted by these changes in the ZnO NPs, with 
larger particles generating more IL-6. This potentially provides a means of tuning the immune 
response for this type of adjuvant. Further, the amounts of both TNF-α and IL-6 produced are 
found to be correlated to the particle size and zeta potential of the NPs, indicating that ZnO NPs 
may comprise a broad family of immunoactive materials. 
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6.1   Introduction 
The immune response elicited following inoculation with layered double hydroxides (LDHs) has 
been found to be controlled by three physicochemical properties of the dosed LDH including the 
zeta potential, as discussed in Section 1.3.3. While two of these parameters (c-parameter and 
metal ion radius) can easily be computed or determined from literature sources, at present it is 
not possible to calculate the zeta potential a priori. 
The liquid layer surrounding a particle is subdivided into the Stern inner layer (where ions are 
strongly bound) and the diffuse outer layer (where ions are less strongly associated). Any 
movement of the particle leads to movement of the ions inhabiting the notional boundary 
between the two layers. The charge at this surface (“slipping plane”) is termed the zeta 
potential. We hypothesised that it should be possible to develop computational models of the 
LDH structure and use the properties of these to devise a simple proxy for the zeta potential. 
The objective of the work reported here thus was to develop an in silico means of predicting the 
zeta potential of layer double hydroxide materials, with the aim of replacing this property in the 
equation developed in previous working linking immunogenicity to physicochemical properties 
(Figure 6.1 [1]). This would allow us to forego the need to synthesise compounds prior to 
predicting their immune response, enabling a high-throughput in silico screening process to 
identify suitable LDH candidates for subsequent synthesis and in vitro / in vivo experimentation. 
This should ultimately permit thousands of compounds to be screened before a few lead 
compounds are down-selected. To expand the limits of the model, di-halide LDH materials were 
also synthesised for in vitro exploration.  
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Figure 6.1: The systems vaccinology approach adopted by Williams et al. A series of layered double 
hydroxide materials was prepared, and the response of human dendritic cells in co-culture or of mice 
upon ovalbumin (OVA) vaccination quantified. The physicochemical properties of the LDHs were then 
considered to be causative of the immune response, and structure/property relationships elucidated. 
Reproduced from ref  [1]. Copyright Rockefeller University Press 2014. 
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6.2   Materials and Methods 
6.2.1 [LiAl2(OH)6]X·yH2O Synthesis Protocol 
To control particle size of the synthesised LDHs, gibbsite [γ-Al(OH)3, a kind gift from Professor 
Dermot O’Hare, Oxford University] was sieved to three different fractions: < 45, 53 – 63 and 71 
– 90 µm using Endecotts test sieves and a Retsch sieve shaker. Li salts were sourced from Sigma 
Aldrich, UK. 
0.5 g of the sieved gibbsite was added to 10 mL of a 10 M LiX salt solution (where X = Cl-, Br-, I- 
or NO3-), placed in a sealed glass tube, and stirred vigorously at 110 °C overnight. Samples were 
left to cool completely then the product was retrieved using vacuum filtration, washed 
thoroughly with copious amounts of deionised water, and dried under vacuum with a small 
volume of acetone to aid the drying process. 
6.2.2 Mixed Halide Synthesis Protocol 
The smallest fraction of sieved gibbsite (< 45μm) was used to make a mixed halide intercalated 
material. 0.5 g of gibbsite was added to mixed LiCl / LiBr solutions with different Cl:Br ratios. The 
synthesis process was conducted as described in Section 6.2.1.   
6.2.3 Characterisation 
6.2.3.1 Powder X-Ray Diffraction 
See Section 3.3.1. 
6.2.3.2 Scanning Electron Microscopy 
See Section 3.3.2. 
6.2.3.3 Fourier Transform Infra-Red Spectroscopy 
See Section 3.3.3. 
6.2.3.4 X-ray Photoelectron Spectroscopy 
See Section 3.3.5. 
6.2.3.5 Zeta Potential Measurements 
See Section 3.3.6. 
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6.2.3.6 Dynamic Light Scattering 
Dynamic Light Scattering (DLS) was performed using a Nanozetasizer ZS (Malvern Instruments). 
10 mg of LDH was dispersed in 1 mL of ethanol and placed in a semi-micro cuvette of 1.6 mL 
capacity and 10 mm light path (Fisher-Brand FB55147) for determination of particle size and size 
distribution. 
6.2.3.7 In silico Simulations 
Static lattice energy minimisations were performed using GULP (General Utility Lattice Program) 
Version 4.0 [2] with the scientific visual software GDIS (Graphical Display Interface for Structures 
[3]) to visualise the structures and generate structural depictions of the optimised layered 
double hydroxide structures. 
6.2.4 Immunoassay Experiments 
See Section 3.3.7.  
6.2.4.1 Alamar Blue Assay 
See Section 3.3.7.1. 
6.2.4.2 Enzyme-Linked Immuno-Sorbent Assay 
See Section 3.3.7.2. 
6.2.4.3 Fluorescence and Confocal Microscopy 
See Section 3.3.7.3. 
6.3   Results and Discussion 
6.3.1 Computer Simulation Set-Up 
The ClayFF force field was implemented to simulate the structures of a hydroxide and two clay 
phases (portlandite, kaolinite and pyrophyllite, respectively) according to work by Cygan et al. 
[5] (see data in Table 6.1). These simulations were performed as calibrants to ensure that the 
force field was set up correctly and producing reliable data, and hence was suitable for 
subsequent LDH simulations. Comparison of our simulated data to Cygan’s data suggests our 
layer cut-offs lead to an improved fit to the experimental data. 
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Table 6.1: A comparison of parameters calculated in this work and by Cygan et al [5] with experimental 
data for model systems. 
 Kaolinite Al2Si2O5(OH)4 Portlandite Ca(OH)2 Pyrophyllite AlSi2O5(OH) 
 Simulated 
Cygan 
[5] 
Observed 
[6] 
Simulated 
Cygan 
[5] 
Observed 
[7] 
Simulated 
Cygan 
[5] 
Observed 
[8] 
a / Å 5.173 5.190 5.154 3.567 3.693 3.589 5.098 5.192 5.160 
b / Å 8.913 8.956 8.942 3.567 3.694 3.589 9.013 9.021 8.966 
c / Å 7.235 7.361 7.391 4.908 4.796 4.911 9.382 9.459 9.347 
α / ° 91.85 90.77 91.92 90.0 82.04 90.0 95.32 91.38 91.18 
β / ° 105.23 104.17 105.05 90.0 97.99 90.0 100.29 98.97 100.46 
γ / ° 89.82 90.40 89.8 120.0 121.59 120.0 89.64 89.81 89.64 
6.3.2 In silico Generation of [LiAl2(OH)6]X·yH2O Structures 
The gibbsite [γ-Al(OH)3] structure is monoclinic and exhibits pseudo-hexagonal symmetry with 
unit cell parameters a ≈ 8.68 Å, b ≈ 5.08 Å and c ≈ 9.74 Å [9]. In Al(OH)3, the trivalent aluminium 
cations occupy 2/3 of the octahedral holes in close-packed sheets of hydroxyl anions [10]. 
Following salt imbibition, the lithium cations occupy the remaining 1/3 of the octahedral holes 
to generate positively charged metal layers of formula [LiAl2(OH)6]+. The unit cell expands in the 
direction perpendicular to the Al(OH)3 place to accommodate the incoming guest anion and 
water molecules which now reside in the interlayer space – see Figure 6.2. 
 
Figure 6.2: GDIS-generated image of [LiAl2(OH)6]Cl·yH2O with [LiAl2(OH)6]+ layers and interlayer regions 
labelled. Molecular water and chloride anions occupy the interlayer space. 
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The original ClayFF forcefield permits the modelling of chloride systems, but does not include 
parameters to model bromide, iodide, nitrate and carbonate ions. Thus, additional interatomic 
potentials were added to the GULP input file to overcome this limitation (personal 
communication with Professor Julian Gale, Curtin University [11]; adapted from Fogg et al, [12]). 
The optimised system was achieved with the interatomic potentials listed in Table 6.2 to Table 
6.5. 
Table 6.2: LDH framework potential parameters - Coulombic charges for bromide, iodide, nitrate and 
carbonate guest anions. 
Species Coulombic charge / e 
Br -1.0000 
I -1.0000 
N 0.4124 
ONitrate -0.4708 
C 0.4280 
OCarbonate -0.4760 
Table 6.3: LDH framework potential parameters - interatomic potentials for bromide and iodide guest 
anions [12]. 
Lennard-Jones: 
𝑨
𝒓𝒎
−
𝑩
𝒓𝒏
 
Interaction 𝐴 / kcal Å9 𝐵 / kcal Å6 
Br – OHydroxyl 144784.0 2020.8 
Br – HHydroxyl 10457.0 285.9 
Br 0.0645 5.04 
I 0.0979 5.40 
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Table 6.4: LDH framework potential parameters - interatomic potentials for nitrate guest anions [12]. 
Harmonic: 
𝟏
𝟐
𝒌𝟐(𝒓 − 𝒓𝟎)
𝟐 +
𝟏
𝟐
𝒌𝟑(𝒓 − 𝒓𝟎)
𝟐 +
𝟏
𝟐
𝒌𝟒(𝒓 − 𝒓𝟎)
𝟒  
Interaction 𝑘2 / eV Å
-2 𝑘3 / eV Å
-3 𝑘4 / eV Å
-4 𝑟0 / Å 
N - ONitrate 50.6370 -408.2327 2779.8844 1.2645 
Three-body Harmonic: 
𝟏
𝟐
𝒌𝟐(𝜽 − 𝜽𝟎)
𝟐 +
𝟏
𝟔
𝒌𝟑(𝜽 − 𝜽𝟎)
𝟑 +
𝟏
𝟏𝟐
𝒌𝟒(𝜽 − 𝜽𝟎)
𝟒 
Interaction 𝑘2 / eV rad
-2 𝑘3 / eV rad
-3 𝑘4 / eV rad
-4 𝜃0 / ° 
ONitrate - N - ONitrate  10.2547 23.9655 74.9604 120.0 
Torsion: 𝒌(𝟏 +𝐜𝐨𝐬(𝒏𝒑𝒉𝒂𝒔𝒆(𝝓 − 𝝓𝟎))) 
Interaction 𝑘 / eV nphase 𝜙0 / ° 
ONitrate – N – ONitrate - ONitrate 0.623163 +1 0.0 
Lennard-Jones: 
𝑨
𝒓𝒎
−
𝑩
𝒓𝒏
 
Interaction 𝐴 / kcal Å9 𝐵 / kcal Å6  
H - ONitrate 768.4 40.72 
H – N 888.1 61.30 
OLayer - ONitrate 16442.0 384.8 
OLayer - N 243936.0 84.2 
Table 6.5: LDH framework potential parameters - interatomic potentials for carbonate guest anions. 
Lennard-Jones interactions from Fogg [12], all other potentials from Archer [13]. 
Harmonic: 
𝟏
𝟐
𝒌𝟐(𝒓 − 𝒓𝟎)
𝟐 
Interaction 𝑘2 / eV Å
-2 𝑟0 / Å 
C - OCarbonate 46.8331 0.00 
Three-body Harmonic: 
𝟏
𝟐
𝒌𝟐(𝜽 − 𝜽𝟎)
𝟐 
Interaction 𝑘2 / eV rad
-2 𝜃0 / ° 
OCarbonate - C - OCarbonate 1.7887 120.0 
Lennard-Jones: 
𝑨
𝒓𝒎
−
𝑩
𝒓𝒏
 
Interaction 𝐴 / kcal Å9 𝐵 / kcal Å6 
H - OCarbonate 670.8 43.30 
H – C 950.9 52.07 
OLayer - OCarbonate 16585.0 450.5 
OLayer - C 20834.0 499.8 
Torsion: 𝒌(𝟏 +𝐜𝐨𝐬(𝒏𝒑𝒉𝒂𝒔𝒆(𝝓 − 𝝓𝟎))) 
Interaction 𝑘 / eV nphase 𝜙0 / ° 
OCarbonate – N – OCarbonate - OCarbonate 0.151 +1 0.0 
Morse: 𝑫𝒆[𝟏 − 𝐞𝐱𝐩 (−𝒂(𝒓 − 𝒓𝟎)))
𝟐 − 𝟏] 
Interaction 𝐷𝑒 / eV 𝐴 / Å-1 𝑟0 / Å 
OCarbonate - C 5.00 2.5155 1.20246 
During the preliminary optimisation stages, the αβγ-angles fluctuated by 1-2% from the starting 
angles. However, following full optimisation, all the LDH materials result in α = β = γ = 90°. 
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Dehydrated [LiAl2(OH)6]X systems (Li/Al-LDH) were modelled where X = Cl-, Br-, I-, CO32- and NO3-
; selected data are presented in Table 6.6 and compared to others’ published data. As noted in 
Cygan’s paper, the Coulombic charge of lithium within LDH structures differs from the published 
value in the ClayFF input file. A charge of +1 eV was implemented for the monovalent lithium 
cation in the Li/Al-LDH species due to the stoichiometry of these LDH structures [5], whereas a 
+0.525 eV charge is implemented for structures such as Li2O [14] which was used in the 
derivation of this partial charge. 
Table 6.6: A comparison of simulated parameters for energy optimised, anhydrous Li/Al-LDH systems in 
this work and by Fogg [12] with experimental data for model systems. 
  [LiAl
2
(OH)
6
]Cl [LiAl
2
(OH)
6
]Br [LiAl
2
(OH)
6
]NO
3
 
  Simulated Fogg 
[12] 
Observed 
[14] 
Simulated Fogg 
[12] 
Observed 
[14] 
Simulated Fogg 
[12] 
Observed 
[14] 
a / Å 5.125 5.064 5.100 5.217 5.071 5.099 5.213   5.070 5.109 
c / Å 14.563 14.736 14.299 14.875 15.474 14.946 12.708 14.154 14.374 
The LDH materials were minimised using GULP with the space group of P63/m, and the optimised 
lattice parameters were found to be similar to the structural refinement values in the literature 
[12]. The values for the Cl and Br-containing systems are very close to those of Fogg’s earlier 
simulation and the experimental values. There is a distinct difference in the c-parameter for the 
nitrate system, with Fogg’s calculation yielding results much closer to the experimental value. 
[LiAl2(OH)6]NO3 (Li/Al-Nitrate) is a disordered structure with its guest anions having partial 
occupancies, which reduces the symmetry within the system. The experimental value of the 
interlayer spacing is 14.374 Å [15], but the simulated result in this work is 12.708 Å (see Table 
6.6). The Li/Al-Nitrate system described by Fogg is also dehydrated, and hence a possible reason 
for the differences in the c-parameters calculated may arise due to differences in the ClayFF 
force field parameters used (Fogg’s model uses his own optimised set of parameter descriptions 
[12]). However, since overall our values are close to observed experimental data, and the model 
makes good chemical sense, our in silico model is appropriate for simulation of LDH structures. 
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[LiAl2(OH)6]Br (Li/Al-Bromide) and [LiAl2(OH)6]I (Li/Al-Iodide) are both isostructural halide 
intercalates of [LiAl2(OH)6]Cl (Li/Al-Chloride), and the unit cells for all three were energy 
minimised in GULP using full symmetry. The results of simulations for Li/Al-Chloride, Li/Al-
Bromide, and Li/Al-Iodide are given in Figure 6.3, with data from all the simulations summarised 
in Table 6.7. 
 
Figure 6.3: Supercell structures of fully optimised Li/Al-LDH materials where the intercalated guest 
anion is (A) chloride (green), (B) bromide (brown) and (C) iodide (purple); with oxygen (red) and 
hydrogen (blue). 
The supercells presented in Figure 6.3 are composed of brucite-like sheets of [LiAl2(OH)6]+, with 
octahedrally co-ordinated trivalent aluminium ions, alternating with interlayer regions of (A) 
chloride, (B) bromide and (C) iodide guest anions. The interlayer spacing parameter increases as 
group 17 of the periodic table is descended (see Table 6.7), which can be attributed to the 
increasing size of the anionic radius of the guest in the interlayer region. This observation arises 
concurrently with a decline in the energy of the systems, due to reduced electrostatic 
interactions. 
The nitrate and carbonate systems demonstrate a collapse in the c-axis which is likely to be a 
result of dehydrating the structure, as well as ordering the anion arrangement within the 
interlayer space (Table 6.7). 
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Table 6.7: Simulated parameters for energy optimised, anhydrous Li/Al-LDH systems. 
 Li/Al-Chloride Li/Al-Bromide Li/Al-Iodide Li/Al-Nitrate Li/Al-Carbonate 
a / Å 5.215 5.217 5.222 5.213 5.144 
c /Å 14.563 14.875 15.461 12.708 10.614 
Volume / Å3 343.055 350.623 364.114 299.073 243.183 
Energy /eV -98.699 -98.361 -97.809 -100.681 -87.255 
The size of the guest anion appears to impact the volume of the optimised structure and the 
interlayer spacing values. Small monovalent anion species have volumes greater than those with 
more complex intercalated guest anions (Table 6.7; Li/Al-Chloride compared to Li/Al-
Carbonate). This is because the simulated carbonate and nitrate systems demonstrate a collapse 
in the c-axis in the dehydrated state, presumably as a result stronger intramolecular forces 
arising between the positive layers and the anionic species in these models resulting in a tighter 
unit cell conformation. 
Given the accuracy of the energy minimisation used for the Li/Al-LDHs, compared to the 
published work, it can be concluded that the ClayFF force field poses a suitable model for LDH 
systems. Model construction can thus be extended for further studies with other LDH materials, 
such as [Ca2Al(OH)6]X and [Mg2Al(OH)6]X species (Ca/Al- and Mg/Al-LDHs, respectively). 
6.3.2.1 Ca/Al- and Mg/Al-LDH Systems 
Dehydrated Ca/Al-LDHs appear to consist of [Ca2Al(OH)6]+ sheets with octahedrally co-ordinated 
calcium (II) cations, alternating with the interlayer guest anion, within the modelled structures. 
These materials have a net positive charge on their metal layers. In reality, the Ca/Al-LDHs have 
a seven co-ordinate Ca2+ cation which binds to six hydroxyl moieties in the [Ca2Al(OH)6]+ layer 
and an interlayer water molecule [16]. It may be that the change in hydration state in these 
simulated structures causes this apparent change in coordination. 
Furthermore, dehydrated Mg/Al-LDHs consist of [Mg2Al(OH)6]+ metal layers with octahedrally 
co-ordinated magnesium (II) cations, alternating with the interlayer guest anion, within the 
modelled structures. These materials have a net positive charge on their metal layers.  
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The in silico data obtained for the Chloride and Nitrate species of both Ca/Al- and Mg/Al-LDHs 
are described in Table 6.8, these will be used for zeta potential proxy deductions in Section 
6.8.3. 
Table 6.8: Simulated parameters for energy optimised anhydrous Ca/Al- and Mg/Al-LDH systems. 
 Ca/Al-Chloride Ca/Al-Nitrate Mg/Al-Chloride Mg/Al-Nitrate 
a / Å 5.935 5.935 5.459 5.442 
c /Å 17.031 17.031 16.879 14.706 
Volume / Å3 519.582 519.582 435.591 377.177 
Energy /eV -72.352 -72.352 -76.753 -77.620 
In conclusion, successful modelling of the Li/Al-, Ca/Al- and Mg/Al-LDH structures was achieved 
using the dehydrated forms of the materials through implementation of the ClayFF force field 
with the addition of optimised parameters for bromide, iodide, nitrate and carbonate anions. 
The simulated data exhibit a close fit to the experimental values, and thus the calculated data 
can be potentially used in place of experimental data for the means of determining a proxy for 
the zeta potential. This will be discussed in Sections 6.5.3 and 6.8. 
6.4  New LDH Materials Characterisation 
Powder X-ray diffraction patterns of Li/Al-LDH materials prepared with the < 45 µm sieved-
gibbsite fraction are shown in Figure 6.4. Identical patterns were obtained for the equivalent 
materials synthesised with the other two fractions of gibbsite. All detectable reflections can be 
assigned by their positions to standard diffraction peaks of published materials. No impurities 
were detected. The reflections observed are very sharp, indicative of the samples’ high 
crystallinity. 
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Figure 6.4: P-XRD patterns of Li/Al-LDH samples, synthesised with <45 μm gibbsite. (A) Li/Al-Chloride 
and –Bromide patterns alongside their reference patterns [15] and (B) Li/Al-Iodide and –Nitrate [15]; 
no reference patterns are available for the Li/Al-Iodide material in panel (B). 
Scanning electron microscopy (SEM) analysis shows that the reaction products are composed of 
particles with hexagonal platelet morphology (Figure 6.5). The images also highlight the sheet-
stacking nature of these materials. 
Chapter 6 The Immunological Properties of Layered Double Hydroxides 
 
213 
 
 
Figure 6.5: SEM images of Li/Al-LDH materials, synthesised with < 45 µm sieved gibbsite, where the 
intercalated guest anion is (A) chloride, (B) bromide, (C) iodide and (D) nitrate. 
The infrared spectra of the Li/Al-LDH materials are shown in Figure 6.6, and the major peak 
assignments for all samples are given in Table 6.9. The main band to note in the halide-
intercalated structures can be attributed to the hydroxyl groups at ca. 940 cm-1 (Figure 6.6A-C), 
whilst the nitrate samples (Figure 6.6D) also exhibit sharp peaks ca. 1385 cm-1 which are 
assigned to V3 absorption bands of nitrate [17]. There is a peak present ca. 1350 cm-1 for the 
Li/Al-iodide materials (Figure 6.6C) which may be attributed to carbonate contamination of the 
sample. 
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Figure 6.6: Fourier transform infrared spectra for Li/Al-LDHs where the guest anion is (A) chloride, (B) 
bromide, (C) iodide and (D) nitrate. 
Table 6.9: FTIR peak assignments for Li/Al-LDH materials – adapted from [18]. 
Wavenumber / cm-1 Assignment 
3450 H-bonding stretching vibrations of hydroxyl group in [LiAl2(OH)6]+ 
metal layer 
1640 Water bending vibrations 
1350 Carbonate incorporation 
1030 Hydroxyl bending vibration in [LiAl2(OH)6]+ metal layer 
940 Hydroxyl moieties in the halide intercalated species 
725 Al – O 
All the different materials produced give identical FTIR spectra with each ion, irrespective of the 
size of the gibbsite used during synthesis. Considering all the data as a whole, it appears that all 
the materials were successfully synthesised and the data obtained are consistent with the 
literature. 
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6.5   Particle Size and Zeta Potential Measurements 
Experiments were performed to determine if changing the particle size of the precursor gibbsite 
influences the zeta potential and size of the LDH materials. 
6.5.1 Particle Size  
A summary of all the particle size data collected is given in Table 6.10. The smallest gibbsite 
fraction appears to lead to smaller particles as the halide interlayer anion increases in size. The 
crystallite size determined by the Scherrer equation (P-XRD in Table 6.10) gives a smaller size 
than the particle size calculated by SEM or DLS, as would be expected.  
Table 6.10: Collated crystallite and particle size data for the Li/Al-LDH materials; for SEM analysis, at 
least 20 particles were measured using the ImageJ software for the mean particle size. 
  P-XRD DLS SEM 
LDH Material 
Gibbsite 
Fraction 
Size  
/ µm 
Mean 
size  
/ nm 
Standard 
Deviation 
/ nm 
Mean 
size   
/ µm 
Standard 
deviation 
/ µm 
Mean 
size  
/ µm 
Standard 
deviation 
/ µm 
Li/Al-
Chloride 
< 45 48.25 22.77 1.69 0.35 10.22 3.08 
53 – 63 37.26 16.60 1.63 0.24 8.99 4.24 
71 – 90 44.12 15.09 1.09 0.64 22.89 13.77 
Li/Al-
Bromide 
< 45 45.37 19.01 1.54 0.24 8.58 4.44 
53 – 63 46.29 20.31 1.86 0.32 5.89 2.09 
71 – 90 32.19 12.78 0.72 0.26 17.68 8.95 
Li/Al-Iodide 
< 45 36.60 14.20 1.46 0.15 4.41 2.05 
53 – 63 33.19 15.90 1.46 0.18 4.50 2.26 
71 – 90 39.73 16.80 1.14 0.31 44.92 --- 
Li/Al-Nitrate 
< 45 51.10 18.49 1.85 0.36 9.10 4.98 
53 – 63 44.45 14.44 0.91 0.35 5.76 3.78 
71 – 90 41.84 15.37 1.05 0.44 22.75 7.24 
There do not appear to be any trends in the size for these materials across the different analysis 
types (Table 6.10). The SEM images provide us with visual depictions of the Li/Al-LDH samples, 
thereby giving arguably the most accurate method of calculating the mean particle size for these 
materials; therefore, the SEM dataset will be used in further work. 
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6.5.2 Zeta Potential Measurements 
With ultrapure water as the diluent, positive zeta potential measurements were recorded – with 
the majority of the data being around +30 mV, which is associated with a stable suspension [19] 
(see data in Table 6.11). In contrast, when the LDH materials were dispersed in PBS, negative 
zeta potential measurements were obtained in the range 0 to -27 mV (Table 6.12). The latter 
outcome is likely to have occurred due to the presence of negatively charged phosphate anions 
within the PBS solution; these are attracted to the positive LDH layers and surround them, 
resulting in a negative zeta potential [20]. 
Table 6.11: Collated zeta potential data for all LDH materials measured with ultrapure water as the 
diluent. 
  0 minutes +10 minutes 
LDH Material 
Gibbsite 
Fraction 
Size / µm 
Mean zeta 
potential 
/ mV 
Standard 
Deviation 
/ mV 
Mean zeta 
potential  
/ mV 
Standard 
Deviation 
/ mV 
Li/Al-Chloride 
< 45 58.2 0.96 56.6 0.89 
53 – 63 26.4 2.46 18.6 0.78 
71 – 90 42.6 5.32 33.3 0.38 
Li/Al-Bromide 
< 45 51.6 1.17 45.9 1.12 
53 – 63 42.0 3.42 32.8 1.17 
71 – 90 20.6 2.00 15.9 0.50 
Li/Al-Iodide 
< 45 30.6 2.23 27.1 0.94 
53 – 63 37.9 2.82 34.7 2.36 
71 – 90 33.3 2.27 26.8 0.72 
Li/Al-Nitrate 
< 45 19.0 0.64 10.5 0.52 
53 – 63 32.9 1.72 22.4 0.93 
71 – 90 12.5 3.45 8.2 0.90 
There are no apparent trends with the PBS-based dataset (Table 6.12), however, with ultrapure 
water there is a decrease in the measured zeta potential as the interlayer anion changes from 
Cl to Br to I, for samples made from the smallest gibbsite fraction. This relationship is not 
consistent across the LDHs made from the other two gibbsite fractions (data in Table 6.11 and 
Table 6.12), which may be due to aggregation of the samples and subsequent sedimentation at 
the base of the zeta cell. Therefore, only the 45 μm fraction will be investigated further. 
Chapter 6 The Immunological Properties of Layered Double Hydroxides 
 
217 
 
Table 6.12: Collated zeta potential data for all LDH materials measured in 0.01 M phosphate buffered 
saline (PBS) solution as the diluent, at pH 7.4. 
6.5.3 Zeta Potential Correlations 
Attempts were made to elucidate any relationships between the mean particle sizes of LDHs 
generated from the 45 μm gibbsite fraction (as measured by SEM) and the zeta potential 
measurements of these Li/Al-LDH materials – the results are given in Table 6.13. Graphical 
representations are presented in Figure 6.7. 
Table 6.13: Relationships between zeta potential measurements and experimental properties of the 
Li/Al-LDH materials. 
Experimental 
parameter / μm (x) 
Zeta potential / mV (y) Equation R2 correlation 
Particle size 
ZP in UP-water y = 0.2076x – 1.9795 0.9979 
ZP in UP-water 
(10 minutes) 
y = 0.1998x – 0.8937 0.9921 
ZP in PBS y = 1.6425x + 27.173 0.9173 
ZP in PBS 
(10 minutes) 
y = 0.6872x + 15.759 0.3874 
  0 minutes +10 minutes 
LDH Material 
Gibbsite 
Fraction 
Size / µm 
Mean zeta 
potential  
/ mV 
Standard 
Deviation 
/ mV 
Mean zeta 
potential  
/ mV 
Standard 
Deviation 
/ mV 
Li/Al-Chloride 
< 45 -10.85 1.71 -11.98 0.90 
53 – 63 -9.08 1.52 -10.37 1.13 
71 – 90 -15.37 0.56 -15.57 0.62 
Li/Al-Bromide 
< 45 -10.8 0.49 -8.82 0.74 
53 – 63 -13.22 0.88 -9.95 0.27 
71 – 90 -25.65 0.98 -26.72 2.19 
Li/Al-Iodide 
< 45 -13.85 0.83 -14.22 1.75 
53 – 63 -13.27 0.80 -11.75 0.84 
71 – 90 -15.82 0.85 -17.00 0.82 
Li/Al-Nitrate 
< 45 -13.32 0.83 -9.58 0.52 
53 – 63 8.00 2.40 5.12 0.71 
71 – 90 -17.13 0.48 -15.30 1.39 
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Figure 6.7: Graphical representations of the relationships described in Table 6.13; with panels A and B 
depicting correlations between particle size (deduced by SEM analysis) and zeta potential 
measurements using UP-water and panels C and D with zeta potentials measured in PBS. 
From the data in Figure 6.7, it appears that there are clear structure/property relationships 
connecting the zeta potential in water with the particle size; these suggest that it should be 
possible to tune the zeta potential through variation of particle size. In contrast, there are no 
clear relationships in the case of the potentials measured in PBS. This is presumably due to the 
presence of the phosphate anions complicating the system. 
Furthermore, it is possible to draw correlations between the zeta potential measurements and 
the energy, volume or a-parameter values derived in silico (Table 6.14 and Figure 6.8, with a-
parameter plots located in Appendix 4). 
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Table 6.14: Relationships between zeta potential measurements and in silico-deduced properties of 
the Li/Al-LDH materials. 
In silico parameter (x) 
Zeta potential / mV 
(y) 
Equation R2 correlation 
a-parameter / Å 
ZP in UP-water 
y = -3992.3x + 20879 0.9975 
Volume / Å³ y = -1.3394x + 519.07 0.9828 
Energy / eV y = -31.697x – 3068.7 0.9763 
a-parameter / Å 
ZP in UP-water 
(10 minutes) 
y = -4126.9x + 21577 0.9927 
Volume / Å³ y = -1.400x + 536.83 1.0000 
Energy / eV y = -33.235x – 3223.5 0.9996 
a-parameter / Å 
ZP in PBS 
y = -463.46x + 2406.5 0.9153 
Volume / Å³ y = -0.1522x + 41.847 0.8645 
Energy / eV y = -3.5809x – 363.8 0.8484 
a-parameter / Å 
ZP in PBS 
(10 minutes) 
y = -466.15x + 2420.7 0.3838 
Volume / Å³ y = -0.1408x + 37.96 0.3063 
Energy / eV y = -3.2256x – 328.71 0.2853 
There appear to be very distinct relationships between the zeta potential values observed 
experimentally in water and the modelled parameters (Figure 6.8). In contrast, the zeta 
potential measurements recorded using PBS as the dispersant display no such clear relationships 
(although there are reasonable correlations when considering the time zero values), consistent 
with the findings which were observed above with particle size. 
The relationships described in Table 6.14 indicate that a more negative calculated lattice energy 
corresponds to a more positive zeta potential measurement in UP water. Further, a smaller unit 
cell volume results in more positive zeta potentials in the same dispersant. This is sensible in 
terms of the chemistry of the systems. Considering the Li/Al-LDH particles, the exterior will 
display [LiAl2(OH)6]+ sheets. Each formula unit carries one unit of charge, and the charge density 
at the surface will be closely related to the a-parameter, since the latter determines the area in 
which each charge unit is present. Comparing the zeta potentials to the calculated a-parameter, 
a smaller value for a gives rise to a greater positive charge density at the surface, with a strong 
negative correlation. Since the LDH-Chloride material has the highest positive charge density at 
the surface, it also has the most positive zeta potential in water.   
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A smaller a-parameter leads to a smaller cell volume, compounded by the smaller anions in the 
chloride case reading to a reduced c-paramater, and thus we also observe a clear relationship 
between cell volume and zeta potential. The smaller a- and c-parameters result in stronger ionic 
interactions between the anions and cations present, and thus a more negative lattice enthalpy; 
a correlation between this and zeta potential is hence also seen. 
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q  
Figure 6.8: Graphical representation of the relationships described in Table 6.14; with calculated data 
for unit cell (UC) volume and lattice energy being correlated against zeta potential measurements in 
either UP water or PBS. (A) UP water (initial) with UC volume, (B) UP water (initial) with lattice energy, 
(C) UP water (10 minutes) with UC volume, (D) UP water (10 minutes) with lattice energy, (E) PBS (initial) 
with UC volume, (F) PBS ( initial) with lattice energy, (G) PBS (10 minutes) with UC volume, and (H) PBS 
(10 minutes) with lattice energy. 
6.6    Mixed Halide LDH Materials 
6.6.1 Mixed Halide Synthesis 
In a bid to probe in more detail correlations between zeta potential and parameters from in 
silico work, a series of mixed halide Li/Al-LDH materials were synthesised, fully characterised, 
modelled in silico, and tested in vitro with RAW264.7 macrophages.  
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Initial efforts to synthesise chloride/bromide di-halide Li/Al-LDHs combined varied volumes of 
10 M LiBr and LiCl salt solutions, while the reaction temperature was maintained at 110 °C and 
the mixture stirred for at least six hours. The resultant P-XRD patterns are very similar to that of 
Li/Al Chloride, with maybe slightly enlarged interlayer spacings. Selected patterns are presented 
in Figure 6.9A; all are largely identical for the first series of samples (LDH_1 – LDH_5). The 
patterns display 004 reflections of greater intensity than the 002 peaks, which is symptomatic 
of bromide incorporation (see Figure 6.9A). Reaction details and mean crystallite size analysis 
are presented in Table 6.15. 
Table 6.15: Optimisation of the synthetic process for generation of mixed-halide Li/Al-LDH materials, 
including the crystallite size deduced from P-XRD patterns (mean ± standard deviation). The 
concentration of the LiBr solution was constant at 10 M. Both d-spacing values for the 002 reflection in 
LDH_6 are provided. 
Sample ID 
[LiCl]  
/ M 
Volume LiCl 
/ mL 
Volume 
LiBr  
/ mL 
XRD Crystallite 
size / nm 
d-spacing /Å 
LDH_1 10 2.5 7.5 28.90 ± 3.82 7.71 
LDH_2 10 4 6 27.66 ± 6.54 7.55 
LDH_3 10 5 5 25.95 ± 3.25 7.30 
LDH_4 10 6 4 22.12 ± 2.43 7.39 
LDH_5 10 7.5 2.5 15.60 ± 4.12 7.42 
LDH_6 10 5 5 30.49 ± 11.93 
7.67 
7.39 
LDH_7 5 5 5 41.66 ± 11.01 7.63 
LDH_8 2 5 5 34.54 ± 10.31 7.57 
LDH_9 1 5 5 23.90 ± 8.09 7.11 
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Figure 6.9: P-XRD patterns of Li/Al-LDH samples, synthesised with <45 μm gibbsite. (A) LDH_1 and 
LDH_4 and (B) LDH_6 and LDH_8, with reference patterns for Li/Al-Chloride and –Bromide in each panel 
[15]. 
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Representative P-XRD patterns are provided in Figure 6.9B for the di-halide materials 
synthesised through altering the concentration of the LiCl solution (LDH_6 to LDH_9). These 
again show evidence of bromide incorporation given the greater intensity of the 004 reflection 
cf. the 002. It is evident from the P-XRD patterns that there are two 002 reflections for the LDH_6 
sample, with both d-spacing values given in Table 6.15. This might indicate a degree of phase 
separation, or possibly different hydration states.  In order to quantify the balance of anions 
present, XPS analysis was undertaken; the compositions calculated from the resultant data are 
given in Table 6.16. 
Table 6.16: Structural composition of the di-halide Li/Al-LDH materials, determined via XPS spectra. 
Sample ID Structural composition 
LDH_1 [LiAl2(OH)6] Br0.49Cl0.51·yH2O 
LDH_2 [LiAl2(OH)6] Br0.25Cl0.75·yH2O 
LDH_3 [LiAl2(OH)6] Br0.14Cl0.86·yH2O 
LDH_4 [LiAl2(OH)6] Br0.09Cl0.91·yH2O 
LDH_5 [LiAl2(OH)6] Br0.04Cl0.96·yH2O 
LDH_6 [LiAl2(OH)6] Br0.12Cl0.88·yH2O 
LDH_7 [LiAl2(OH)6] Br0.38Cl0.62·yH2O 
LDH_8 [LiAl2(OH)6] Br0.38Cl0.62·yH2O 
LDH_9 [LiAl2(OH)6] Br0.71Cl0.29·yH2O 
The chemical composition of the synthesised materials highlights the need to use a large excess 
of LiBr over LiCl to obtain high Br contents in the LDH produced (e.g. see LDH_6 to LDH_9 in 
Table 6.16). Because of their smaller size and greater charge density, chloride ions will 
preferentially intercalate over bromide ions, and therefore reducing the amount of chloride in 
the reaction mixture should increase the chance of successful intercalation of bromide. 
The data obtained via XPS indicate successful intercalation of both anions, with varying amounts 
of each in the interlayer (data in Table 6.16). The second series of materials, LDH_6 to LDH_9 
have between 12 – 71% of the interlayer anions as bromide, giving a wide range of compositions. 
These will be carried forward for further testing using the relative compositions deduced by XPS 
analysis to model the structures in silico. 
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6.6.2 Further Mixed Halide Li/Al-LDH Materials Characterisation 
Prior to in silico work, the characterisation of the LDHs produced was completed using SEM and 
FTIR analysis on the selected materials. The SEM images clearly demonstrate the LDHs to 
comprise hexagonal platelets with layered structures (Figure 6.10), and the FTIR spectra are all 
identical and contain the standard features expected with LDHs (Figure 6.11) with the same peak 
assignments as are previously listed in Table 6.9. 
 
Figure 6.10: SEM images for the four mixed halide intercalates LDH_6 to LDH_9. (A) Li/Al-Br0.12Cl0.88, 
(B) Li/Al-Br0.38Cl0.62, (C) Li/Al-Br0.62Cl0.38 and (D) Li/Al-Br0.71Cl0.29. 
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Figure 6.11: FTIR spectra comparing the four mixed-halide Li/Al-LDH materials LDH_6 to LDH_9. 
6.6.3 Zeta Potential Measurements 
Measurements were recorded when the materials were dispersed in phosphate-buffered saline 
(Table 6.17) and ultrapure water (Table 6.18). 
Table 6.17: Zeta potential measurements for the four mixed halide Li/Al-LDH materials of interest, 
performed in 0.01 M phosphate-buffered saline (PBS) solution of pH 7.4. 
  0 minutes 10 minutes 
Sample ID Sample ID Zeta potential / mV Zeta potential / mV 
LDH_6 Li/Al-Br0.12Cl0.88 -25.85 ± 1.11 -23.27 ± 1.32 
LDH_7 Li/Al-Br0.38Cl0.62 -18.77 ± 0.66 -13.12 ± 0.75 
LDH_8 Li/Al-Br0.62Cl0.38 -16.02 ± 1.34 -19.57 ± 1.33 
LDH_9 Li/Al-Br0.71Cl0.29 -14.55 ± 1.17 -17.25 ± 0.93 
The zeta potentials obtained when using PBS as the dispersant are all negative, and the 
suspensions seem relatively stable over the 10 minute timescale. 
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Table 6.18: Zeta potential measurements for the four mixed halide Li/Al-LDH materials of interest, 
performed in UP-water with resistance of 18.2 mΩ. 
  0 minutes 10 minutes 
Sample ID Sample ID Zeta potential / mV Zeta potential / mV 
LDH_6 Li/Al-Br0.12Cl0.88 12.26 ± 2.05 15.55 ± 1.30 
LDH_7 Li/Al-Br0.38Cl0.62 37.48 ± 2.77 33.55 ± 1.34 
LDH_8 Li/Al-Br0.62Cl0.38 32.62 ± 1.28 24.83 ± 1.02 
LDH_9 Li/Al-Br0.71Cl0.29 35.07 ± 1.33 36.62 ± 1.47 
There appears to be a trend in terms of how the potential varies with the Br content, such that 
when measured in PBS a higher bromide content leads to a more negative the zeta potential (0 
minutes, Table 6.17). The zeta potential measurements for dispersions using ultrapure water 
(Table 6.18) are less positive than those recorded for the previously described pure Cl/Br 
intercalates (Table 6.11). Again, the suspensions appear relatively stable over the 10 minute 
timescale. 
6.6.4 In silico modelling 
The relative contents of chloride and bromide anions from the XPS data (Table 6.16) were 
translated into fractional occupancies. Calculated data generated using GULP are summarised 
in Table 6.19. 
Table 6.19: Calculated unit cell parameters for energy optimised di-halide Li/Al-LDH systems. The 
difference in electronegativity is calculated by subtracting the electronegativity of the metal cation from 
the guest anionic species with the anionic component being a weighted mean of the two halide ions’ 
electronegativity values using their percentages deduced by XPS analysis. 
      
LDH Material a / Å c / Å 
Energy  
/ eV 
Volume  
/ Å3 
Difference in 
electronegativity 
[LiAl2(OH)6]Cl 5.215429 14.56306 -98.69947 343.0547 2.180 
[LiAl2(OH)6]Br1/8Cl7/8 5.215692 14.61327 -98.64790 344.2721 2.155 
[LiAl2(OH)6]Br3/8Cl5/8 5.216167 14.70099 -98.55412 346.4017 2.105 
[LiAl2(OH)6]Br5/8Cl3/8 5.216583 14.77664 -98.47066 348.2401 2.055 
[LiAl2(OH)6]Br5/7Cl2/7 5.216718 14.80145 -98.44299 348.8426 2.037 
[LiAl2(OH)6]Br 5.217113 14.87473 -98.36110 350.6229 1.980 
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The data presented in Table 6.19 compare well with the simulated data for the mono-halide 
materials, because they lie within the limits of the pure Cl/Br intercalates. A reduction in the 
chloride-content of the LDH leads to an increase in the a- and c- parameters, which is consistent 
with an increase in the anionic radius in the unit cell. The simulated value for energy becomes 
less negative on increasing the bromide content, because weaker interactions between the 
interlayer anions and the hydroxide layers arise as the size of the guest anion increases the 
distance between them and the charge density of the anion reduces. 
6.7   In Vitro Experiments 
6.7.1 Cell Viability 
The viability of cells exposed to LDHs was determined by the Alamar Blue in vitro assay; the data 
obtained are given in Figure 6.12 and Figure 6.13. In general, the cell viability is very close to the 
untreated cells control. However, there is evidence of a high degree of cell cytotoxicity for the 
mono-halide Li/Al-LDH materials (Figure 6.12) ca. 27 – 28 hours post-adjuvant exposure. This 
can be attributed to the doubling time of the RAW264.7 cell line [21]. As a result, the cell count 
appears to diminish during the mitotic stages of cell division but the viability level is restored in 
the following hour. Therefore, the adjuvant causes a temporary reduction in cell numbers, but 
these recover within an hour.  
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Figure 6.12: Cell viability results. RAW264.7 macrophages were exposed to Li/Al-LDH materials at 476 
μg mL-1 for 24 hours, with <45, 53-63 and 71-90 μm fractions of gibbsite used for LDH synthesis. Cells 
exposed to commercial alums (Alhydrogel® and Adju-Phos®) were used for comparative purposes at the 
same concentrations as the Li/Al-LDH materials. Cell viability was quantified by Alamar Blue, with n = 
3; each independent experiment contained nine replicates. (A) LDH_Chloride, (B) LDH_Bromide, (C) 
LDH_Iodide and (D) LDH_Nitrate. 
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There is similarly little evidence of cell cytotoxicity for the mixed-halide Li/Al-LDH materials 
(Figure 6.13) with RAW264.7 cell exceeding 90% viability across all the samples. 
 
Figure 6.13: Cell viability results. RAW264.7 macrophages were exposed to mixed halide Li/Al-LDH 
materials at 476 μg mL-1 for 24 hours. Cells exposed to commercial alums (Alhydrogel® and Adju-Phos®) 
were used for comparative purposes at the same concentrations as the Li/Al-LDH materials. Cell viability 
was quantified by Alamar Blue with n = 3; each independent experiment contained nine replicates. 
6.7.2 Immunoassay Experiments 
The immunological response of RAW264.7 cells exposed to LDHs was determined by ELISA 
assays; the data for TNF-α and IL-6 cytokine production are given in Figure 6.14 and Figure 6.15. 
The tumour necrosis factor-alpha (TNF-α) cytokine release profile from RAW cells exposed to 
mono-halide Li/Al-LDHs is constant and does not change with the intercalated guest anion 
(Figure 6.14). However, increasing the size of the anion’s radius induces an increase in 
interleukin-6 (IL-6) production (Figure 6.15), and therefore there is some evidence of a tuneable 
immune response.  
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Figure 6.14: TNF-α production in response to LDH adjuvants. RAW264.7 macrophages were exposed to 
LDH materials at 476 μg mL-1 for 24 hours. Cell free supernatants were collected and TNF-α cytokine 
secretions were quantified via ELISA assays with n = 3 and each independent experiment containing nine 
replicates. Commercial alums (Alhydrogel and Adju-Phos) were used for comparative purposes at the 
same concentrations as the Li/Al-LDH materials and lipopolysaccharide (LPS) was used as a positive 
control. 
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Figure 6.15: IL-6 production in response to LDH adjuvants. RAW264.7 macrophages were exposed to 
LDH materials at 476 μg mL-1 for 24 hours. Cell free supernatants were collected and IL-6 cytokine 
secretions were quantified via ELISA assays with n = 3 and each independent experiment containing nine 
replicates. Commercial alums (Alhydrogel and Adju-Phos) were used for comparative purposes at the 
same concentrations as the Li/Al-LDH materials and lipopolysaccharide (LPS) was used as a positive 
control. 
The cytokine profiles for the di-halide Li/Al-LDH materials are not consistent with the trend 
observed with the mono-halide species (Figure 6.14 and Figure 6.15). For both TNF-α and IL-6, 
Li/Al-Br0.38Cl0.62 and Li/Al-Br0.62Cl0.38 cause the production of greater amounts of the cytokines 
than do Li/Al-Br0.12Cl0.88 and Li/Al-Br0.71Cl0.29. Therefore, the relative composition of the two 
anions in the interlayer region influences the immune response in a different manner. The Li/Al-
Br0.12Cl0.88 and Li/Al-Br0.71Cl0.29 samples have the highest chloride and bromide content, 
respectively, and exhibit similar secretion patterns for both cytokines assayed. The two 
intermediate samples (Li/Al-Br0.38Cl0.62 and Li/Al-Br0.62Cl0.38) also have similar cytokine secretion 
patterns. Therefore, the dominant anion does not appear to impact the immune response 
elicited, and it may be that it is the relative composition of the two that modulates the cytokine 
output. 
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Overall, the in vitro data provides evidence that the LDH samples are likely to be safe to dose as 
adjuvants, and the data obtained indicate that it may be possible to tune the immune response 
by varying the composition of the materials. 
Correlations between immune responses and zeta potentials will be explored in Section 6.8. 
6.7.3 Fluorescent Microscopy 
All LDH materials were labelled with FITC and the RAW264.7 cells with the DAPI nuclear stain. 
The Li/Al-Chloride/Bromide/Iodide/Nitrate materials’ interaction with the RAW cells was 
visualised with fluorescent microscopy, with representative images given in Figure 6.16. The 
mixed halide species were also assessed. All the LDH particles are rod-like in appearance under 
the fluorescent microscope, which suggests that aggregation may have occurred since they 
exhibit platelet morphology by SEM analysis (Figure 6.5). There is some evidence of cellular 
attachment to the surface of the LDH particles. This is consistent with the suggestion of Flach et 
al. that lipid membrane disturbances contribute to the immunogenic effect of alum adjuvants 
[22]. 
 
Figure 6.16: Fluorescent microscopy with FITC-labelled LDH materials (green) with DAPI nuclear staining 
of the RAW264.7 cell (blue); (A) cells alone, (B) Alhydrogel, (C) Adju-Phos, (D) LDH-Chloride, (E) LDH-
Bromide, (F) LDH-Iodide; and (G) LDH-Nitrate.  
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Confocal microscopy was attempted, but the adherent nature of the RAW264.7 cells meant that 
they ruptured during transfer from a 24 well plate to a microscope slide for imaging, and thus 
no images could be obtained. 
6.8  Immune Response Predictions 
6.8.1 Experimental Parameters 
Correlations were determined between various experimental parameters and the 
immunological output of RAW264.7 cells in attempts to deduce a means of predicting the 
immune response induced by these materials. The results summarised in Table 6.20 compare 
the cytokine concentrations with particle size and zeta potential measurements. 
Table 6.20: Relationships between experimental parameters and immunoassay data for the single 
halide-intercalated Li/Al-LDH materials; with particle size (μm) being derived by SEM analysis and zeta 
potential measurements being recorded in mV. 
Experimental 
parameter (x) 
Cytokine concentration / pg mL-1 (y) Equation 
R2 
correlation 
Particle size 
TNF-α y = 1.0191x + 52.25 0.9858 
IL-6 y = -3.7541x + 64.72 0.9697 
ZP in UP-water 
TNF-α y = 0.2104x + 50.288 0.9728 
IL-6 y = -0.7858x + 72.45 0.9835 
ZP in UP-water 
(10 minutes) 
TNF-α y = 0.2058x + 51.245 0.9991 
IL-6 y = -0.7381x + 67.563 0.9318 
ZP in PBS 
TNF-α y = 1.6136x + 79.228 0.8405 
IL-6 y = -6.4935x – 41.164 0.9865 
ZP in PBS  
(10 minutes) 
TNF-α y = 0.5948x + 67.077 0.2755 
IL-6 y = -3.1536x – 1.1369 0.5613 
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It is evident that the immunological output of both TNF-α and IL-6 from RAW264.7 cells can be 
reliably predicted using physicochemical properties of the mono-halide LDH samples (see Figure 
6.17A and B and Table 6.20). Both TNF-α and IL-6 production appear to be strongly correlated 
with the particle size data and zeta potential measurements obtained using UP-water (initial and 
10 minutes) and PBS (initial measurements only). In contrast, there are no clear relationships 
observed when comparing the immunological output of RAW264.7 cells to the zeta potential 
measurements recorded with PBS as the dispersant at 10 minutes after forming the dispersion 
(R2 = 0.2755 and 0.5613 for TNF-α and IL-6, respectively). The experimental parameter which 
gives the best correlations to both cytokines is the zeta potential measured initially with UP-
water, with R2 values of 0.9728 and 0.9835 for TNF-α and IL-6 secretions, respectively (Figure 
6.17A and B). 
Therefore, it is clear that the particle size and zeta potential of the mono-halide Li/Al-LDH 
materials can influence the secretion of TNF-α and IL-6 cytokines by RAW264.7 cells which may 
mean tuning the immune response is possible by varying the size of the LDHs. Good correlations 
with both are to be expected because it was found earlier (Section 6.5.3) that particle size and 
zeta potential are highly correlated. Similar relationships are also observed for the zeta 
potentials measured in UP-water, providing another potential means of tailoring the immune 
response in vitro. 
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Figure 6.17: Graphical representation showing the relationships between the zeta potential 
measurements recorded in UP water immediately after dispersion formation and the mono-halide Li/Al-
LDH materials' production of (A) TNF-α and (B) IL-6, and also those obtained with the di-halide species 
in terms of (C) TNF-α and (D) IL-6. 
For the di-halide Li/Al-LDH materials, there are no clear relationships between the 
physicochemical properties of the compounds and the immune response provoked (Figure 
6.17C and D and Table 6.21). 
Table 6.21: Relationships between experimental parameters and immunoassay data for the mixed 
halide-intercalated Li/Al-LDH materials. Particle size is measured in μm and zeta potentials are recorded 
in mV. 
Experimental 
parameter (x) 
Cytokine concentration / pg mL-1 
(y) 
Equation 
R2 
correlation 
Particle size 
TNF-α y = 0.7339x + 24.225 0.8454 
IL-6 y = 0.8762x + 33.782 0.3001 
ZP in UP-water 
TNF-α y = 0.2865x + 39.773 0.3118 
IL-6 y = 0.9551x + 34.35 0.8627 
ZP in UP-water 
(10 minutes) 
TNF-α y = 0.139x + 44.343 0.0493 
IL-6 y = 0.8659x + 38.458 0.4761 
ZP in PBS 
TNF-α y = 0.2807x + 53.462 0.0563 
IL-6 y = 1.7704x + 95.667 0.5572 
ZP in PBS  
(10 minutes) 
TNF-α y = 0.8624x + 63.968 0.3815 
IL-6 y = 2.2962x + 104.41 0.6736 
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Attempts were also made to use the combined dataset from both the mono- and mixed-halide 
LDHs in order to obtain more insight: the findings are summarised in Table 6.22. Representative 
plots may be found in Figure 6.18, with all other plots located in Appendix 4. 
Table 6.22: Relationships between experimental parameters and immunoassay data of the combined 
chloride/bromide mono- and di-halide intercalated Li/Al-LDH materials. Particle sizes are measured in 
μm and zeta potentials in mV. 
Experimental 
parameter (x) 
Cytokine concentration / pg mL-1 
(y) 
Equation 
R2 
correlation 
Particle size 
TNF-α y = -0.3349x + 61.052 0.2808 
IL-6 y = 1.3231x + 18.355 0.8167 
ZP in UP-water 
TNF-α y = 0.4528x + 35.565 0.7476 
IL-6 y = -0.5856x + 73.474 0.2330 
ZP in UP-water 
(10 minutes) 
TNF-α y = 0.4465x + 36.857 0.6017 
IL-6 y = -0.7722x + 78.718 0.3353 
ZP in PBS 
TNF-α y = 1.0332x + 69.389 0.4823 
IL-6 y = -1.3727x + 29.143 0.1586 
ZP in PBS  
(10 minutes) 
TNF-α y = 1.3065x + 73.184 0.6858 
IL-6 y = -1.56+ 26.855 0.1822 
It is evident that the correlations in Table 6.22 are mainly representative of the trends observed 
for the di-halide species. The only truly convincing correlation is obtained for IL-6 production 
and the particle size of the Li/Al-LDH materials (Figure 6.18). 
Overall, the correlations for the combined datasets are weaker than those obtained for the 
mono-halide species. However, in favourable instances it is possible to predict the 
immunological output of RAW264.7 macrophages following exposure to Li/Al-LDH materials via 
other experimental data obtained for these samples, when the two different classes of Li/Al-
LDH material are considered separately. 
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Figure 6.18: Graphical representation of (A) the effect of zeta potential in UP water immediately after 
dispersion formation with the combined mono- and di-halide Li/Al-LDH materials' inducing the 
simulation of TNF-α and (B) the effect of particle size on the production of IL-6 by RAW cells. 
6.8.2 Correlating Immune Response to Calculated Unit Cell Parameters 
The principle of attempting to predict the immune response was expanded to use the in silico 
data obtained through structural optimisation of the Li/Al-LDH materials and also the difference 
in electronegativity, calculated by subtracting the electronegativity of the metal cation from the 
guest anionic species [23]. All calculated data for the mono-halide Li/Al-LDH samples appear to 
be strongly predictive of the concentration of cytokines produced by RAW cells exposed to them 
(minimum R2 = 0.9090). The findings are summarised in Table 6.23, and exemplar plots are 
presented in Figure 4.19, with all other plots located in Appendix 4. 
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Table 6.23: Relationships between calculated and immunoassay data for the mono-halide Li/Al-LDH 
materials. The electronegativity difference is obtained by subtracting the electronegativity of the metal 
cation from that of the guest anionic species. 
In silico 
parameter (x) 
Cytokine concentration / pg mL-1 
(y) 
Equation 
R2 
correlation 
a / Å 
TNF-α y = 846.98x + 4479.7 0.9867 
IL-6 y = 3116.7x – 16227 0.9684 
Interlayer 
spacing / Å 
TNF-α y = -6.7356x + 160.94 0.9978 
IL-6 y = 24.287x – 327.82 0.9402 
Difference in 
Electronegativity 
TNF-α y = 12.215x + 36.355 0.9999 
IL-6 y = -43.263x – 612.42 0.9090 
Energy / eV 
TNF-α y = -6.8425x – 612.42 0.9999 
IL-6 y = 24.404x + 2434.3 0.9218 
Volume / Å³ 
TNF-α y = -0.288x + 161.69 0.9988 
IL-6 y = 1.0344x – 329.06 0.9337 
As previously described in Section 6.5.3, the zeta potential measurements of the mono-halide 
materials are closely related with calculated energy of the modelled structures, and therefore it 
seems that these energy values are a plausible proxy for the zeta potential. TNF-α and IL-6 
cytokine production by the RAW264.7 cells is strongly correlated (R2 = 0.9999 and 0.9218, 
respectively) with this energy value (see Figure 6.19).  
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Figure 6.19: Graphical representation of the calculated lattice energy values with (A) TNF-α and (B) IL-6 
concentrations secreted by RAW264.7 cells. 
It is not possible to reliably predict the cytokine production by RAW264.7 cells in response to di-
halide Li/Al-LDHs; the highest R2 is 0.4205 (Table 6.24). When combining the mono- and di-
halide species’ datasets together, the correlations were even weaker than those detailed in 
Table 6.24 for the di-halide Li/Al-LDH materials. 
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Table 6.24: Relationships between calculated and immunoassay data of the di-halide Li/Al-LDH 
materials. 
In silico 
parameter (x) 
Cytokine concentration / pg mL-1 
(y) 
Equation 
R2 
correlation 
a / Å 
TNF-α y = 1305.3x – 6760.5 0.0103 
IL-6 y = 16258x – 84743 0.3995 
Interlayer 
spacing / Å 
TNF-α y = 7.298x – 59.265 0.0109 
IL-6 y = 89.037x – 1248.5 0.4205 
Electronegativity 
TNF-α y = -6.7916x + 62.366 0.0037 
IL-6 y = -134.13x + 342.46 0.3588 
Energy / eV 
TNF-α y = 6.1685x + 655.96 0.0092 
IL-6 y = 80.872x + 8030.6 0.3938 
Volume / Å³ 
TNF-α y = 0.300x – 55.897 0.0108 
IL-6 y = 3.6649x – 1209.1 0.4023 
Overall, it is evident that the pure halide Li/Al-LDH materials exhibit strong relationships 
between their simulated parameters and their in vitro cytokine production, but this is not 
observed for the di-halide systems and when the datasets are combined. This may arise due to 
the complexity of the Cl/Br materials, which means that correlating to only one parameter is 
insufficient in determining a strong relationship. Another reason for the complexity may be 
explained in part by the use of fractional occupancies to predict the location of both halide 
anions in the interlayer region, thus the weighted average resembles a Li/Al-Chloride material. 
Quantum calculations would enable all configurations of the di-halide LDHs to be considered; 
however, the issues within the model used here would be magnified with ab initio calculations 
at a great computational cost. 
6.8.3 Immunological Equation 
As previously described in Section 1.3.3, Williams and co-workers [1] deduced an immunological 
equation (Equation 6.1) to predict the magnitude of the in vitro immune response elicited 
following exposure to LDH materials. The 𝐴, 𝐵, and 𝐶𝑖 parameters in Equation 6.1 are 
coefficients for a given immunological response, and the 𝑃𝑖 component is the value for each of 
three physiochemical properties. 
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Equation 6.1  
ln(𝑟𝑒𝑠𝑝𝑜𝑛𝑠𝑒) = 𝐴 + 𝐵 ∑ 𝐶𝑖𝑃𝑖
𝑖=3
𝑖=1
 
The three physicochemical properties involved in the published work are the mono- or divalent 
cationic radius, the interlayer spacing and the zeta potential [1]. The former two properties can 
easily be obtained through the literature [24], whilst the latter has previously always been 
deduced through experimental measurements. Here we endeavoured to replace this with 
parameters generated from the in silico models described in Section 6.3.  
The RStudio statistics package was utilised [25], with parameters obtained from in silico 
modelling being used in place of the experimental physicochemical properties of the LDHs. The 
aim was to try to correlate the response of human dendritic cells to these parameters by using 
the previously reported datasets [1]. All the physicochemical properties of the LDHs, both 
measured and simulated, were standardised to have mean of 0 and unit variance before being 
entered into the model. Every combination of three properties was assessed for its ability to 
reliably predict the immune response a priori, with three different arrangements proving to be 
good alternatives for the existing trio. These were (i) the a-parameter, interlayer spacing and 
GULP-simulated energy, (ii) the interlayer spacing, GULP-simulated energy and volume, and (iii) 
the a-parameter, GULP-simulated energy and volume. The GULP-simulated value for energy can 
replace the zeta potential component of the original set of physicochemical properties [1]; 
details of the A, B and Ci constants generated when doing so are listed in Table 6.25. It is 
important to note that the Ci values are correlation coefficients, which are multiplied by the 
standardised value for each corresponding physicochemical property for the CiPi component of 
Equation 6.1. 
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Table 6.25: Coefficient responses of human dendritic cells (DC) to LDHs in vitro can be expressed by 
Equation 6.1. Values for the constants A and B, and the coefficients Ci are shown for each respective DC 
response measured. For TNF-α and IL-6 the formula calculates ln (response / ng mL-1), for other cytokines 
and chemokines it gives log (response / pg mL-1), and for the cell surface markers (Section 1.2.1.3.2) ln 
(response / MFI). For any give response, the relative magnitudes of Ci for the three standardised (to 
have mean 0 and unit variance) properties are proportional to the influence that the respective 
properties have in controlling that response. The top table depicts data from Williams and co-workers 
[1] and the bottom table data using GULP-simulated energy as a proxy for the zeta potential. 
Response A B 
Ci 
Correlation Ionic radius 
(M+ or  
M2+)  
Interlayer 
spacing  
 
Zeta 
potential  
IL-6 -3.244 1.899 0.883 0.053 -1.050 0.884 
IL-8 7.735 -0.554 -1.032 0.162 1.041 0.556 
IL-12p70 1.747 1.223 1.033 0.060 -1.122 0.843 
TNF-α -1.062 2.262 1.008 0.036 -1.122 0.909 
IL-1β 2.790 2.941 0.911 0.087 -1.054 0.927 
CD274 7.194 0.725 0.791 -0.095 -0.968 0.848 
CD40 7.287 0.405 0.501 -0.011 -0.766 0.888 
CD86 6.691 0.768 0.979 0.065 -1.099 0.921 
Response A B 
Ci 
Correlation 
Ionic radius 
(M+ or  
M2+)  
Interlayer 
spacing  
 
Energy 
IL-6 -3.359 1.752 -0.032 -0.172 -0.171 0.830 
IL-8 7.706 -0.789 -0.091 0.149 0.218 0.576 
IL-12p70 1.678 1.142 0.046 -0.115 -0.244 0.799 
TNF-α -1.746 2.151 0.056 -0.202 -0.209 0.893 
IL-1β 2.645 2.914 -0.024 -0.037 -0.287 0.921 
CD274 7.190 0.818 -0.045 -0.218 0.104 0.791 
CD40 7.278 0.386 -0.181 -0.136 -0.118 0.858 
CD86 6.656 0.752 0.0339 -0.165 -0.238 0.856 
The calculated lattice energy within the system allows for direct replacement of the zeta 
potential whilst maintaining the reliability of the equation’s predictions (Table 6.25), with the 
correlations being similar to those obtained in the literature. For example, for TNF-α, the 
literature correlation is 0.909 and that obtained using the zeta potential-proxy is 0.893. In one 
instance, the proxy model performs better than the published work, with an IL-6 correlation of 
0.576, compared to the literature value of 0.556. 
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Williams et al. also were able to predict the in vitro response by dendritic cells to two untested 
LDHs, [LiAl2(OH)6]NO3·yH2O and [Mg2Al(OH)6]Cl·yH2O [1]. This can also be achieved when 
replacing the zeta potential value with the simulated energy (Figure 6.20).  
 
Figure 6.20: Multiple dendritic cell (DC) responses induced by newly synthesised LDHs can be predicted 
with a high degree of accuracy. DC response to LiAl2-NO3 were predicted with Equation 6.1 following 
calibration of the model using (A) experimental parameters from Williams and co-workers [1] and (B) 
replacing the zeta potential with the energy calculated in GULP. The observed responses are shown 
along a straight line of gradient 1, and the predicted ln responses as squares on the same plot. 
From the plots given in Figure 6.20 it is clear that the use of a simulated parameter provides a 
reliable substitution for the experimental zeta potential measurements with the Li/Al-Nitrate 
LDH, this is also true for the Mg/Al-Chloride species with plots given in Figure 6.21. 
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Figure 6.21: Multiple dendritic cell (DC) responses induced by newly synthesised LDHs can be predicted 
with a high degree of accuracy. DC response to Mg2Al-Cl were predicted with Equation 6.1 following 
calibration of the model using (A) experimental parameters from Williams and co-workers [1] and (B) 
replacing the zeta potential with the energy calculated in GULP. The observed responses are shown 
along a straight line of gradient 1, and the predicted ln responses as squares on the same plot. 
It is perhaps at first sight surprising that a more negative lattice energy should lead to an 
improved immune response (Figure 6.19 and Table 6.23). More negative lattice energies are 
associated with increased stability and reduced solubility of a system, and so if the LDHs were 
functioning through dissolution to free ions into solution, we would expect to see the reverse 
effect. The findings reported here provide a strong indication that dissolution is not a particularly 
significant factor in considering the immune response. LDH materials exhibit poor solubility at 
physiological pH and thus are unlikely to dissolute [26]. It is our hypothesis that the reason such 
a correlation with lattice energy is seen is because of the inter-relationship between the lattice 
energy and zeta potential; there is literature to suggest that alum adjuvants act through 
interactions with the cell membrane [22], and the zeta potential will affect the strength of these 
and thus can provide a basis for varying the adjuvanticity. Further experiments will be needed 
to confirm this, but it appears a viable explanation given the data presented here, and also in 
the literature [27]. 
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Furthermore, three other combinations [(i) the a-parameter, interlayer spacing and GULP-
simulated energy, (ii) the interlayer spacing, GULP-simulated energy and volume, and (iii) the a-
parameter, GULP-simulated energy and volume] proved to be successful alternatives when 
predicting the in vitro immune response. Two of these conserved one of the original 
physicochemical properties used in the equation (interlayer spacing), with the remainder of the 
parameters being other simulated properties (Table 6.26). As discussed in Section 6.5.3, the 
calculated values for lattice energy, volume and a-parameter are highly correlated to the zeta 
potential (measured in UP water), and thus all can act as proxies for this value in the 
immunological equation. As for the energy, we believe that it is the fact that the volume and a-
parameter can act as proxy values for the zeta potential, and the effect this has on interactions 
with the cell membrane, which permits them to be used to predict the immune response. 
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Table 6.26: Coefficient responses of human DC to LDHs in vitro can be expressed by Equation 6.1. Values 
for the constants A and B, and the coefficients Ci are shown for each respective DC response measured. 
The a-parameter, energy and interlayer spacing values used are simulated values obtained via GULP 
calculations. 
Response A B 
Ci 
Correlation a-
parameter  
Interlayer 
spacing  
Energy  
IL-6 -3.376 1.771 0.145 -0.306 -0.228 0.827 
IL-8 7.685 0.943 0.621 -0.319 -0.658 0.612 
IL-12p70 1.675 1.190 0.344 -0.249 -0.491 0.813 
TNF-α -1.760 2.188 0.235 -0.244 -0.391 0.896 
IL-1β 2.637 2.921 -0.727 -0.817 1.117 0.922 
CD274 7.173 0.885 -0.774 -1.326 1.630 0.795 
CD40 7.280 0.364 0.071 0.370 -0.733 0.818 
CD86 6.652 0.798 -0.833 -1.149 1.523 0.860 
Response A B 
Ci 
Correlation Interlayer 
spacing  
Energy  Volume  
IL-6 -3.387 -1.797 0.579 0.217 -0.385 0.829 
IL-8 7.686 -0.885 0.949 0.448 -0.974 0.601 
IL-12p70 1.658 -1.277 0.835 0.434 -0.841 0.839 
TNF-α -1.773 -2.217 0.581 0.338 -0.493 0.898 
IL-1β 2.642 -2.914 0.099 0.287 -0.003 0.922 
CD274 7.178 -0.820 0.441 0.210 -0.243 0.768 
CD40 7.280 -0.367 -0.372 -0.082 0.723 0.822 
CD86 6.656 -0.750 0.235 0.268 -0.103 0.856 
Response A B 
Ci 
Correlation a-
parameter  
Energy  Volume  
IL-6 -3.363 1.724 0.349 -0.285 -0.429 0.822 
IL-8 7.688 0.957 0.880 -0.724 -0.482 0.613 
IL-12p70 1.686 1.142 0.468 -0.534 -0.310 0.800 
TNF-α -1.748 2.154 0.399 -0.439 -0.340 0.893 
IL-1β 2.658 2.908 -0.004 -0.261 -0.104 0.922 
CD274 7.193 0.785 0.091 -0.159 -0.297 0.771 
CD40 7.279 0.370 -0.344 0.196 -0.152 0.820 
CD86 6.666 0.741 -0.024 -0.198 -0.147 0.855 
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Comparing the published data in Table 6.25 to that presented in Table 6.26 for the three sets of 
alternative physicochemical properties, it is evident that the majority of the correlations for the 
various chemokines, cytokines and cell surface markers are similar to those obtained in the 
published work, thereby suggesting a purely in silico means of predicting the immunological 
response in vitro. For example, the literature correlation value for the cytokine TNF-α, is 0.909; 
the correlations obtained using the alternative combinations range from 0.893 to 0.898  
The predicted responses for the cytokine, chemokine and membrane molecules of human 
dendritic cells, following application of Li/Al-Nitrate, are plotted in Figure 6.22 against the 
observed responses (both natural logarithms) using the three alternative combinations detailed 
in Table 6.26. This visual representation highlights how similar predictions are obtained using 
each set of properties, thereby emphasising that they are suitable alternatives to the published- 
and proxy-models. Therefore, it appears that we can predict the immune response in human 
dendritic cells using purely simulated properties, which means that in the future in silico 
adjuvant design may be possible.  
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Figure 6.22: Multiple dendritic cell (DC) responses induced by newly synthesised LDHs can be predicted 
with a high degree of accuracy. DC response to LiAl2-NO3 were predicted with Equation 6.1 following 
calibration of the model using data from Williams and co-workers [1]. The observed responses are 
shown along a straight line of gradient 1, and the predicted ln responses as squares on the same plot. 
The plots present the alternative combinations with (A) a-parameter, interlayer spacing and energy, (B) 
a-parameter, energy and volume, and (C) interlayer spacing, energy and volume.  
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6.9   Conclusions 
Anhydrous LDH structures could be successfully modelled with the GULP simulation code [2] and 
implementation of the ClayFF force field [5]. Following synthesis and characterisation of a range 
of LDH materials, comparisons were performed between experimentally measured zeta 
potentials and simulated structural parameters, with the GULP-simulated value for energy 
proving a good proxy for this in favourable cases. 
The mono-halide Li/Al-LDH materials’ physicochemical properties appeared to be strongly 
causative of the immunological output of RAW264.7 cells; however, the same outcome was not 
observed for the di-halide systems, with few convincing relationships evident. A possible reason 
for this may be due to the increased complexity of the di-halide LDHs, such that relating 
properties to only one other parameter is insufficient in deducing strong connections in the data. 
A key goal of this work was to be able to replace the zeta potential in the equation previously 
derived to predict the immune response from the physicochemical properties of LDHs. It was 
found that the energy of the structure as simulated in silico is able to fulfil this goal. Further, 
three alternative combinations of properties have been found to reliably predict the magnitude 
of the immunological response in vitro. All three include the energy value obtained from GULP 
with the other parameter in the trio being (a) a-parameter and interlayer spacing, (b) interlayer 
spacing and volume, and (c) a-parameter and volume. Therefore, these in silico properties of 
the LDH materials appear to be highly useful in predicting a material’s immunogenical effect in 
vitro. 
These findings offer the potential to screen many LDH structures in silico and predict their 
immunological effect with no laboratory work requirement, ultimately allowing an in silico –
down-selection of lead candidates for further exploration and significantly reducing the cost and 
animal requirements of vaccine development. 
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7.1   Hydroxy Double Salts 
7.1.1 Introduction 
Hydroxy double salts (HDS) are a class of lamellar material with structural similarities to layered 
double hydroxides (LDHs). HDS materials contain two divalent metal cations in their hydroxide 
layer and have a general formula of [(M2+aN2+b)(OH)y]( 2a+2b-y )+An-(2a+2b-y)/n·zH2O. Here, M2+ and N2+ 
denote two different divalent metal cation species and An- represents a charge-balancing, 
interlamellar anion – the nature of this anionic species and the water controls the interlayer 
separation [1]. 
With zinc (II)-based hydroxy double salts, the structure contains brucite-like sheets of 
[Zn3(OH)8]2- composition, in which 25% of the octahedral positions are vacant. Two Zn (II) cations 
adopt tetrahedral positions above and below these vacancies in the layer [2]. The tetrahedral 
Zn (II) anions are coordinated by a water molecule and three hydroxyl groups of the brucite-like 
sheets. The guest anion species (e.g. Cl-, NO3-) reside between the resultant positively-charged 
[Zn5(OH)8]2+ layers, compensating the positive charge [3, 4] – see Figure 7.1. This sub-class of 
HDS materials are defined as Type IIb structures according to Louer’s classification [5-7]. 
HDSs differ from LDHs in that they generally have a smaller tolerance for difference in the ionic 
radii of the metal cations of the sheet structure. The radii of  M2+ and N2+ tend to differ by no 
more than 0.05 Å whilst larger radii differences are accommodated in LDHs (e.g. Ca2+ and Al3+ 
differ by 0.48 Å) [3]. However, evidence from Brindley and Brown suggest that HDSs can tolerate 
a 0.22 Å difference, as demonstrated by the existence of a mixed Cd2+/Cu2+ HDS material [9]. A 
number of HDSs have anion-exchange capacities, as described by Stahlin and Oswald [10]. 
Chapter 7 Hydroxy Double Salts as Vaccine Adjuvants 
 
255 
 
Figure 7.1: A schematic depicting the Type IIb structure of HDS materials, highlighting the position of 
inter-lamellar anions and water molecules with respect to the hydroxide layers.  Adapted from [8]. 
7.1.2 Synthesis Protocols 
There are a variety of different preparation routes that have been described in the literature, 
but the most commonly reported ones for HDS materials, such as zinc hydroxy nitrate, are (i) 
thermal decomposition of zinc nitrate hexahydrate [11], (ii) reaction between zinc oxide and zinc 
nitrate hexahydrate [2] and (iii) the reaction of zinc nitrate hexahydrate with sodium hydroxide 
[12]. Both the physical and chemical properties of the resultant HDS material can be dependent 
on the chosen synthesis route. 
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7.1.3 Aims 
HDS materials have been reported as drug delivery systems [13, 14] and preliminary data 
indicated that they have adjuvant properties [15]. However, a systematic exploration of HDSs as 
adjuvants has never been performed. Therefore, the main aim of this work was to assess these 
materials’ potential to elicit varied immune responses and determine if there is a way to predict 
this response from the physicochemical properties of the materials or in silico using parameters 
deduced from simulating the structures. 
7.2   Materials and Methods 
7.2.1 HDS Synthesis 
All materials were procured from Sigma Aldrich UK and were used as supplied. Zinc 
hydroxynitrate, [Zn5(OH)8](NO3)2·yH2O (HDS-Nitrate), was prepared through reaction of 4.2 g 
zinc oxide and 24.1 g zinc nitrate hexahydrate in 60 mL deionised water. The reaction mixture 
was stirred for 7 days at room temperature and pressure. The resultant white powder was 
recovered by vacuum filtration, washed with copious amounts of deionised water and a small 
volume of acetone, then left to dry under vacuum for approximately 30 minutes. 
Other HDS materials were prepared using an analogous procedure. Zinc hydroxychloride, 
[Zn5(OH)8]Cl2·yH2O (HDS-Chloride) was synthesised with 3.0 g ZnO and 7.26 g zinc chloride in 18 
mL deionised water. Zinc hydroxyacetate ([Zn5(OH)8](CH3COO)2·yH2O; HDS-Acetate) was 
prepared from 3.0 g ZnO and 8.05 g zinc acetate di-hydrate in 18 mL deionised water. Cobalt 
zinc hydroxynitrate (Zn3.8Co1.2(OH)8](NO3)2·yH2O; HDS-Cobalt/Nitrate) was generated from 3.0 g 
ZnO and 8.73 g cobalt (II) nitrate hexahydrate in 18 mL deionised water. Nickel zinc 
hydroxynitrate ([Zn3Ni2(OH)8](NO3)2·yH2O; HDS-Nickel/Nitrate) was prepared using 3.0 g ZnO 
and 8.73 g nickel (II) nitrate hexahydrate in 18 mL deionised water. In all cases, the reactions 
were stirred at room temperature for 1 week. All four HDS materials were recovered by the 
vacuum filtration method described above. The Zn-materials were white powders, whilst the 
[Zn3.8Co1.2(OH)8](NO3)2·yH2O was pink in colour and the [Zn3Ni2(OH)8](NO3)2·yH2O material was a 
blue-green powder. 
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7.2.2 Materials Characterisation 
7.2.2.1 Powder X-ray Diffraction 
See Section 3.3.1. 
7.2.2.2 Scanning Electron Microscopy 
See Section 3.3.2. 
7.2.2.3 Fourier Transform Infra-Red Spectroscopy 
See Section 3.3.3. 
7.2.2.4 Thermogravimetric Analysis 
Thermogravimetric analysis of the HDS materials was conducted in a Discovery TGA (TA 
Instruments) using the automated pan arrangement. Approximately 10 mg of each sample was 
heated in an aluminium TGA pan to 400 °C under a flowing stream of nitrogen, at a heating rate 
of 10 ºC min-1. The nitrogen flow rate was 25 mL min-1. 
7.2.2.5 Surface Area and Pore Volume Analysis 
See Section 4.3.4. 
7.2.2.6 Zeta Potential Measurements 
See Section 3.3.6. 
7.2.2.7 In silico Simulation Codes 
A static energy minimisation code was implemented for calculations using GULP (General Utility 
Lattice Program) Version 4.0 [16], alongside the scientific visualisation code GDIS (Graphical 
Display Interface for Structures [17]) to generate structural depictions of the optimised hydroxy 
double salt structures. 
7.2.3 Immunoassay Experiments 
See Section 3.3.7. 
7.2.3.1 Alamar Blue Assay 
See Section 3.3.7.1. 
7.2.3.2 Enzyme-Linked Immuno-Sorbent Assay 
See Section 3.3.7.2. 
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7.2.3.3 Fluorescence and Confocal Microscopy 
See Section 3.3.7.3. 
7.3   Results and Discussion 
7.3.1 Materials Characterisation 
P-XRD patterns of the HDS materials are shown in Figure 7.2. All detectable reflections can be 
assigned by their positions to Bragg reflections of the published HDS structures in the case of 
HDS-Chloride and HDS-Nitrate (see Figure 7.2A) [2, 19]. No impurities were detected. 
There are no published structures for the HDS-Acetate, HDS-Cobalt/Nitrate or HDS–
Nickel/Nitrate, but the unit cells were predicted using the HDS-Nitrate material [2]. The 
observed patterns can be indexed using unit cells very similar to those reported in the literature 
using Celref [20]. Diffraction patterns are presented in Figure 7.2B and comparisons between 
the predicted and observed reflection positions are given in Table 7.1, and the refined unit cell 
details for each material listed in Table 7.2. It is clear that the patterns obtained for these 
materials also agree well with the literature. 
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Figure 7.2: P-XRD patterns for the hydroxy double salt materials. (a) HDS-Nitrate and HDS-Chloride 
alongside their reference patterns obtained from [2] and [19], and (b) the remaining HDS materials 
synthesised with reflections not being able to be indexed using the HDS unit cell being labelled with a 
*. 
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Table 7.1: Predicted and observed reflection positions in the P-XRD patterns for the (A) HDS-Acetate, (B) 
-Cobalt/Nitrate, and (C) –Nickel/Nitrate samples with indexed reflections and the difference between 
the predicted and observed values. 
(A) HDS-Acetate 
Reflection 
index 
Predicted 
peak 
positions 
/ 2θ 
Observed 
peak 
positions  
/ 2θ 
Difference 
110 14.8955 13.6433 -1.2522 
001 16.1801 16.8998 0.7197 
310 19.7465 20.2227 0.4762 
111 22.2464 22.5487 0.3023 
-401 23.8109 23.8115 0.0006 
401 25.1633 25.4729 0.3096 
600 27.5507 27.7990 0.2483 
020 28.5758 28.5965 0.0207 
-601 31.3142 31.3213 0.0071 
511 32.3202 31.7865 -0.5337 
-202 33.5033 33.5808 0.0775 
420 34.1280 34.1790 0.0510 
112 36.3402 36.2392 -0.101 
-312 37.8055 37.5683 -0.2372 
-711 38.3579 38.2329 -0.1250 
-602 42.0262 42.2204 0.1942 
-222 44.5989 44.4135 -0.1854 
-712 47.6326 47.5371 -0.0955 
1110 53.9562 53.9171 -0.0391 
313 54.9909 54.914 -0.0769 
040 59.1535 59.4331 0.2796 
 
(B) HDS-Nickel/Nitrate 
Reflection 
index 
Predicted 
peak 
positions  
/ 2θ 
Observed 
peak 
positions / 2θ 
Difference 
200 9.0014 9.3900 0.3886 
310 19.3476 19.0265 -0.3211 
-202 33.2319 33.1821 -0.0498 
202 34.3690 34.1125 -0.2565 
223 59.2249 59.4331 0.2082 
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(C) HDS-Cobalt/Nitrate 
Reflection 
index 
Predicted 
peak 
positions  
/ 2θ 
Observed 
peak 
positions / 2θ 
Difference 
200 9.0884 9.0577 -0.0307 
400 18.2347 18.2954 0.0607 
-111 21.813 21.9506 0.1376 
111 22.2101 22.1500 -0.0601 
-401 23.702 23.6785 -0.0235 
-311 25.0565 25.0077 -0.0488 
311 26.0908 25.9381 -0.1527 
510 26.9874 27.0679 0.0805 
020 28.5641 28.5965 0.0324 
220 30.034 29.9256 -0.1084 
-601 31.1878 31.1219 -0.0659 
511 32.2977 32.3181 0.0204 
601 32.8715 32.8498 -0.0217 
-221 34.0042 33.9131 -0.0911 
221 34.5328 34.5777 0.0449 
710 35.3354 35.3752 0.0398 
112 36.2429 36.3721 0.1292 
-312 37.6461 37.7012 0.0551 
-711 38.2291 38.1000 -0.1291 
402 38.5489 38.4987 -0.0502 
312 39.0847 39.0304 -0.0543 
801 41.4605 41.5558 0.0953 
-131 46.7670 46.8060 0.039 
-422 47.0674 47.2048 0.1374 
023 58.3776 58.3033 -0.0743 
 
Table 7.2: Refined unit cell parameters for the HDS-Acetate, -Cobalt/Nitrate, and -Nickel/Nitrate 
samples, with standard errors. 
Unit Cell Parameter HDS-Acetate HDS-Cobalt/Nitrate HDS-Nickel/Nitrate 
Volume / Å³ 665.9 669.9 697.1 
a / Å 19.46 ± 0.137 19.49 ± 0.030 19.69 ± 1.49 
b / Å 6.25 ± 0.034 6.25 ± 0.008 6.43 ± 0.317 
c / Å 5.49 ± 0.035 5.51 ± 0.008 5.52 ± 0.200 
α / ° 90.00 ± 0.000 90.00 ± 0.000 90.00 ± 0.000 
β / ° 93.14 ± 1.337 93.35 ± 0.279 93.60 ± 22.39 
γ / ° 90.00 ± 0.000 90.00 ± 0.000 90.00 ± 0.000 
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Mean crystallite size data are presented in Table 7.3, calculated using all reflections in the P-XRD 
patterns and using a K value of 1 in the Scherrer equation. 
Table 7.3: Mean crystallite size of the HDS materials deduced via application of the Scherrer equation 
to P-XRD patterns; mean ± standard deviation. 
HDS material Mean crystallite size / nm 
HDS-Nitrate 36.72 ± 5.93 
HDS-Chloride 33.95 ± 9.68 
HDS-Acetate 15.01 ± 6.52 
HDS-Cobalt/Nitrate 40.86 ± 8.34 
HDS-Nickel/Nitrate 13.66 ± 7.95 
 
Figure 7.3: Scanning electron micrographs of (A) HDS-Nitrate, (B) HDS-Chloride, (C) HDS-Acetate, (D) 
HDS-Cobalt/Nitrate and (E) HDS-Nickel/Nitrate. 
SEM analysis shows the reaction products are composed of microparticles of platelet 
morphology (Figure 7.3). Size analysis was performed using these images and the mean particle 
size data are presented in Table 7.4. The particles are calculated to be much larger than the 
crystallite size determined by the Scherrer equation; this is to be expected because particles are 
composed of many crystallites.
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Table 7.4: Particle size data for the HDS materials, determined from SEM images, mean ± standard 
deviation. 
HDS sample Mean particle size / μm 
HDS-Nitrate 1.77 ± 0.84 
HDS-Chloride 0.56 ± 0.28 
HDS-Acetate 0.91 ± 0.34 
HDS-Cobalt/Nitrate 0.38 ± 0.24 
HDS-Nickel/Nitrate 0.70 ± 0.27 
IR spectra were recorded, and are presented in Figure 7.4. All the HDS samples’ infra-red spectra 
contain a broad band ca. 3400 cm-1, which is attributed to the O-H vibrational absorption modes 
(see Table 7.5) of both the hydroxyl layer and the weakly hydrogen-bonded water molecules of 
the interlayer [21]. The breadth of this band varies with the nature of the interlayer anion, which 
can be attributed to differences in the interactions between the OH groups in the layers and the 
guest. H-bonding interactions will be possible in the case of nitrate and acetate species, while 
when Cl- ions are present between the layers only weaker dipole-dipole interactions will exist. 
As a result, the OH band is sharper in the latter case. 
 
Figure 7.4: FTIR spectra for the HDS materials (A) HDS-Nitrate, (B) HDS-Chloride, (C) HDS-Acetate, (D) 
HDS-Cobalt/Nitrate and (E) HDS-Nickel/Nitrate. 
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The peak present at ca. 1630 cm-1 is attributed to the δ-bend of water; the low intensity of this 
peak is associated with the small amount of water residing in the interlayer or adsorbed to the 
surface [12, 22]. Metal-oxygen (M-O) vibrations of the HDS layers occur below 1000 cm-1 [23-
25]. 
For the HDS-Acetate material, a broad shoulder to the OH band, at ca. 2900 – 3050 cm-1, 
indicates the presence of the symmetric and asymmetric bands of C-H bonds in the acetate 
moiety. Furthermore, bands at ca. 1560 and 1390 cm-1 can be attributed to the vas and vs 
vibrational modes of the carboxylate component of the acetate, respectively. In the literature, 
these two peaks suggest a bidentate co-ordination of the acetate anion [26, 27]. These data are 
in agreement with literature values [12, 22-27], supporting P-XRD data to confirm the successful 
synthesis of HDS materials. A full assignment of all the bands observed may be found in Table 
7.5. 
Table 7.5: FTIR assignments for HDS materials. 
Wavenumber / cm-1 Assignment 
3550 O-H stretch 
3445 (Co)O-H stretch 
3400 νOH absorptions of OH-layers and co-intercalated water 
3200 - 3540 Broad peak attributed to OH- groups involved in H-bonding [28] 
2900 - 3040 νs and νas (C-H) in acetate moiety 
1630 Deformation of water 
1560 νas (COO-) vibrational mode of carboxylate 
1450 νas nitrate anion 
1390 νs (COO-) vibrational mode of carboxylate 
1360 N-O stretch 
1352 νs nitrate anion 
1050 νas nitrate anion 
1000 Zn-O vibrational modes 
7.3.2 Thermogravimetric Analysis 
Thermogravimetric analysis (TGA) was undertaken to deduce the water content in each of the 
five synthesised materials. Exemplar data are shown in Figure 7.5. 
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Figure 7.5: TGA data for the HDS-Nickel/Nitrate sample. 
Decomposition of the HDS materials exhibit two thermal events, with the first at 50 – 150 °C 
being assigned to the loss of adsorbed and interlayer water, and the second (at 250 – 285 °C) to 
the release of water from decomposition of the layers. The first thermal event can be used to 
determine the molar water content of the sample whilst the second provides information of the 
chemical composition. The water content values calculated are given in Table 7.6. The values 
observed concur with those recorded in the literature [2, 19]. 
Table 7.6: Details of the expected water loss from each HDS material and the observed value, as deduced 
from the TGA curves, with the chemical composition deduced using the moles of water per formula unit. 
Material 
Expected 
water loss 
/ % 
Observed 
water 
loss / % 
Moles of 
water per 
formula 
unit 
Chemical composition 
HDS-Nitrate 5.78 5.78 2.00 [Zn5(OH)8](NO3)2·2H2O 
HDS-Chloride 3.26 3.38 1.03 [Zn5(OH)8]Cl2·1.03H2O 
HDS-Acetate 5.84 6.05 2.25 [Zn5(OH)8](CH3COO)2·2.25H2O 
HDS-Cobalt/Nitrate 5.85 5.37 1.84 [Zn3.2Co1.2(OH)8](NO3)2·1.84H2O 
HDS-Nickel/Nitrate 5.91 5.68 1.92 [Zn3Ni2(OH)8](NO3)2·1.92H2O 
Zn3Ni2 NO3
First Thermal Event:
Predicted Weight Percent Loss: 5.677%
Weight Percent Loss: 5.67736 %
Moles of water = 1.92
Second Thermal Event
Predicted Weight Percent Loss: 0
Weight Percent Loss: 9.26115 %
Evidence of degradation of sample
above 250 C
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7.3.3 Surface Area and Pore Volume 
Surface area and pore volume analyses were completed for each of the five HDS samples with 
the adsorption isotherms presented in Figure 7.6. In all cases, the samples were dried at 100 °C 
under vacuum prior to analysis. 
 
Figure 7.6: Adsorption isotherms of the hydroxy double salt materials, (A) HDS-Nitrate, (B) HDS-
Chloride, (C) HDS-Acetate, (D) HDS-Cobalt/Nitrate; and (E) HDS-Nickel/Nitrate. 
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The isotherms, as presented in Figure 7.6, are evidently Type II which is consistent with what 
has been reported in the literature [29]. This classification of isotherm corresponds to the 
materials being non-porous, as is supported by all samples having a pore volume less than 0.085 
mL g-1, with multiple adsorption layers arising on the adsorbent’s surface [30]. The intermediate, 
plateau portion of the isotherm indicates the formation of a monolayer on the sample surfaces. 
A full adsorption/desorption program was run between 0 and 1 relative pressures to confirm 
the absence of any mesopores. Mesoporous materials would exhibit a plateau in the isotherm 
ca. 0.9 Ps/Po [30]; as this is absent from the isotherms in Figure 7.6, it is evident that the HDS 
materials are not mesoporous. Surface area and pore volume data for the five HDS materials are 
summarised in Table 7.7. 
Table 7.7: Surface area and pore volume data. 
Sample ID Surface Area / m2 g-1 Pore Volume / mL g-1 
HDS-Nitrate 1.544 0.0078 
HDS-Chloride 0.912 0.0043 
HDS-Acetate 16.013 0.0810 
HDS-Cobalt/Nitrate 3.141 0.0248 
HDS-Nickel/Nitrate 13.212 0.0829 
Increasing the size of the anion in the HDS interlayer region appears to cause an increase in the 
surface area of the sample (Table 7.7) which may arise due to the interlayer space expanding to 
accommodate the larger guest anions. Comparing the three nitrate species (HDS-Nitrate, HDS-
Cobalt/Nitrate and HDS-Nickel/Nitrate) there is a change in the surface area with the 
composition of the layer.  This follows the inverse trend to the particle size data (for size, HDS-
Nitrate > HDS-Nickel/Nitrate > HDS-Cobalt/Nitrate), and thus may be attributed to a reduction 
is particle size of these materials. 
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7.3.4 Zeta Potential Measurements 
As mentioned in previous chapters, the zeta potential has been shown to be an important 
physicochemical property in determining the magnitude of the immune response to LDH 
adjuvants; therefore, this was also investigated for the HDS materials. Data are presented in 
Table 7.8 and Table 7.9. It is evident that changing the dispersion medium causes a change in 
the zeta potential: negative readings are generally recorded when PBS is used as the dispersant 
due to negative phosphate anions within the PBS solution being adsorbed to the surface of the 
particles and altering the charge at the slipping plane. Positive readings are obtained when UP-
water was used as the dispersant. 
Unexpected results for HDS-Nitrate and HDS-Cobalt/Nitrate are obtained when PBS is the 
dispersant, with pronounced changes in the zeta potential in the 10 minutes after the 
suspension was prepared. These measurements have been repeated and the outcomes were 
reproducible, however. It is not certain why this occurs, but it may arise due to sedimentation 
of a fraction of the particles and/or aggregation. Whilst it is not possible to determine the long-
term stability of HDS dispersions from their zeta potential measurements alone, the data 
presented in Table 7.9 suggests that UP-water may lead to stable suspensions, with readings 
generally above +30 mV [31]. 
Table 7.8: Mean zeta potential measurements for the HDS materials, when dispersed in 0.01 M 
phosphate buffered saline solution (PBS) at pH 7.4; mean ± standard deviation. 
Sample ID Initial ZP / mV ZP after 10 minutes / mV 
HDS-Nitrate 2.90 ± 2.46 -37.98 ± 1.08 
HDS-Chloride -36.87 ± 1.72 -58.9 ± 8.59 
HDS-Acetate -15.40 ± 3.97 -13.45 ± 2.26 
HDS-Cobalt/Nitrate -45.28 ± 1.69 -0.88 ± 4.54 
HDS-Nickel/Nitrate -29.02 ± 1.44 -30.23 ± 1.07 
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Table 7.9: Mean zeta potential measurements for the HDS materials, when dispersed in ultra-pure water 
with conductivity of 18.2 mΩ; mean ± standard deviation. 
Sample ID Initial ZP / mV ZP after 10 minutes / mV 
HDS-Nitrate 60.02 ± 1.52 70.03 ± 2.47 
HDS-Chloride 24.47 ± 1.08 27.95 ± 1.99 
HDS-Acetate 14.10 ± 1.26 13.37 ± 1.10 
HDS-Cobalt/Nitrate 69.97 ± 1.16 75.88 ± 0.38 
HDS-Nickel/Nitrate 36.36 ± 1.90 41.05 ± 0.43 
7.3.5 Structure/Property Relationships 
In previous chapters, clear relationships between the particle size and zeta potential were noted 
for the alum and LDH materials (Sections 3.4.8 and 6.5.3). Therefore, efforts to elucidate similar 
relationships for the HDS materials were made. A summary of these is presented in Table 7.10 
with representative plots in Figure 7.7. 
Table 7.10: Relationships between zeta potential measurements and the particle size of the HDS 
materials. 
Experimental 
parameter / μm (x) 
Zeta potential / mV 
(y) 
Equation R2 correlation 
Particle size 
ZP in UP-water y = 15.711x + 27.432 0.1039 
ZP in UP-water 
(10 minutes) 
y = 19.75x + 28.62 0.1591 
ZP in PBS y = 29.427x – 50.118 0.7084 
ZP in PBS 
(10 minutes) 
y = -2.1641x – 26.421 0.0027 
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Figure 7.7: Graphical representation of the relationships described in Table 7.10. Panels A and B depict 
plots of zeta potential measurements using UP-water vs. particle size, and panels C and D analogous 
graphs with zeta potentials measured using PBS. 
It is clear that there are no straightforward relationships here, which is perhaps not surprising 
given that, as well as a range of sizes, the different materials also have different layer 
chemistries. 
Further correlations were sought in an attempt to elucidate relationships between 
physicochemical properties of the HDS materials and their zeta potential measurements. These 
are described in Table 7.11. There appear to be no apparent trends between the ionic radii or 
the electronegativity of the metal cations and the zeta potential measurements, which may be 
ascribed to the zeta potential being determined by a complex interplay of factors, and thus a 
single x-variable is not sufficient to determine any correlations. Weighted mean values of either 
property were implemented for the HDS-Cobalt/Nitrate and HDS-Nickel/Nitrate materials. 
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Table 7.11: Relationships between zeta potential measurements and physicochemical properties of the 
HDS materials. 
Experimental 
parameter (x) 
Zeta potential / mV 
(y) 
Equation R2 correlation 
Ionic radius / pm 
ZP in UP-water y = 3.8477x – 296.17 0.0221 
ZP in UP-water 
(10 minutes) 
y = 3.8817x – 294.48 0.0173 
ZP in PBS y = 1.8642x – 186.51 0.0078 
ZP in PBS 
(10 minutes) 
y = 2.1687x – 218.32 0.0078 
Electronegativity 
ZP in UP-water y = 127.26x – 173.05 0.0642 
ZP in UP-water 
(10 minutes) 
y = 135.24x – 181.80 0.0558 
ZP in PBS y  = -179.65x + 277.41 0.1973 
ZP in PBS 
(10 minutes) 
y = 149.07x – 279.00 0.0974 
Plots of some of the relationships presented in Table 7.11 are shown in Figure 7.8, with all other 
plots located in the Appendix 5. 
 
Figure 7.8: Graphical representation of the relationships described in Table 7.11. Panels A and C depict 
plots of zeta potential measurements using UP-water vs. ionic size or electronegativity, and panels B 
and D analogous graphs with zeta potentials measured using PBS vs. ionic size or electronegativity. 
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Subsequent investigations assessed possible relationships between the weighted mean 
reduction potential of the metal cations (values obtained from [32]) and the zeta potential 
measurements. No clear linear fits could be obtained, and therefore polynomials were explored; 
the results are given in Table 7.12.  
Table 7.12: Relationships between zeta potential measurements and physicochemical properties of the 
HDS materials. 
Experimental 
parameter / 
V (x) 
Zeta potential / mV 
(y) 
Equation R2 correlation 
Reduction 
Potential 
ZP in UP-water y = 29.82x2 + 104.04x + 94.812 0.4773 
ZP in UP-water 
(10 minutes) 
y = 30.84x2 + 107.44x + 101.07 0.3999 
ZP in PBS y = -12.25x2 – 37.239x – 37.716 0.4491 
ZP in PBS 
(10 minutes) 
y = 25.341x2 + 86.643x + 14.522 0.4841 
Representative plots for the data in Table 7.12 are shown in Figure 7.9. 
 
Figure 7.9: Graphical representation of the relationships described in Table 7.12. Panels A and B depict 
plots of zeta potential measurements using UP-water vs. the weighted mean of the metal cation’s 
reduction potential, and panels C and D are analogous graphs with zeta potentials measured using PBS 
vs. the weighted mean of the metal cation’s reduction potential. 
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Again the relationships presented here are very weak, indicating that there are no apparent 
linear or polynomial correlations arising between the physicochemical properties of the HDS 
materials. As such, this means it does not appear to be possible to tailor the zeta potential 
through altering the particle size or ionic radius of the cation, for example. In comparison to 
relationships deduced for the alum and LDH samples, these are poor and highlight the complex 
nature of the zeta potential of this class of material. 
7.3.6 In Silico Experiments 
There is a published immunological equation for the structurally related LDH materials [33], 
allowing the immune response to be predicted from the physicochemical properties of the 
materials. Further, in Chapter 6 it was shown that simulated properties of LDH structures may 
be used to make such predictions. A similar means of predicting the immune response was 
therefore sought for the HDS materials. In order to attempt this, an in silico model was first 
constructed. 
In order to optimise the structures, a suitable force field was required. Two pre-existing force 
fields were investigated (ClayFF and LDH-FF [34, 35]), with limited success. To obtain models of 
suitable quality a hybrid was developed, containing interatomic potentials from both the ClayFF 
and LDH-FF. It was also necessary to incorporate the interatomic potential parameters for the 
nitrate guest anionic species, previously described for the simulation of Li/Al-LDH structures in 
Section 6.3.2, because potentials for these anions were not present in the original LDH-FF force 
field. The framework parameters are detailed in Table 7.13 to Table 7.15. 
Table 7.13: HDS framework potential parameters - Coulombic charges. 
Species Coulombic charge / e 
Zn core 2.000 
O1 core -0.9500 
H1 core 0.4250 
O2 core -0.8200 
H2 core 0.4100 
N core 0.4124 
ONitrate core -0.4708 
Cl core -1.000 
Co core 2.000 
Ni core 2.000 
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Table 7.14: HDS framework potential parameters - Interatomic potentials for nitrate anions [36]. 
Harmonic: 
𝟏
𝟐
𝒌𝟐(𝒓 − 𝒓𝟎)
𝟐 +
𝟏
𝟐
𝒌𝟑(𝒓 − 𝒓𝟎)
𝟑 +
𝟏
𝟐
𝒌𝟒(𝒓 − 𝒓𝟎)
𝟒  
Interaction 𝑘2 / eV Å
-2 𝑘3 / eV Å
-3 𝑘4 / eV Å
-4 𝑟0 / Å 
N - ONitrate 50.6370 -408.2327 2779.8844 1.2645 
Three-body Harmonic: 
𝟏
𝟐
𝒌𝟐(𝜽 − 𝜽𝟎)
𝟐 +
𝟏
𝟔
𝒌𝟑(𝜽 − 𝜽𝟎)
𝟑 +
𝟏
𝟏𝟐
𝒌𝟒(𝜽 − 𝜽𝟎)
𝟒 
Interaction 𝑘2 / eV rad
-2 𝑘3 / eV rad
-3 𝑘4 / eV rad
-4 𝜃0 / ° 
ONitrate - N - ONitrate  10.2547 23.9655 74.9604 120.0 
Torsion: 𝒌(𝟏 +𝐜𝐨𝐬(𝒏𝒑𝒉𝒂𝒔𝒆(𝝓 − 𝝓𝟎))) 
Interaction 𝑘 / eV nphase 𝜙0 / ° 
ONitrate – N – ONitrate - ONitrate 0.623163 +1 0.0 
Lennard-Jones: 
𝑨
𝒓𝒎
−
𝑩
𝒓𝒏
 
Interaction 𝐴 / kcal Å9 𝐵 / kcal Å6  
H - ONitrate 768.4 40.72 
H – N 888.1 61.30 
OLayer - ONitrate 16442.0 384.8 
OLayer - N 243936.0 84.2 
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Table 7.15: HDS framework potential parameters - Interatomic potentials. 
Harmonic: 𝑘𝑏,2(𝑏 − 𝑏0)
2 + 𝑘𝑏,3(𝑏 − 𝑏0)
3 +  𝑘𝑏,4(𝑏 − 𝑏0)
4 
Interaction 𝑏0 / Å 
𝑘𝑏,2 /  
kcal mol-1 Å-2 
𝑘𝑏,3 /  
kcal mol-1 Å-3 
𝑘𝑏,4 / 
kcal mol-1 Å-4 
Co core – O core 2.280 63.0 -162.8 121.5 
Ni core – O core 2.310 71.6 -150.6 141.2 
Zn core – O core 2.360 60.2 -354.7 137.1 
O core – H core 0.965 532.5 -1282.0 2004.0 
Three-Body: : 𝑘𝑎,2(𝜃 − 𝜃0)
2 +  𝑘𝑎,3(𝜃 − 𝜃0)
3 +  𝑘𝑎,4(𝜃 − 𝜃0)
4 
Interaction 
 
𝜃0 / ° 
𝑘𝑎,2 /  
kcal mol-1 rad-2 
𝑘𝑎,3 /  
kcal mol-1 rad-3 
𝑘𝑎,4 / 
kcal mol-1 rad-4 
Ni core – O core – Ni core 102.0 83.9 -113.1 0.0 
Zn core – O core – Zn core 107.0 82.2 -101.3 0.0 
Co core – O core – Co core 102.0 49.5 -50.0 0.0 
O core – Ni core – O core 135.0 -42.2 0.0 34.2 
O core – Zn core – O core 135.0 -39.5 0.0 32.1 
O core – Co core – O core 135.0 -42.7 0.0 34.7 
Ni core – O core – H core 120.0 14.9 -25.6 43.5 
Zn core – O core – H core 123.3 4.2 -21.1 61.2 
Co core – O core – H core 127.0 5.1 -23.8 10.5 
Cross terms: 𝐸𝑟𝑟′(𝑟 − 𝑟0)(𝑟
′ − 𝑟′0) 
 Bond-Bond Bond-Angle 
Interaction 
 
𝑘𝑏𝑏′  / 
kcal mol-1 Å-2 
𝑘𝑏𝑎  / 
kcal mol-1 Å-2 rad-1 
𝑘𝑏′𝑎  / 
kcal mol-1 Å-2 rad-1 
Ni core – O core – Ni core 12.25 -2.560 --- 
Zn core – O core – Zn core 18.55 -1.675 --- 
Co core – O core – Co core 14.88 -4.131 --- 
O core – Ni core – O core 20.25 -3.255 --- 
O core – Zn core – O core 15.19 0.469 --- 
O core – Co core – O core 20.63 -3.347 --- 
Ni core – O core – H core 2.90 1.550 0.1940 
Zn core – O core – H core 4.59 0.000 0.2859 
Co core – O core – H core 3.05 0.007 -0.1097 
Lennard-Jones: 𝜺𝒊𝒋 [𝟐 (
𝒓𝒊𝒋
𝟎
𝒓𝒊𝒋
)
𝟗
− 𝟑 (
𝒓𝒊𝒋
𝟎
𝒓𝒊𝒋
)
𝟔
] + 𝟑𝟑𝟐. 𝟏(
𝒒𝒊𝒒𝒋
𝒓𝒊𝒋
) 
Interaction 𝑟𝑖 / Å 𝜀𝑖  / kcal mol
-1 𝑞𝑖 / e 
Co core 6.235 0.028 0.830 
Ni core 6.010 0.036 0.730 
Zn core 6.280 0.020 1.070 
H core 1.098 0.013 0.460 
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The outcomes of these simulations are described below. Considering first the HDS-Nitrate 
system, it can be observed that the unit cell volume is less than 50% of the experimental value 
(Table 7.16). There is also a wide difference in the a-parameter and β-angle, with minor 
differences being recorded for the b-parameter and α, γ angles. 
Table 7.16: Optimised data obtained from GULP simulations of HDS-Nitrate and the published data. 
HDS-Nitrate 
Parameter 
Published 
[2] 
Optimised 
Percentage 
difference 
Volume / Å3 6023.76 2799.79 53.52 
There are clear structural differences between the published crystal structure of HDS-Nitrate 
(Figure 7.10A, [2]) and the GULP-optimised one presented in Figure 7.10B. The published 
structure shows an ordered arrangement of atoms whereas the simulated one, using the 
interatomic potentials listed in Table 7.13 to Table 7.15, is disordered with an apparent collapse 
in the interlayer space region. This may occur due to partial optimisation of the structure. 
 
Figure 7.10: Visual depictions of (A) the reference HDS-Nitrate material obtained from [2], and (B) the 
simulated structure in GULP. Zinc is grey, Oxygen is red and Nitrogen is blue. 
Attempts to model the HDS-Chloride material in silico also met with limited success. The volume 
of the optimised structure calculated is more than twice that observed experimentally (Table 
7.17), with significant differences in all unit cell parameters. 
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Table 7.17: Optimised data obtained from GULP simulations of HDS-Chloride and the published data. 
HDS-Chloride 
Parameter 
Published 
[19] 
Optimised 
Percentage 
difference 
Volume / Å3 7410.95 16195.70 118.54 
There is a high degree of order in the atomic arrangement in the published structure (Figure 
7.11A, [19]) which is lost in the GULP-optimised structure shown in Figure 7.11B. 
 
Figure 7.11: Visual depictions of (A) the reference HDS-Chloride material obtained from [19], and (B) the 
simulated structure in GULP. Zinc is grey, Oxygen is red and Chlorine is green. 
Both the HDS-Nitrate and HDS-Chloride materials have been successfully simulated in silico using 
Materials Studio [37], therefore, it is possible that the problems arising with the simulations in 
GULP are due to problems with the software. 
There are no published crystal structures for the mixed metal layer HDS materials (HDS-
Cobalt/Nitrate and HDS-Nickel/Nitrate). Both contain nitrate anions intercalated into the 
interlayer region, however, and therefore attempts were made to produce models using the 
known structure of the all-Zn HDS-Nitrate as a starting point [2]. Fractional occupancies allowed 
for compositional changes in the metal layers, with ions inserted according to the ratios in the 
structural formulae. 
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The HDS-Nickel/Nitrate structure could not be modelled with the GULP program, with bond 
lengths within the structure exceeding the limits described in the model during the calculations. 
However, this was not observed for the HDS-Cobalt/Nitrate structure, for which partial 
optimisation was achieved. The calculated unit cell volume is given in Table 7.18 which indicates 
there is an error in the force field. 
Table 7.18: Calculated unit cell volume obtained from GULP simulations of the HDS-Cobalt/Nitrate 
material and the published data of HDS-Nitrate. 
HDS-Cobalt/Nitrate 
Parameter 
Published 
[2] 
Optimised 
Percentage 
difference 
Volume / Å3 6023.76 3183.61 47.15 
As for the other structures, large differences between the published and modelled structures 
were noted. Overall therefore, while extensive effort allowed for partial optimisation of the HDS 
structures within GULP, none of the materials could be completely optimised. The data 
presented in Table 7.16 to Table 7.18 clearly demonstrate there is a high degree of variation 
between the published and the calculated data, which we believe arises because of restricted 
interatomic potentials, limited crystallographic data for the HDS materials and bond length 
tolerances with the GULP program. 
7.3.7 In Vitro Experiments 
7.3.7.1 Cell Viability 
There is very little cytotoxicity recorded following exposure of the RAW264.7 macrophages to 
the HDS materials (Figure 7.12). In all cases, viability is observed to be above 90 %. The HDSs 
show very similar results to the commercial adjuvant controls. The apparent biocompatibility of 
these materials is similar to that observed for both zinc oxide and cobalt oxide species in the 
literature [38-40]. However, nickel oxide has been reported to induce ca. 25% cell death of 
RAW264.7 cells following a 24 hr exposure period [41], which is not observed for the Ni-
containing HDS studied here. This suggests that the cytotoxicity of nickel is attenuated by its 
inclusion into the layer of an HDS. 
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Figure 7.12: Cell viability results. RAW264.7 macrophages were exposed to HDS microparticles at 476 
μg mL-1 for 24 hours. Cells exposed to commercial alums (Alhydrogel® and Adju-Phos®) at the same 
concentration were used for comparative purposes. Cell viability was quantified by Alamar Blue assays 
with n=3 with each independent experiment containing nine replicates. 
There is evidence of some cell death at the 28 hours post-adjuvant exposure point (Figure 7.12). 
This might be attributed to the doubling time of the cell line [42]; alternatively, it could be a 
temporary effect of the adjuvants, but nevertheless the cell numbers recover by the subsequent 
read point at 29 hours.  
7.3.7.2 Immunoassay Experiments 
Cytokine concentrations were quantified by means of an ELISA assay on the cell-free 
supernatants of the RAW264.7 cells. TNF-α concentrations appear to be relatively constant 
across the five HDS samples with concentrations in the range of ca. 50 – 60 pg mL-1 (Figure 7.13). 
All the materials perform on par with the commercial Alhydrogel control for TNF-α production, 
and instigate a greater amount of production than with Adju-Phos. The concentrations recorded 
lie in a similar range to those recorded for the AlO(OH) and LDH materials reported in Sections 
3.5.2 and 6.7.2. 
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Figure 7.13: TNF-α production in response to HDS adjuvants. RAW264.7 macrophages were exposed to 
HDS microparticles at 476 μg mL-1 for 24 hours. Cells exposed to commercial alums (Alhydrogel® and 
Adju-Phos®) were used for comparative purposes with lipopolysaccharide (LPS) as a positive control. 
TNF-α cytokine secretions were quantified by ELISA assays with n=3; each independent experiment 
contained nine replicates. 
There appears however to be some potential for tuning the immune response in terms of IL-6 
production (Figure 7.14). 
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Figure 7.14: IL-6 production in response to HDS adjuvants. RAW264.7 macrophages were exposed to 
HDS microparticles at 476 μg mL-1 for 24 hours. Cells exposed to commercial alums (Alhydrogel® and 
Adju-Phos®) were used for comparative purposes with lipopolysaccharide (LPS) as a positive control. IL-
6 cytokine secretions were quantified by ELISA assays with n=3; each independent experiment contained 
nine replicates. 
The HDS-Nitrate and HDS-Chloride species induce only low concentrations of IL-6, with no 
increase relative to the untreated cells control. In contrast, the other materials lead to much 
greater IL-6 production. The HDS-Cobalt/Nitrate material stimulates more IL-6, and appears to 
lead to approximately equal amounts of both IL-6 and TNF-α being produced; thus, it could be 
suggested that a balanced immune response may be evoked following application of this 
material. This is supported by the literature, since cobalt has been shown to induce both Th1- 
and Th2-type cytokines [43]. 
Furthermore, the remaining two HDS samples (HDS-Acetate and HDS-Nickel/Nitrate) produce 
much greater amounts of IL-6, with HDS-Acetate producing even more than the LPS positive 
control. These materials thus might be Th2-type polarisers (Figure 7.14). Overall, there is 
evidence that the elemental composition of the highly diverse class of HDS materials could 
provide a means of tailoring the immune response. 
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7.3.7.3 Fluorescent Microscopy 
All HDS materials were labelled with FITC and the RAW264.7 cells with the DAPI nuclear stain; 
giving rise to green and blue images under the fluorescent microscope, respectively. There is 
evidence of sample aggregation in the images shown in Figure 7.15 because no platelet 
morphology is obvious with most presenting as rod-like or spherical aggregates. 
The RAW264.7 macrophages appear to be located around the perimeter of the HDS samples 
which could suggest that they might elicit their immunogenic effect in a similar way to a 
proposed mechanism of AlO(OH), via lipid membrane disturbances, which would require direct 
contact of cells with the adjuvant particle [44]. 
 
Figure 7.15: Fluorescent microscopy with FITC-labelled HDS samples with DAPI nuclear staining; (A) cells 
alone, (B) Alhydrogel, (C) Adju-Phos, (D) HDS-Nitrate, (E) HDS-Chloride, (F) HDS-Acetate, (G) HDS-
Cobalt/Nitrate; and (H) HDS-Nickel/Nitrate. 
Confocal microscopy was undertaken but proved unsuccessful due to the semi-adherent nature 
of the murine macrophage cell line meaning that the cells ruptured during the transfer stage 
from the transwell plate, to the microscope slide. 
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7.4   Structure/property relationships 
Since the physicochemical properties of LDHs have been shown to control directly the immune 
response stimulated, we attempted to deduce similar relationships for the HDS materials. The 
results of these attempts are summarised in Table 7.19. 
There are no obvious linear relationships in these data (in contrast to those noted in previous 
chapters) which means that the physicochemical properties of the HDS materials and the 
immunological output of the RAW264.7 cells are more complex than such a simple relationship 
can describe. Therefore, polynomial and exponential plots were also explored to seek links 
between the two variables. Some plots are presented in Figure 7.16, with all others in Appendix 
5. 
Table 7.19: Relationships between experimental parameters and immunoassay data of the HDS 
materials; with particle size being derived by SEM analysis (μm) and zeta potential measurements in 
mV. 
Experimental 
parameter (x) 
Cytokine 
concentration 
/ pg mL-1 (y) 
Equation 
R2 
correlation 
Particle size 
TNF-α y = 1.708x + 57.367 0.0526 
IL-6 y = -113.28x2 + 225.83x -12.708 0.3232 
ZP in UP-water 
TNF-α y = -0.0418x + 60.554 0.0595 
IL-6 y = 0.0624x2 – 6.2942x + 196.55 0.4208 
ZP in UP-water 
(10 minutes) 
TNF-α y = 0.0014x2 – 0.1652x + 62.677 0.0805 
IL-6 y = 0.0456x2 – 5.1498x + 184.9 0.4497 
ZP in PBS 
TNF-α y = -0.0073x2 – 0.1757x + 61.066 0.5958 
IL-6 y = -0.1192x2 – 4.9702x + 55.402 0.4556 
ZP in PBS  
(10 minutes) 
TNF-α y = -0.0086x2 – 0.4402x + 56.664 0.9034 
IL-6 y = -0.0368x2 – 0.8831x + 90.414 0.4852 
Chapter 7 Hydroxy Double Salts as Vaccine Adjuvants 
 
284 
 
Figure 7.16: Graphical representation of the (A) TNF-α and (B) IL-6 cytokine concentrations correlated 
to particle size; and the (C) TNF-α and (D) IL-6 cytokine concentrations correlated with the zeta potential 
measurements recorded in PBS (10 minute-time point). With both linear (blue) and polynomial (red) 
correlations to highlight the differences in correlations. 
However, when altering the relationship type to polynomial, we obtain some degree of 
correlation, with a very strong relationship between TNF-α and the zeta potential measured in 
PBS (10 minute time point, see Figure 7.16). This finding suggests that it may be possible to tailor 
the TNF-α production by RAW264.7 cells by tuning the zeta potential of the HDS particles. 
Further attempts were made to deduce relationships between the simulated parameters for 
HDS-Nitrate, HDS-Chloride and HDS-Cobalt/Nitrate and the cytokine concentrations of TNF-α 
and IL-6, with the outcomes presented in Table 7.20. Selected plots are shown in Figure 7.17; 
all other plots are located in the Appendix 5. 
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Table 7.20: Relationships between simulated unit cell parameters for HDS-Nitrate, HDS-Chloride and 
HDS-Cobalt/Nitrate and immunoassay data.  
Simulated 
parameter (x) 
Cytokine concentration / pg mL-1 (y) Equation 
R2 
correlation 
Volume / Å³ 
TNF-α y = -0.0004x + 59.168 0.6736 
IL-6 y = -0.0015x + 51.815 0.2400 
a / Å 
TNF-α y = 0.4935x + 42.627 0.9995 
IL-6 y = -0.2456x + 47.942 0.0055 
b / Å 
TNF-α y = -0.7506x + 72.769 0.6661 
IL-6 y = -3.0718x + 107.69 0.2468 
c / Å 
TNF-α y = -0.1635x + 59.054 0.6453 
IL-6 y = -0.7055x + 52.138 0.2660 
α / ° 
TNF-α y = 0.1906x + 40.9 0.6510 
IL-6 y = 0.8109x – 25.266 0.2608 
β / ° 
TNF-α y = -0.1064x + 64.347 0.9993 
IL-6 y = 0.0491x + 37.415 0.0047 
γ / ° 
TNF-α y = -0.1995x + 75.975 0.6698 
IL-6 y = -0.8088x + 120.06 0.2435 
There are no strong linear relationships between the simulated data and the amount of IL-6 
produced in response to the samples with R2 values not exceeding 0.27. However, TNF-α output 
appears to be correlated to the GULP-simulated values for the a-parameter and β-angle, with R2 
values of 0.9995 and 0.9993, respectively (Table 7.20). The TNF-α concentration range is small, 
but the relationship nevertheless appears to be clear. 
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Figure 7.17: Graphical representation of the (A) TNF-α and (B) IL-6 cytokine concentrations correlated 
to the calculated a-parameter; and the (C) TNF-α and (D) IL-6 cytokine concentrations correlated with 
the calculated β-angle. 
The results presented here show that there is some evidence of tunability of the immune 
response to HDS materials. The chemical nature of the HDS materials appears to influence IL-6 
production, with a range of different concentrations being produced in response to the different 
chemical compositions and the HDS-Acetate material out-performing LPS for this cytokine. In 
the literature, it has been reported that both TNF-α and IL-6 cytokine concentrations vary with 
the HDS material [15] for human dendritic cells, and the findings reported here agree with the 
previous results, showing that this variation in response occurs across cell lines. Constant TNF-α 
production, observed here in response to the HDS materials, is not a trait of the RAW264.7 cells, 
with the literature providing evidence of TNF-α being predominantly produced cytokine over IL-
6 [45]. Therefore, it is likely that this response pattern is directly caused by the HDS samples.  
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The structurally-related class of layered double hydroxide (LDH) compounds has been shown to 
produce relatively consistent levels of TNF-α in RAW cells, regardless of chemical composition 
(see Section 6.7.2) [46, 47], and thus both families of materials behave the same in this regard 
(Figure 7.13). Some LDH materials have been suggested to exhibit Th1-polarising effects [48]; 
from the data reported here it is not possible to ascertain whether this is also possible for HDS 
systems, but it does appear the immune response can be tailored immune through variation of 
chemical composition. 
7.5   Conclusion 
A range of hydroxy double salt (HDS) materials were prepared and fully characterised. 
Simulating the structures of the HDS materials proved to be challenging owing to the need to 
develop and optimise a new force field that can build every HDS configuration, in addition to a 
lack of detailed structural information. Nevertheless, partial structure optimisation was 
achieved for the zinc hydroxynitrate, zinc hydroxychloride and zinc/cobalt hydroxynitrate 
species, with further work being required to achieve complete structure optimisation. 
In vitro and immunoassay investigations indicated the non-toxic nature of the HDS materials, 
and while all materials caused RAW264.7 cells to produce largely constant amounts of TNF-α, 
IL-6  production could be modulated through the composition of the HDS. As a result, it appears 
clear that this class of material might comprise a broad family of tuneable adjuvants. 
Attempts were made to seek relationships between physicochemical or simulated parameters 
of the HDSs and the immunological output of the RAW264.7 cells. The physicochemical 
properties returned no apparent correlations. However, TNF-α production appears to be highly 
correlated with two in silico parameters (a-parameter and β-angle). 
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8.1 Summary of Experimental Findings 
The aims of this project were to synthesise an array of different adjuvant candidates and test 
their adjuvant effect in vitro, with structure/property relationships being sought to link 
physicochemical properties of the samples to the immune response they stimulate. 
8.1.1 Particle Engineering of Aluminium Oxyhydroxide 
The work performed for this chapter demonstrated that it is possible to synthesise AlO(OH) 
materials from a variety of different Al-sources using hydrothermal processes. In general, sub-
70 °C temperatures in continuous plastic flow synthesis were shown to produce gibbsite [γ-
Al(OH)3] whilst temperatures exceeding 80 °C generated boehmite [AlO(OH)]. For reactions 
using a nitrate Al-source, sub-84 °C temperatures produced Al(OH)3 and above this temperature, 
phase transition to AlO(OH) occurred. However, although there is some evidence of particle size 
and morphology control through variation of the experimental parameters, in general the 
particles produced are largely spherical and fall in the size range 40 to 200 nm. The 
immunological output of these materials being on par or greater than the cytokine 
concentrations observed for commercially available alums (TNF-α and IL-6). 
Attempts to elucidate relationships between physicochemical properties of the nanoparticles 
and the immunological output by RAW cells found that the particle size appeared causative of 
the TNF-α output after exposure to samples synthesised using an Al-chloride source, with some 
much weaker evidence also found with those generated with an Al-nitrate source and via the 
continuous hydrothermal flow process (CHFS). 
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8.1.2 Particle Engineering of Hydroxyapatite Nanoparticles 
The hydroxyapatite nanoparticles produced were all of a similar size, 150 – 165 nm, but 
increasing the temperature of the reaction led to an increase in the number of morphologies 
within the collected sample. The lowest reaction temperature (70 °C) and washing the product 
with methanol produced solely spherical nanoparticles, while increasing the temperature by 10 
– 20 °C led to samples containing spherical and rod-like hydroxyapatite nanoparticles. However, 
when using deionised water as the cleaning solvent, spherical, rod-like and platelet shaped 
nanoparticles are obtained at 90 °C. 
In vitro experiments suggested an increase in morphology types may induce a weaker IL-6 
response from the RAW264.7 cells, with constant TNF-α concentrations. It is therefore possible 
that there may be potential for tuning the immune response through engineering the 
hydroxyapatite particles. There were no clear relationships between the physicochemical 
properties of the particles and the immunological output, however. 
8.1.3 Particle Engineering of Zinc Oxide Nanoparticles 
Control of the particle size of zinc oxide in the CHFS process requires the addition of Ti(II) salt to 
the reaction mixture. Increasing the concentration of the Ti(II) salt in the synthetic process 
corresponds to a decrease in size of the particles from 90 to 42 nm, as well as an increase in the 
number of particle morphologies present. For the largest sample size only spherical particles are 
obtained, with rod-like particles additionally being present in the medium-sized material 
generated in the presence of a small amount of Ti(II). Further, the smallest size material 
additionally contains platelet-shaped nanoparticles. The particle size was found to be strongly 
related to the zeta potential measured in phosphate buffered saline. 
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An increase in ZnO particle size corresponded to an increase in IL-6 production by RAW264.7 
cells in vitro, with the largest sample being more potent than the positive control. Cytokine 
production by RAW264.7 cells is strongly correlated to both the particle size and zeta potential 
of the ZnO materials, and thus particle engineering may provide a means of tailoring the immune 
response. 
8.1.4 The Immunological Properties of Layered Double Hydroxides 
A series of LDH materials was generated following literature protocols. All the samples exhibited 
platelet morphology, and an increase in the radius of the guest anion intercalated into the LDHs’ 
interlayer region appeared to lead to larger particles. It was also possible to synthesise LDH 
materials with two guest anions intercalated into the interlayer space, and to vary the balance 
of these depending on the reaction conditions. 
In vitro, the LDH materials induced fairly constant concentrations of TNF-α following exposure 
of RAW cells to these adjuvants, while an increase in the ionic size of the guest seemed to 
correspond to an increase in IL-6 production. Relationships between physicochemical properties 
and the immunological output were sought, with strong correlations being obtained for the 
mono-halide LDH species in terms of their particle size and zeta potential measurements, but 
weaker ones for the di-halide systems,. Clearly, varying the chemical composition may enable 
tuning of the immune response.  
Dehydrated LDH structures were simulated in silico, with the optimised unit cell parameters 
being found to be predictive of the immunological output of the RAW264.7 cells in some cases: 
as before, strong correlations were observed for the mono-halide LDHs and weak trends 
observed for the di-halide systems. 
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Finally, a suitable proxy for the zeta potential was obtained through computational modelling. 
The simulated value for the energy of the LDH structures could be used in place of the 
experimentally derived zeta potential measurements to predict the immune response using the 
equation previously derived [1]. This opens up the opportunity to undertake in silico screening 
of potentially thousands of LDH structures to identify lead candidates for a given vaccine 
scenario. 
8.1.5 Hydroxy Double Salts as Adjuvants 
HDS materials were successfully synthesised following literature protocols; all exhibit platelet 
morphologies and exist as microparticles. Limited success was obtained with in silico modelling 
of this class of material, with only [Zn5(OH)8](NO3)2·yH2O, [Zn5(OH)8]Cl2·yH2O and 
[Zn3.8Co1.2(OH)8](NO3)2·yH2O being simulated with any degree of success. Even then, it did not 
prove possible to fully optimise the structures because of problems arising with the interatomic 
potential parameters, bond lengths exceeding the maximum cut-offs placed on the system, and 
a lack of crystallographic insight into the locations of the  cobalt and nickel cations in the metal 
layer.  
In vitro the samples vary in terms of the IL-6 concentration they induce in RAW cells, but similar 
TNF-α concentrations are secreted in response to all the HDS materials. 
[Zn5(OH)8](CH3COO)2·yH2O stimulates extremely high IL-6 concentrations, greater than the 
positive control. Furthermore, the presence of two divalent cations in the layer 
([Zn3.8Co1.2(OH)8](NO3)2·yH2O and [Zn3Ni2(OH)8](NO3)2·yH2O) induces a marked increase in the IL-
6 concentration over the single-metal layer system, [Zn5(OH)8](NO3)2·yH2O.  
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Efforts to correlate the immunological output data to the unit cell parameters calculated in silico 
produced two strong relationships for TNF-α production. These parameters were GULP-
simulated values for the a-parameter and the β-angle of the HDS unit cell. In contrast, no clear 
correlations were found between the physicochemical properties of the HDS materials (such as 
zeta potential measurements and particle size). As noted for the LDH materials, changes in the 
chemical composition lead to different cytokine concentrations being stimulated in vitro, and 
this offers a route by which the immune response could be tuned. 
8.2 Comparison of Systems Explored 
There are a variety of different parameters that may affect the ability to tune the immune 
response. Of the five different materials investigated in this work, it seems that the LDH and HDS 
materials have the greatest potential as future adjuvants for the reasons set out below. 
The two types of layered material (LDH and HDS) possess a high degree of compositional 
variability due to their capacity to contain a wide variety of metals in the layer, and numerous 
guest anion species intercalated into the interlayer region. This work has shown that changing 
the composition of these materials has an impact on the elicited immune response, and 
therefore there is the potential to fine tune the immune response. 
The zinc oxide nanoparticles may lead to some modulation of the immune response, with potent 
IL-6 concentrations being stimulated in response to large particles. This could provide 
prophylactic treatment to diseases that would respond to such high cytokine concentrations. 
However, both the work undertaken here and the literature indicate that a Th2 immune 
response is overwhelmingly produced in response to ZnO. The existing alum adjuvants also drive 
a Th2 response, and therefore it is not clear that ZnO offers any major advantages here. 
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The remaining materials explored (aluminium oxyhydroxide and hydroxyapatite) appear to have 
less potential for exploitation: it is challenging to control the particle size and shape in the 
particle engineering approaches applied, and also these materials do not have the same degree 
of tuneability in the immune response provoked. 
8.3 Future Work 
8.3.1 Particle Engineering of Aluminium Oxyhydroxide 
In order to take this work further, further investigation into synthetic routes for AlO(OH) 
production, using alternative Al-sources within the continuous plastic hydrothermal flow 
synthesis (CPFS) process, could be considered. This would allow a broader range of systems to 
be explored, to determine to what extent the Al-source affects the product generated in terms 
of particle size and morphology. If it proved possible to tune these over a wider range, further 
exploration of their adjuvanticity would be warranted. 
8.3.2 Particle Engineering of Hydroxyapatite Nanoparticles 
Future work for these materials could include a more detailed assessment of the temperature 
at which the particle morphology changes, by performing reactions at a wider range of 
temperatures.  Investigations into the impact of other solvents on the calcium leaching from the 
hydroxyapatite nanoparticles would also be interesting to explore. If a greater degree of control 
over particle size, shape or composition could be obtained, then a further exploration of their 
adjuvant properties could be considered. 
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8.3.3 Particle Engineering of Zinc Oxide Nanoparticles 
The continuous hydrothermal flow synthesis (CHFS) process used for production of ZnO 
nanoparticles showed that increasing the concentration of Ti(II) in the reaction mixture resulted 
in a decrease in the size of the collected ZnO nanoparticles, as well as increasing the number of 
morphologies contained within each sample size. Therefore, future work could involve exploring 
a wider range of concentrations to see if the range of sizes/shapes which can be accessed could 
be expanded. In order to reduce the costs of the process and aid translation to the clinic, 
attempting to translate this synthetic route to the CPFS reactor and determine the effect of sub-
100 °C temperatures has on the obtained products would also be of interest. 
8.3.4 The Immunological Properties of Layered Double Hydroxides 
There are thousands of LDH systems in existence. The work done to date has shown their 
physicochemical properties to be causative of the immune response, and that the latter can be 
predicted a priori. However, because of time constraints only a limited number of systems has 
been used for calibration of the mathematical models developed. To take this work forward, 
further work is required to expand the range of systems explored, including the intercalation of 
immunogenic guests such as succinate and malate, and expand the relationships obtained to 
date across a wider range of structures. 
8.3.5 Hydroxy Double Salts as Adjuvants 
Future work for the HDS class of layered materials would require detailed crystallographic 
information about the exact atomic positions of the divalent metal cations, particularly the 
location of Co2+ and Ni2+ in the mixed metal species, to allow for simulations of the mixed metal 
sheet HDS materials to represent the composition of the synthesised sample without using 
fractional occupancies. Furthermore, extensive research and optimisation of the interatomic 
potential parameters described in this work would be beneficial, with the aim of refining the 
input data to successfully simulate the structures. 
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More broadly, a wider range of systems could be synthesised for exploration, including via the 
intercalation of immunogenic guest species such as succinate and malate, and their in vitro 
effect on RAW cells determined. This might lead to the recognition of relationships between the 
immunological output and the physicochemical properties or in silico data for the HDSs. 
8.4 Future Outlook 
In this work, the role of inorganic particulate matter as vaccine adjuvants is considered. Given 
the limitations of alum, in that it can only induce strong humoral (antibody) immune responses 
but not the cellular immunity required to combat intracellular pathogens or tumours, the 
development of new adjuvants is vitally important. The use of particle size and shape 
engineering has tremendous potential to generate adjuvants that can trigger enhanced or 
bespoke immune responses, as dose chemical composition control.  
It should be noted that there will be significant obstacles to moving a research adjuvant into the 
clinic. Regardless of the promise inorganic adjuvants present, to obtain approval from regulatory 
authorities, such as the FDA and European Medicines Agency, a range of in-depth studies will be 
required to ensure safety. Extensive toxicity screening must be undertaken to study both the 
extent and duration of local inflammation at the site of injection (e.g. pain, redness and swelling) 
and potential systemic issues (e.g. anaphylaxis, nausea, diarrhoea and carcinogenicity).  
Adjuvants also have the potential to induce autoimmune diseases, such as systemic lupus 
erythematosus, and even though the risk is incredibly small the impact on an individual would 
be high. The rate of elimination of the new particulate adjuvants will need to be robustly 
established. Extensive clinical trials will be required to demonstrate unequivocally the benefits 
of the proposed adjuvant compared to unadjuvanted immunisation and currently-licensed 
adjuvants.  
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Although the hurdles to patients benefiting from the new adjuvant materials being developed 
are thus high, in my opinion the immense benefit bestowed on humankind by vaccination means 
that the effort and cost involved in overcoming these will be worthwhile. It is also my view that 
use of particle engineering and chemical composition control will expand exponentially in the 
years to come, hopefully leading to the exploration of potent new adjuvant materials in the 
clinic. 
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Figure A1.1: Graphical representation of the relationships for CPFS-Chloride samples. Plots depict the 
relationship of zeta potential measurements using (A) UP-water, (B) PBS (initial), and (C) PBS (10 minute 
time-point) to particle size. 
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Figure A1.2: Graphical representation of the relationships for CPFS-Nitrate samples. Plots depict the 
relationship of zeta potential measurements using (A) PBS (initial), and (B) PBS (10 minute time-point) 
to particle size. 
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Figure A1.3: Graphical representation of the relationships for CHFS samples. Plots depict the relationship 
of zeta potential measurements using (A) UP-water (10 minute time-point), and (B) PBS (initial) to 
particle size. 
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Figure A1.4: Graphical representation of relationships for CPFS-Chloride materials with (A and B) 
particle size, (C and D) zeta potentials measured in UP water (initial), and (E and F) zeta potentials 
measured in PBS (initial), correlated to TNF α and IL-6 cytokine concentrations. 
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Figure A1.5: Graphical representation of relationships for the CPFS-Nitrate samples with (A and B) 
particle size, (C) zeta potentials measured in PBS (initial), correlated to TNF α and IL-6 cytokine 
concentrations. 
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Figure A1.6: Graphical representation of CHFS samples with  (A and B) particle size, (C) zeta potentials 
measured in UP water (initial), and (D and E) zeta potentials measured in PBS (initial), correlated to TNF 
α and IL-6 cytokine concentrations. 
 
Appendix 2 Particle Engineering of Hydroxyapatite Nanoparticles 
 
308 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 2: Particle Engineering of Hydroxyapatite 
Nanoparticles 
  
Appendix 2 Particle Engineering of Hydroxyapatite Nanoparticles 
 
309 
 
Figure A2.1: Graphical representation of the relationships for hydroxyapatite samples. Plots depict the 
relationship of (A) TNF-α, (B) IL-6 cytokine concentrations with zeta potential measurements in UP water 
(initial). 
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Figure A2.2: Graphical representation of the relationships for hydroxyapatite samples. Plots depict the 
relationship of (A) TNF-α, (B) IL-6 cytokine concentrations with zeta potential measurements in UP water 
(10 minutes). 
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Figure A2.3: Graphical representation of the relationships for hydroxyapatite samples. Plots depict the 
relationship of (A) TNF-α, (B) IL-6 cytokine concentrations with zeta potential measurements in PBS 
(initial). 
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Figure A3.1: Graphical representation of the relationships for ZnO samples. Plots depict the relationship 
of (A) TNF-α, (B) IL-6 cytokine concentrations with zeta potential measurements in UP water (initial). 
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Figure A3.2: Graphical representation of the relationships for ZnO samples. Plots depict the relationship 
of TNF-α and IL-6 cytokine concentrations with zeta potential measurements in (A) UP water (initial), 
and (B and C) in PBS (initial).
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Figure A4.1: Graphical representation of the mono-halide LDH materials. The zeta potential 
measurements recorded in (A) UP water (initial), (B) UP water (10 minutes), (C) PBS (initial) and (D) PBS 
(10 minutes) are correlated to the calculated lattice a-parameter. 
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Figure A4.2: Graphical representation of the relationships for mono-halide LDH samples. Plots depict 
the relationship of (A) TNF-α and (B) IL-6 cytokine concentrations with particle size and (C) TNF-α and 
(D) IL-6 cytokine concentrations with zeta potential measurements in UP water (10 minute time-point). 
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Figure A4.3: Graphical representation of the relationships for mono-halide LDH samples. Plots depict 
the relationship of (A) TNF-α and (B) IL-6 cytokine concentrations with zeta potential measurements in 
PBS (initial) and (C) TNF-α and (D) IL-6 cytokine concentrations with zeta potential measurements in PBS 
(10 minute time-point). 
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Figure A4.4: Graphical representation of the (A) TNF-α and (B) IL-6 cytokine concentrations correlated 
to calculated unit cell a-parameter; the (C) TNF-α and (D) IL-6 cytokine concentrations correlated with 
calculated unit cell interlayer spacing-parameter. 
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Figure A4.5: Graphical representation of the (A) TNF-α and (B) IL-6 cytokine concentrations correlated 
to calculated unit cell volume-parameter; the (C) TNF-α and (D) IL-6 cytokine concentrations correlated 
with difference in electronegativity. 
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Figure A4.6: Graphical representation of the relationships for di-halide LDH samples. Plots depict the 
relationship of (A) TNF-α and (B) IL-6 cytokine concentrations with particle size and (C) TNF-α and (D) IL-
6 cytokine concentrations with zeta potential measurements in UP water (10 minute time-point). 
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Figure A4.7: Graphical representation of the relationships for di-halide LDH samples. Plots depict the 
relationship of (A) TNF-α and (B) IL-6 cytokine concentrations with zeta potential measurements in PBS 
(initial) and (C) TNF-α and (D) IL-6 cytokine concentrations with zeta potential measurements in PBS (10 
minute time-point). 
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Figure A4.8: Graphical representation of the di-halide LDH materials’ (A) TNF-α and (B) IL-6 cytokine 
concentrations correlated to calculated unit cell a-parameter; the (C) TNF-α and (D) IL-6 cytokine 
concentrations correlated with calculated unit cell interlayer spacing-parameter, and the (E) TNF-α and 
(F) IL-6 cytokine concentrations correlated to difference in electronegativity. 
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Figure A4.9: Graphical representation of the di-halide LDH materials’ (A) TNF-α and (B) IL-6 cytokine 
concentrations correlated to calculated unit cell volume-parameter; the (C) TNF-α and (D) IL-6 cytokine 
concentrations correlated with calculated lattice energy-parameter. 
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Figure A4.10: Graphical representation of the relationships for combined mono- and di-halide LDH 
samples. Plots depict the relationship of (A) TNF-α cytokine concentrations with particle size, (B) IL-6 
cytokine concentrations with the zeta potential measured in UP water (initial), and (C) TNF-α and (D) IL-
6 cytokine concentrations with zeta potential measurements in UP water (10 minute time-point). 
Appendix 4 The Immunological Properties of Layered Double Hydroxides 
 
326 
 
Figure A4.11: Graphical representation of the relationships for combined mono- and di-halide LDH 
samples. Plots depict the relationship of the (A) TNF-α and (B) IL-6 cytokine concentrations with zeta 
potential measured in PBS (initial), and (C) TNF-α and (D) IL-6 cytokine concentrations with zeta 
potential measurements in PBS (10 minute time-point). 
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Figure A4.12: Graphical representation of the combined mono- and di-halide LDH materials’ (A) TNF-α 
and (B) IL-6 cytokine concentrations correlated to calculated unit cell a-parameter, and (C) TNF-α and 
(D) IL-6 cytokine concentrations correlated with the calculated unit cell interlayer spacing-parameter. 
Appendix 4 The Immunological Properties of Layered Double Hydroxides 
 
328 
 
Figure A4.13: Graphical representation of the combined mono- and di-halide LDH (A) TNF-α and (B) IL-
6 cytokine concentrations correlated to materials’ calculated unit cell volume; the (C) TNF-α and (D) IL-
6 cytokine concentrations correlated with calculated lattice energy-parameter, and the E) TNF-α and (F) 
IL-6 cytokine concentrations correlated with difference in electronegativity. 
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Figure A5.1: Graphical representation of the relationships for HDS samples. Plots depict the relationship 
of zeta potential measurements in UP water (10 minute-point) and PBS (10 minute time-point) with (A 
and B) ionic size, and (C and D) weighted mean of the metal cation’s electronegativity. 
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Figure A5.2: Graphical representation of the relationships for HDS samples. Plots depict the relationship 
of TNF-α and IL-6 cytokine concentrations with zeta potential measurements in (A and B) UP water 
(initial), (C and D) UP water (10 minute time-point), and (E and F) PBS (initial). 
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Figure A5.3: Graphical representation of the (A) TNF-α and (B) IL-6 cytokine concentrations correlated 
to calculated unit cell volume parameter; the (C) TNF-α and (D) IL-6 cytokine concentrations correlated 
with calculated unit cell  b-parameter, and the (E) TNF-α and (F) IL-6 cytokine concentrations correlated 
to calculated unit cell c-parameter. 
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Figure A5.4: Graphical representation of the (A) TNF-α and (B) IL-6 cytokine concentrations correlated 
with calculated unit cell α-angle, and the (C) TNF-α and (D) IL-6 cytokine concentrations correlated to 
calculated unit cell γ-angle. 
